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ABSTRACT 
Cartilage tissue engineering has been emerging as a promising therapeutic approach, 
where engineered constructs or scaffolds are used as temporary supports to promote regeneration 
of functional cartilage tissue. Hybrid constructs fabricated from cells, hydrogels, and solid 
polymeric materials show the most potential for their enhanced biological and mechanical 
properties. However, fabrication of customized hybrid constructs with impregnated cells is still 
in its infancy and many issues related to their structural integrity and the cell functions need to be 
addressed by research. Meanwhile, it is noticed that nowadays monitoring the success of tissue 
engineered constructs must rely on animal models, which have to be sacrificed for subsequent 
examination based on histological techniques. This becomes a critical issue as tissue engineering 
advances from animal to human studies, thus raising a great need for non-invasive assessments 
of engineered constructs in situ. To address the aforementioned issues, this research is aimed to 
(1) develop novel fabrication processes to fabricate hybrid constructs incorporating living cells 
(hereafter referred as “construct biofabrication”) for cartilage tissue regeneration and (2) develop 
non-invasive monitoring methods based on synchrotron X-ray imaging techniques for examining 
cartilage tissue constructs in situ.    
Based on three-dimensional (3D) printing techniques, novel biofabrication processes 
were developed to create constructs from synthetic polycaprolactone (PCL) polymer framework 
and cell-impregnated alginate hydrogel, so as to provide both structural and biological properties 
as desired in cartilage tissue engineering. To ensure the structural integrity of the constructs, the 
influence of both PCL polymer and alginate was examined, thus forming a basis to prepare 
materials for subsequent construct biofabrication. To ensure the biological properties, three types 
of cells, i.e., two primary cell populations from embryonic chick sternum and an established 
chondrocyte cell line of ATDC5 were chosen to be incorporated in the construct biofabrication. 
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The biological performance of the cells in the construct were examined along with the influence 
of the polymer melting temperature on them. The promising results of cell viability and 
proliferation as well as cartilage matrix production demonstrate that the developed processes are 
appropriate for fabricating hybrid constructs for cartilage tissue engineering.    
To develop non-invasive in situ assessment methods for cartilage and other soft tissue 
engineering applications, synchrotron phase-based X-ray imaging techniques of diffraction 
enhanced imaging (DEI), analyzer based imaging (ABI), and inline phase contrast imaging (PCI) 
were investigated, respectively, with samples prepared from pig knees implanted with low 
density scaffolds. The results from the computed-tomography (CT)-DEI, CT-ABI, and extended-
distance CT-PCI showed the scaffold implanted in pig knee cartilage in situ with structural 
properties more clearly than conventional PCI and clinical MRI, thus providing information and 
means for tracking the success of scaffolds in tissue repair and remodeling. To optimize the 
methods for live animal and eventually for human patients, strategies with the aim to reduce the 
radiation dose during the imaging process were developed by reducing the number of CT 
projections, region of imaging, and imaging resolution. The results of the developed strategies 
illustrate that effective dose for CT-DEI, CT-ABI, and extended-distance CT-PCI could be 
reduced to 0.3-10 mSv, comparable to the dose for clinical X-ray scans, without compromising 
the image quality. Taken together, synchrotron X-ray imaging techniques were illustrated 
promising for developing non-invasive monitoring methods for examining cartilage tissue 
constructs in live animals and eventually in human patients.   
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CHAPTER 1: INTRODUCTION 
1.1 Health challenge of cartilage damage 
Osteoarthritis (OA) is the leading cause of joint disability in North America [1,2]; 
Approximately 4.4 million Canadians aged 15 years and older (more than 10% of the total 
population) are reported to suffer from OA [2, 3]. Although osteoarthritis can emerge at any 
time, regardless of age, physical condition or ethnic background, it is most common among 
seniors aged 75 years and older [4]. The prevalence of OA is observed to be higher among 
women than men: average women to man ratio of 1.5 [3]. It is expected that due to the aging of 
the population and the obesity epidemic [1], the number of affected Canadians will increase to 
approximately 10.4 million by 2040 [3]. Cartilage injuries in weight-bearing articulating joints 
caused by traumatic and sport-related events are also serious health problems that mainly affect 
young populations [5]. In addition to causing disability in the joints, cartilage injuries can be the 
onset for gradual degeneration of the tissue and initiation and progression of OA. OA and 
traumatic cartilage injuries pose large financial and lifestyle costs to the patients [5]. Significant 
clinical challenges with management of cartilage defects mainly stem from the limited intrinsic 
ability of cartilage to regenerate; the lack of vascular supply and sparse amount of cells 
(chondrocytes) residing in mature cartilage contribute to such limited healing capacity [6]. 
Although different clinical techniques are currently used for resurfacing the articular cartilage 
defects to alleviate the pain and restore some of the function, the results are inconsistent and not 
successful for long-term treatment [7, 8]. This often results in arthroplasty or total joint 
replacement procedure for end-stage cartilage or joint pathology.  
 
1.2 Cartilage tissue engineering 
New techniques that aim to promote regeneration of functional cartilage through different 
approaches, referred to as tissue engineering (TE) and regenerative medicine, could revolutionize 
joint treatments over the next decades [7]. The three main elements of the TE approaches are 
cells, scaffolds and biological-biomechanical signals. Scaffolds are three-dimensional (3D) 
structures contain characteristics essential for tissue regeneration, and can perform as carriers of 
cells and/or biological signals (e.g. growth factors, proteins, serum). The emerging TE 
techniques include categories of cellular and acellular (cell-free), and scaffold-based and 
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scaffold-free techniques. Clinical results from cell-based techniques that do not use scaffolds, 
such as autologous chondrocyte implantation, have shown variable results, which can partly be 
related to the lack of a supportive scaffold to guide and organize tissue matrix synthesis [7]. The 
major advantages of scaffold-based techniques over scaffold-free approaches include increased 
control over the geometry and size of the engineered tissue graft with better stability, possibility 
of in vitro culture and tissue synthesis prior to implantation, a less technically challenging 
procedure during in situ implantation, and, most importantly, providing a 3D environment 
favorable for cellular activities [7, 9]. 
In scaffold-based approaches, a suitable biomaterial scaffold could be incorporated with 
cells (primary chondrocytes or undifferentiated stem cells) and/or bioactive molecules (e.g., 
growth factors) [10, 11] to produce a supportive environment in which the cells can lay down 
cartilaginous extracellular matrix (ECM) as the foundation for new tissue formation. Cell-free 
scaffolds are often incorporated with bioactive molecules to encourage infiltration of native cells 
from the body into the scaffold upon implantation. When cell-based scaffold techniques are used 
the construct could initiate synthesis of tissue matrix in vitro prior to implantation; other cell 
sources (such as stem cells and allogenic chondrocytes) could be used in case of limited 
available autologous chondrocytes. In either case, the dynamic interaction of cells, scaffold, and 
bioactive molecules is believed to be essential in the success of TE approach [12, 13].  
A wide range of materials and approaches have been used for developing 3D scaffolds for 
regenerating cartilage tissue. When cartilage tissue scaffolds are designed, different initial 
properties are often considered such as scaffold material biocompatibility, degradability, 
suitability for cellular activities, and mechanical strength. Mechanical characteristics are required 
to maintain the structural integrity of the scaffold throughout fabrication and handling (in vitro 
and/or during implantation procedure), protect the in-scaffold cells from excessive forces, and 
withstand the in vivo loading environment until the newly regenerated tissue can assume a load-
bearing function [14].  
 
1.3 Design and fabrication of cartilage tissue scaffolds 
Exceptional biomechanical behavior of articular cartilage is largely attributed to its 
biphasic composition as well as the complex biochemistry and physical structure of its ECM. 
Natural articular cartilage is usually described as a biphasic material comprised of a fluid phase 
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(mainly water); 65-80 % (by weight), and a solid phase (collagen and proteoglycan); 20-35% 
[15]. The interaction of the liquid and solid phases results in the highly elastic and load 
absorbing performance of the articular cartilage. Furthermore, mature articular cartilage is 
organized into four different zones; superficial, middle (or transitional), deep, and calcified 
zones, from the articulating surface down to the subchondral bone [16]. Cartilage ECM 
composition and structure, as well as chondrocytes morphology and arrangement, vary through 
these zones, which results in zonal variation of mechanical properties and functionality against 
different types of mechanical loadings, e.g. tensile, shear, and compression. To develop more 
functional tissue scaffolds that can provide conducive environments for cellular activities and 
cartilage tissue regeneration, some of the natural characteristics of articular cartilage tissue can 
be incorporated in the structure and/or material composition of the scaffold. For example, 
biphasic and zonal-structure tissue scaffolds, inspired by natural properties and organization of 
cartilage tissue, could directly or indirectly introduce stimulations beneficial for formation of 
more natural-like cartilage tissue substitutes [17]. Successful development of such designed and 
relatively complicated 3D scaffolds is dependent on employed fabrication methods.  
Hydrogels (highly hydrated polymer networks) and solid synthetic polymers are typical 
materials used for constructing cartilage scaffolds. Hydrogels are easy to be prepared and 
embedded with chondrocytes, and are able to retain chondrocyte phenotype and morphology 
through cell impregnation [18, 19]. However, hydrogels have poor mechanical strength, which 
limits their application to cartilage TE [20]. Polyester-based materials could be used for making 
scaffolds with superior mechanical characteristics [5, 21], but are less favorable for cellular 
activities than hydrogels. One approach to develop more functional scaffolds is to recruit both 
types of materials--hydrogels and solid polymers--in making hybrid constructs with synergistic 
properties. In such hybrid scaffold, polyester-based solid structure provides a reinforcing 
skeleton for mechanical strength and hydrogel provides a cell delivery/supportive matrix within 
the solid framework [21, 22]. By meeting these two essential properties, hydrogel-solid hybrid 
scaffold emerges as effective strategy for articular cartilage TE through mimicking the biphasic 
nature and function of the articular cartilage [5]. Successful implementation of such synergistic 
properties into the tissue scaffold or construct depends on the employed fabrication technique.  
Fabrication of scaffold is one of the important factors in the success of cartilage TE as it 
can influence the scaffold properties including structural architecture, mechanical properties, 
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biocompatibility, and biological properties [23]. Conventional fabrication methods often rely on 
prefabrication of the solid framework and then manual perfusion of the hydrogel (with or without 
cells) into the framework. Such methods result in non-uniform distribution of hydrogel and cells 
throughout the construct, and do not allow design-based, reproducible fabrication of structurally 
complex hybrid construct from dissimilar materials of cells, hydrogels, bioactive molecules, and 
polyester polymers (e.g. constructs with designed cell distribution). The conventional fabrication 
techniques also demand post-fabrication cell seeding which is inefficient, time consuming, and 
cumbersome. The aforementioned fabrication issues negatively affect the scaffold function, the 
quality of regenerated tissue, and clinical translation of the technique due to limited 
reproducibility at economic cost and speed [24]. Advances in this regard can be achieved by 
using high-end technologies such as 3D printing for biofabrication of tissue engineering 
constructs. Computer-controlled, design-based, and multi-material fabrication features of the 3D 
printing technology can facilitate fabrication of hybrid 3D constructs from cells and multiple 
scaffold materials (e.g. polyester polymers and hydrogels). The 3D printing can also address the 
issues of reproducibility and difficulties with making constructs that have customized external 
geometry and internal architecture.  
In order to develop a hybrid 3D printing-based method that can print living cells along 
with other materials into a construct, hereafter referred to as biofabrication process, parameters 
of materials processing condition are required to be studied and optimized. Materials printability, 
physical stability, and processing conditions cytocompatibility are factors that can potentially 
affect the success of 3D printing hybrid biofabrication. Often fabrication processing conditions 
that are suitable for accurate printing of polyesters and hydrogels are not cytocompatible or 
optimally suitable for biological activities of incorporated cells. Organic solvent-dissolved or 
high temperature-melted polyesters, stiff, high concentration or cross-linked hydrogels are 
examples of materials conditions suitable for 3D printing of physically and mechanically stable 
constructs [25]. However, organic solvent-free, low temperature-melted polymers, soft and low 
concentration hydrogels are more favourable conditions for cell viability, proliferation, and 
differentiation. Therefore, 3D printing-based hybrid biofabrication processes that maintain both 
physical and structural integrity as well as cytocompatibility and conducive cellular environment 
in the construct must be sought. The performance of the optimized biofabrication process must 
be verified by long-term assessment of cellular activities in the hybrid constructs. It is 
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noteworthy to mention that cell types from different tissue origins or differentiation phases could 
have different sensitivity or resistance to 3D printing process and materials conditions. As such, 
evaluating the biocompatibility of hybrid 3D printing process for incorporating different cell 
types is also importance to be investigated.  
 
1.4 Non-invasive assessment of cartilage tissue engineering 
The success of TE in repairing damaged cartilage tissue has to be verified both in vitro 
and in vivo. The functionality of employed strategies must be monitored and assessed at different 
time points throughout the tissue regeneration in order to understand the TE repair process and 
further modify and improve the approach for better regeneration results. Different conventional 
methods, such as histological and molecular biology techniques and microscopy, have long been 
used for evaluating the structure and biochemical composition of tissue constructs in vitro. 
However, conventional methods have limitations for application to animal in vivo studies and 
human trials. Due to the destructive and invasive procedure involved in the conventional 
methods, animals of in vivo studies have to be sacrificed at different time points during a 
longitudinal study in order to excise the repaired tissue/constructs for further assessments. With 
the advances in TE technology and the need for performing more animal model studies and 
eventually clinical human trials, the conventional assessment methods will not be efficient. As 
such, new assessment methods are required to be developed to enable longitudinal non-invasive 
evaluation of cartilage TE repair in vivo through a follow-up intermediate assessment on 
individual animal models. Advanced biomedical imaging techniques can significantly facilitate 
tissue engineering technology through non-invasive imaging and evaluation methods. 
Synchrotron radiation (SR)-based X-ray imaging techniques have shown great promise 
for non-invasive, quantitative, and qualitative visualization of soft tissues with detailed structural 
information. Novel X-ray imaging techniques that are based on refraction contrast mechanisms-
phase-based imaging- rather than absorption mechanisms have shown promising capabilities for 
resolving histological and structural details of low density materials such as cartilage [26-29], 
which is invisible in clinical radiography. Such phase-based X-ray imaging techniques hold 
promise for non-invasive imaging of low density TE scaffolds and newly formed cartilage tissue 
in situ (in the body). Therefore, new non-invasive assessment methods can be developed based 
on phase-based imaging techniques to monitor the functionality of tissue scaffolds and new 
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tissue regeneration dynamically throughout longitudinal in vivo studies. By using non-invasive 
assessment methods, longitudinal in vivo studies can be performed more realistically, efficiently, 
and economically without the need for scarifying a large number of animals. Furthermore, 
dynamic information on the functionality and degradation of TE scaffolds as well as neocartilage 
tissue formation and remodeling could be obtained at intermediate time-points throughout the 
repair process in situ. Such information would largely contribute to the improvement and 
optimization of tissue engineering strategies including the design and material properties of the 
tissue scaffolds for promoting better repair results. 
 
1.5 Research objectives 
This research is aimed to develop 3D hybrid scaffold bioprinting and non-invasive 
assessment techniques for cartilage tissue engineering applications. Advanced 3D printing 
technology has the potential for fabricating tissue constructs with advanced properties such as 
making biphasic (solid-gel) structure with spatially-controlled distribution of cells in the 
construct. It is hypothesised that a cytocompatible 3D printing-based hybrid biofabrication 
process, based on co-deposition of melt-polymer and cell-impregnated hydrogel solution, can be 
developed which enables maintaining of both reproducible physical integrity and biological 
functionality of the printed hybrid construct. Furthermore, advanced phase-based X-ray imaging 
techniques have great potential to be investigated and employed for non-invasive assessment of 
tissue scaffolds and cartilage repair in situ. Potentials of such biomedical imaging techniques are 
needed to be investigated for developing non-invasive methods that can facilitate current 
longitudinal animal in vivo studies as well as follow-up assessments of the future human trials. 
Therefore, the specific objectives of this thesis are as follow: 
 
1) To develop a 3D printing-based biofabrication process for making reproducible hybrid 
tissue constructs from cartilage cells, hydrogel, and solid polyester materials, 
2) To identify suitable processing conditions of melted polymer and non-cross-linked, 
low concentration hydrogel for cytocompatible 3D bioprinting of cell-impregnated 
hybrid constructs with structural integrity and biological functionality,  
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3) To evaluate the cytocompatibility of the 3D hybrid printing process with different cell 
types (two primary cell populations and one chondrogenic cell line), and to assess 
their long term biological activities in the 3D hybrid constructs in vitro, 
4) To develop non-invasive assessment methods for visualization and characterization of 
cartilage tissue scaffolds in situ using different synchrotron radiation, phase-based X-
ray imaging techniques; and 
5) To develop low dose non-invasive assessment methods for safe and efficient cartilage 
tissue engineering applications to future longitudinal animal in vivo studies and 
possible human clinical trials.  
 
1.6 Organization of the dissertation 
The dissertation is organized into 6 chapters. In addition to this Introduction (Chapter 1), 
it includes four manuscripts (Chapters 2, 3, 4, and 5), followed by a final section (Chapter 6) 
summarizing the Conclusions drawn from this research and suggestions for future studies.  
Chapter 2 is a comprehensive literature review on the two main aspects of this research--
scaffold design and fabrication techniques for cartilage tissue repair and imaging-based 
evaluation techniques for cartilage tissue engineering applications. The first section of the 
literature review focuses on cartilage tissue injuries and clinical treatments, the importance of 
scaffold design and the effect of scaffold properties on tissue regeneration, cartilage scaffold 
fabrication techniques, and recent strategic designs of hybrid and zonal scaffolds for cartilage 
tissue regeneration. The second section of the literature review chapter focuses on the 
conventional assessment techniques in tissue engineering, major synchrotron phase-based X-ray 
imaging techniques, and their applications in cartilage tissue engineering. 
Chapter 3 describes development of a hybrid 3D printing biofabrication process for 
making designed hydrogel-solid (alginate-polycaprolactone(PCL)) constructs impregnated with 
cartilage cells. The thermal effect induced during melted-polymer printing is investigated for 
identifying the cytocompatible processing condition of PCL polymer. A suitable processing 
condition is also identified for structurally stable, 3D printing of non-cross-linked, low 
concentration alginate into the hybrid construct. Long-term biological performance and 
chondrogenic activities of different cell populations, 3D-printed in the hybrid constructs, are also 
discussed.  
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Chapter 4 presents a novel synchrotron-based X-ray imaging technique for visualization 
and characterization of low density cartilage tissue scaffold implanted in situ in the knee joint of 
an animal model. The explored technique is also compared with clinical gold standard imaging 
technique of MRI as well as a conventional synchrotron X-ray imaging method.  
In Chapter 5, three SR phase-based X-ray biomedical imaging techniques of computed 
tomography (CT)-diffraction enhanced imaging, CT-analyzer-based imaging, and CT-phase-
contrast imaging are examined and compared for development of a non-invasive assessment 
method for cartilage tissue engineering applications. Furthermore, different strategies are 
investigated in this chapter to optimize the radiation dose and scan time of the developed non-
invasive methods for safe and practical applications to future animal in vivo studies. Different 
quantitative and qualitative assessment criteria were developed and used for evaluation and 
comparison of the low dose imaging strategies. Moreover, the potential of the techniques for 
other soft tissue imaging and assessments applications such as in rheomotology diagnosis was 
also discussed. 
Chapter 6 presents the conclusions drawn from this research and the suggestions and 
recommendations for possible future research. 
 
1.7 Contributions of the primary investigator  
The manuscripts included in this thesis are co-authored; however it is the mutual 
understanding of all authors that Zohreh Izadifar, as the first author, is the primary investigator 
of the research work. The contributions of other authors are greatly appreciated and 
acknowledged in this thesis. 
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CHAPTER 2: LITERATURE REVIEW 
This chapter provides a literature review on the two main aspects of this thesis: (1) biofabrication 
of strategically designed tissue scaffolds for cartilage repair, and (2) synchrotron-based X-ray 
imaging techniques for cartilage tissue engineering assessment applications. The contents of this 
chapter are divided into two sections, which have been published as "Izadifar Z, Chen X, Kulyk 
W. (2012) Strategic design and fabrication of engineered scaffolds for articular cartilage repair. 
Journal of Functional Biomaterials. 3(4): 799-838", and published as parts of "Olubamiji AD, 
Izadifar Z, Chen DX. (2014) Synchrotron imaging techniques for bone and cartilage tissue 
engineering: potential, current trends, and future directions. Tissue Engineering Part B Reviews. 
20(5): 503-522". “According to the Copyright Agreement, "the authors retain the right to include 
the journal article, in full or in part, in a thesis or dissertation". The most recent literature review 
(2013-2015) on these two aspects of the thesis are provided in the Chapters 3-5. 
 
2.1 STRATEGIC DESIGN AND FABRICATION OF ENGINEERED SCAFFOLDS 
FOR ARTICULAR CARTILAGE REPAIR 
 
2.1.1 Abstract  
Tissue Engineering has raised the hope for the repair of articular cartilage with the help of 
biocompatible supportive structures, called scaffolds. Over the past two decades, different 
designs and fabrication techniques have been investigated for developing TE scaffolds suitable 
for the construction of transplantable artificial cartilage tissue substitutes. Advances in 
fabrication technologies now enable the strategic design of scaffolds with complex, biomimetic 
structures and properties. In particular, scaffolds with hybrid and/or biomimetic zonal designs 
have recently been developed for cartilage tissue engineering applications. This review discusses 
critical aspects of the design of engineered scaffolds for articular cartilage repair as well as the 
available advanced fabrication techniques. In addition, recent studies on the design of hybrid and 
zonal scaffolds for use in cartilage tissue repair are highlighted. 
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2.1.2 Introduction 
Articular cartilage is a specialized tissue that covers the ends of the bones in articulating 
joints. It provides a low friction, highly elastic surface [1] that can withstand dynamic 
compressive loads several times body weight [2]. This behavior is attributed to the complex 
biochemistry and physical structure of the cartilage extracellular matrix (ECM), which is 
secreted by the chondrocyte cells that reside therein. Unfortunately, the natural healing ability of 
human articular cartilage is extremely limited, which poses significant clinical challenges for the 
treatment of joint cartilage defects [3]. These include articular cartilage degeneration resulting 
from osteoarthritis (OA), a debilitating joint disease that affects ~70% of the population aged 65 
years and older [4]. In addition, articular cartilage lesions resulting from traumatic joint injuries 
in children and young adults are a serious health problem with, at present, no entirely satisfactory 
clinical management solution [5]. Although some clinical treatments are available for articular 
cartilage repair [6], their success to date has been limited as they do not result in long-term 
correction of cartilage pathologies [1].  
Tissue engineering (TE) aims to replace damaged articular cartilage with a long-lasting 
biomanufactured replacement tissue, and holds great promise as an effective treatment for joint 
repair. Most cartilage tissue engineering strategies incorporate three main components: a suitable 
biocompatible scaffold, live chondrocytes or multipotent mesenchymal cells capable of 
developing into chondrocytes, and a combination of appropriate bioactive molecules (e.g., 
growth factor proteins (GFs)) [7,8]. It is hoped the dynamic interaction of these components will 
generate a transplantable artificial tissue construct that integrates well with normal articular 
cartilage and approximates its unique biomechanical properties [9,10]. The TE scaffold is 
typically a three-dimensional (3-D) structure manufactured from synthetic polymers and/or 
natural biopolymers to provide temporary mechanical physical and biological support for the 
embedded chondrocytic cells; this in turn promotes their growth ex vivo, maintains their 
phenotype, and encourages their production of cartilage-specific extracellular matrix 
components. In addition, the fabricated scaffold exerts control over the shape and volume of the 
engineered cartilage tissue construct [11–14]. Accordingly, scaffold design and manufacturing 
techniques are critical elements for successful cartilage tissue engineering.  
Because cartilage tissue engineering is aimed at creating artificial constructs for use in 
joint cartilage repair, this review will begin with a synopsis of relevant features of normal 
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articular cartilage structure and the pathology of osteoarthritic cartilage breakdown. The main 
body of this review will focus on critical considerations in the design of scaffolds for cartilage 
TE and the fabrication techniques currently available. Finally, I discuss recent and promising 
advances in biomimetic scaffold construction, including the use of hybrid solid 
polymer/hydrogel scaffolds and zonal scaffolds to manufacture cartilage tissue substitutes that 
more closely replicate the biomechanical characteristics and stratified organization of natural 
articular cartilage.  
 
2.1.2.1 Structure and organization of natural articular cartilage 
Articular cartilage is a smooth, partially translucent tissue that covers the distal ends of 
bones in diarthrodial joints of the body, such as the knee and elbow. It provides a deformable, 
low friction surface that facilitates the movement of articulating bones within the joint and is 
capable of supporting high dynamic compressive loads. The unique biomechanical properties of 
articular cartilage are attributable to the composition of its specialized extracellular matrix 
(ECM), which is the secretory product of its single resident cell type: chondrocytes. Although 
cartilage ECM contains a plethora of molecular components [5,15], it is primarily comprised of 
fibrils of type II collagen protein together with a cartilage-specific proteoglycan, aggrecan 
(Figure 2.1A). The collagen II fibrils, which account for up to 60% of articular cartilage dry 
weight [16], provide the tissue with high tensile strength and the ability to withstand shear 
stresses. In contrast, the aggrecan proteoglycans (which comprise ~35% of cartilage dry weight) 
confer cartilage tissue with the ability to support high compressive loads. Each individual 
aggrecan molecule consists of a polypeptide core protein from which extend numerous 
covalently linked glycosaminoglycan (GAG) side chains, specifically chondroitin sulfate and 
keratan sulfate polysaccharides. Molecules of link protein, which associate with the base of each 
aggrecan core protein, mediate the attachment of numerous aggrecan monomers to a common long 
hyaluronan polysaccharide chain (Figure 2.1A). This creates huge supramolecular cartilage 
proteoglycan complexes embedded within the collagen II fibril network. The high negative charge 
densities of the chondroitin sulfate and keratan sulfate GAG side chains of the entrapped aggrecan 
complex create an osmotic potential that draws water into the cartilage ECM from the synovial 
fluid of the joint cavity and other adjacent tissues. Therefore, articular cartilage consists of up to 
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80% water with respect to total wet weight. Indeed, the fluid phase of articular cartilage is a critical 
factor for its load-bearing function [16]. 
 
Figure 2.1 Principal components and zonal organization of articular cartilage tissue:  
(A) fibrils of type II collagen, proteoglycan complexes composed of aggrecan and hyaluronan, 
and chondrocytes cells; (B) zonal chondrocytes; and (C) zonal collagen fibers. ((B) and (C) are 
reproduced from Buckwalter et al. [17]). 
Natural articular cartilage has a layered or “zonal” organization (Figure 2.1B,C). Its four 
layers, going from the articular surface down to underlying subchondral bone, are usually termed 
the superficial zone, the middle (or transitional) zone, the deep zone, and the calcified zone [18]. 
These zones differ with respect to the molecular composition and organization of the cartilage 
ECM, the shape and density of the resident chondrocytes, and their mechanical properties. The 
superficial zone, which faces the synovial joint cavity, represents 10%–20% of total articular 
cartilage thickness. It is characterized by densely packed, tangentially oriented, fine collagen 
fibrils [19] and a relatively low proteoglycan content [20]. The superficial zone is the layer 
primarily responsible for bearing tensile and shear stresses [21]. The middle zone (40%–60% of 
articular cartilage thickness) is characterized by randomly oriented collagen fibrils [18] and the 
highest proteoglycan content [2], which may contribute to the higher compression modulus in 
this zone [22] caused by the larger osmotic water swelling effect. The deep zone (30%–40% of 
articular cartilage thickness) exhibits radially oriented, larger diameter collagen fibers and a 
lower proteoglycan content than the middle zone [20,23]. The cell density of chondrocytes 
decreases from the superficial zone to the deep zone, and their morphology changes from a 
flattened discoidal shape in the superficial zone, to a more spherical shape in the middle zone, to 
a slightly elongated form in the deep zone [24] (Figure 2.1B). The calcified zone provides a 
transition between the hyaline cartilage tissue of the overlying zones and the basal subchondral 
Hyaluronic 
acid 
backbone
Core protein
Chondroitin sulphate
Keratan sulphate
Link protein
Aggrecan molecule
Chondrocytes
Collagen
A
Superficial zone
B C
 16 
 
bone [5]. Within the calcified zone, the cartilage ECM is mineralized and type II collagen is 
replaced by a distinct type X collagen. 
2.1.2.2 Cartilage injuries, osteoarthritis (OA), and traditional cartilage repair strategies 
Traumatic joint injuries, abnormal joint loading, and degenerative joint diseases can all 
cause defects in articular cartilage tissue. Unfortunately, cartilage tissue has an extremely limited 
ability for self repair. This is attributed to its lack of both a vascular supply and any intrinsic 
mesenchymal stem cell population to facilitate tissue regeneration. Physical trauma to the knee 
or other articular joints can lead to several types of focal cartilage lesions, which are classified as 
chondral lesions, osteochondral lesions, and microfractures. Chondral defects solely affect the 
articular cartilage layer and do not extend to the underlying subchondral bone. In osteochondral 
lesions, the damage extends through the articular cartilage into the subchondral bone [5]. 
Microfractures, or fractures in the cartilage that are not visible to the naked eye but affect the 
collagen network [25], can lead to further matrix destruction upon repeated loading [17]. 
Because of the inability of articular cartilage to repair itself, the initial focal cartilage damage 
leads to abnormal compressive loading and increased mechanical stress in the surrounding 
healthy cartilage, which gradually expands the area of articular damage. Over a period of years, 
this leads to a gradual erosion of the articular cartilage layer of the joint, resulting in 
osteoarthritic disease. In the end stages of osteoarthritic disease progression, the articular 
cartilage is totally destroyed thus exposing the subchondral bone [5]. This results in debilitating 
joint pain and severely reduced joint mobility. Due to the potential of traumatic joint injuries to 
initiate osteoarthritic disease progression, and the serious clinical consequences of late stage OA, 
there is tremendous interest in developing improved therapies for articular cartilage repair. 
Nonsurgical treatment of OA includes activity modification, physical therapy, dietary 
supplements, weight loss, anti-inflammatory drugs (e.g., aspirin, ibuprofen, Celebrex), and 
injections of viscous hyaluronan preparations into the synovial cavity [5]. These mainly alleviate 
the pain and discomfort in the arthritic joint without correcting the underlying pathology. Current 
surgical therapies include arthroscopic microfracture, autologous chondrocyte implantation 
(ACI) [26], osteotomy, and arthroplasty. In microfracture surgery, damaged cartilage is removed 
at the site of lesion and the subchondral bone is microfractured to stimulate a healing response 
from subchondral bone mesenchymal stem cells and growth factors. However, the repair tissue 
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induced by microfracture treatment is predominantly fibrocartilage that contains more type I 
collagen than type II collagen and has inferior biomechanical properties to articular cartilage 
[27]. In ACI, articular chondrocytes isolated from a healthy non-load-bearing region of a 
patient’s joint are expanded in tissue culture and subsequently reimplanted into the site of the 
cartilage lesion [28]. The tissue formed following ACI can be hyaline articular cartilage (~15% 
of cases) or fibrocartilage [29,30]. The scarcity of source material, donor site morbidity, and the 
requirement for multiple invasive surgeries limit the use of ACI [5]. Osteotomy decreases 
pressure in the defected area by reshaping the bone to shift the mechanical axis of bearing load to 
the healthier part of the joint. Osteotomy can temporarily restore knee function and decrease 
osteoarthritic pain, but over the long term often results in joint deterioration and eventual 
arthroplasty [31]. Arthroplasty, or joint replacement surgery, is the treatment for end-stage OA 
and involves replacement of the arthritic joint by an artificial prosthesis. Eventual loosening and 
deterioration of the prosthetic implant, and possible stress shielding effect induced damage to the 
adjacent bone, are some limitations of arthroplasty surgery. Moreover, arthroplasty is unsuitable 
for child and adolescent patients whose skeletons are still growing and who require a long-term 
solution [5]. Indeed, the common problem in most current therapies is their inability to provide 
long-term relief and resumption of activity [5]. The aim of cartilage tissue engineering is to 
promote long-lasting, functional repair of defective articular cartilage lesions through the 
development and ex vivo manufacture of implantable artificial cartilage tissue substitutes. 
2.1.3 Scaffold design for cartilage tissue engineering 
Design of TE scaffolds for cartilage repair generally includes customization of biochemical 
and physical properties for better engineering of cartilage tissue constructs [32]. Biochemical 
design concerns chemical composition and biological properties of the scaffold, which mainly 
affect the cellular behavior and activity. Physical design concerns the internal and external 
scaffold architecture, mechanical properties, and degradation properties. This review discusses 
physical design considerations of engineered scaffolds with a brief discussion of the typical 
backbone materials used for cartilage tissue engineering.  
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2.1.3.1 Scaffold backbone materials 
The scaffold material is one of the main design factors to be considered in scaffold-based 
cartilage TE. The chosen material should meet several criteria, including biocompatibility, 
mechanical strength, cell affinity and ability to promote cartilage tissue formation, and adjustable 
biodegradability. The mechanical properties of the material are particularly important for 
cartilage TE applications due to the load-bearing nature of the target tissue. More precisely, a 
scaffold material must maintain its structural integrity and stability during fabrication, clinical 
handling, and fixation at the implant site [33]. It should also protect the embedded cells from 
harmful mechanical stresses and withstand the in vivo loading environment until the newly 
formed tissue can assume the load-bearing function. Furthermore, it should provide a desirable 
environment for biological activities such as cell attachment, proliferation, differentiation, and 
cell–cell interaction [5,32,33]. Hydrogels (highly hydrated polymer networks) and solid 
polymers are typical scaffold materials and have been widely investigated for cartilage tissue 
engineering (Figure 2.2).  
 
Figure 2.2 Examples of (A) hydrogel; and (B) solid scaffolds. 
Hydrogels are easily prepared and embedded with chondrocytes, which retain their 
phenotype and morphology through impregnation [34,35]. Hydrogels can be made of a wide 
variety of biomaterials, including natural materials, which may be carbohydrate-based (e.g., 
alginate, agarose, chitosan, hyaluronic acid (HA)), protein-based (e.g., fibrin glue, collagen type 
I and II, silk) [5,28], or some combination of the two, and synthetic materials, such as 
poly(hydroxyethyl methacrylate), polyethylene glycol and its derivatives, or poly(vinyl alcohol) 
(PVA) [36]. Hydrogels exhibit characteristics similar to soft tissues and therefore provide a 
supportive matrix for chondrocyte activity and cartilage ECM secretion both in vitro and in vivo 
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[37–40]. High efficiency of cell encapsulation and uniform cell distribution within the hydrogel 
are advantages that influence the quality of formed tissue. However, hydrogels have very weak 
mechanical properties that limit their application for cartilage TE [41]; for example, their 
compression moduli can range from 10% to 20% [42,43] to 50% [44] of natural cartilage values. 
Limited control over shape and internal structure is another issue that makes architectural design 
of hydrogel scaffolds difficult. A comprehensive review of hydrogel scaffolds for cartilage TE is 
given in [45].  
Polyester-based solid scaffolds are generally created from biocompatible synthetic 
materials and have superior biomechanical properties to those based on hydrogels [1,5]. 
Furthermore, these materials allow easier fabrication of scaffolds with designed shapes and 
internal architectures. Some frequently used synthetic polymers in cartilage TE include poly 
(glycolic acid) (PGA), poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), poly-
caprolactone (PCL), and poly(ethyl glycol) (PEG), all of which received FDA approval more 
than 20 years ago. Created by chemical processes, synthetic polymers allow for easier 
customization of material properties, e.g., mechanical and degradation properties, compared to 
hydrogel materials. PCL- and PGA-based scaffolds with exactly the same structure exhibit 
markedly different mechanical properties; for example, the aggregate modulus of a PCL-based 
scaffold was 0.787 MPa compared to 0.173 MPa for a PGA-based scaffold [46]. Mechanical 
modulus values of scaffolds made of poly(glycerol sebacate) (PGS) polymer, a newly developed 
biomaterial, can be increased to the range of native articular cartilage by material modifications 
that include changing the molar ratios of glycerol:sebacic acid and increasing the polymer curing 
time [47]. Although their adjustment can improve scaffold mechanical strength, material 
properties should still allow for gradual hydrolytic attack and degradation of the temporary 
scaffold [48] and replacement by neocartilage. Although mechanically suitable for cartilage TE, 
solid synthetic scaffolds have shown less affinity for cell adhesion and activity than hydrogels 
[28]. Different techniques have been used to improve surface cell adhesion and bioactivity of 
synthetic polymers, such as blending or copolymerization with hydrophilic/hydrophobic 
materials including chitosan [49], polymethacrylic acid [50], fibronectin and collagen [51,52], 
and chondroitin sulfate molecules [36]. A review of polymeric materials for cartilage tissue 
engineering is given in Puppi et al. [53]. Recently, decellularized tissue materials (i.e., shattered 
natural cartilage ECM) have been used to create solid scaffolds for cartilage TE [54–56]; natural 
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ECM proteins and structures present in the decellularized scaffolds promote good cell affinity 
and ECM formation.  
2.1.3.2 Scaffold physical architecture  
As natural cartilage tissue originally develops in a 3D environment, there are distinct 
advantages of using 3D vs. 2D scaffold structures, including better maintenance of chondrocyte 
morphology and differentiation [48,57] and higher expression of genes that regulate cell 
activities and ECM production [58,59]. The most commonly used 3D scaffold architectures in 
cartilage TE are porous 3D sponges and nonwoven fibrous structures (Figure 2.3A,B) [60]. 
Gradient fibrous structures [61], whose architectural properties vary through the depth of 
scaffold (Figure 2.3C), and woven architectures [46] (Figure 2.3D) have also been developed for 
cartilage TE. Different design parameters within these architectures, including pore size and 
geometry, pore distribution, pore accessibility and tortuosity, and porosity, play significant roles 
in the morphology, composition, mechanical properties, and functionality of the neocartilage 
[48,62–64].  
 
Figure 2.3 Different scaffold structural designs for cartilage tissue engineering: (A) 3D sponge 
[57]; (B) fibrous [57]; (C) gradient [61]; and (D) woven [46]. 
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The influence of scaffold pore size on cartilage formation has been studied [65–67]. The 
presence of both macro and micropores are important in 3D scaffolds, as macropores (>50 µm) 
promote cell migration [68] and micropores promote cell–cell interaction and mass transport, 
which improve tissue formation especially in vivo [69]. Titanium alloy constructs with a small 
average pore size (13 μm) form thicker cartilage tissue with significantly greater proteoglycan and 
cell density than those with larger pore sizes (43 and 68 μm) [67]. Larger pore sizes (400 μm) in 
nonwoven fibrous scaffolds cultured with cells result in a significantly larger GAG content 
compared to constructs with 100 and 200 μm pore sizes [70]. Lien et al. [71] show that pore sizes 
between 250 and 500 μm in scaffolds are appropriate for chondrocyte proliferation and ECM 
secretion. Cell response and chondrogenesis may vary with pore size and influence different 
components of tissue formation, such as cell phenotype and activity as well as the amount and 
composition of ECM; small pore sizes might help maintain chondrocyte phenotypes, as 
chondrocytes are more likely to differentiate when the pore size is about 30 times the cell diameter 
(10–15 µm) [72–74]. On the other hand, larger pore sizes increase the extension of ECM. In other 
words, small pore sizes increase the tendency for cell proliferation, while large pore sizes benefit 
the formation of ECM [71]. Gradient structures [61] or composite scaffolds (micro to macropore 
structures [69]) that exhibit a range of pore sizes can better facilitate both chondrocyte activity 
and secretion of ECM. In addition to pore size, scaffold fiber size affects the cell activity. 
Relatively large fiber diameters (hundreds of micrometers) in fibrous scaffolds negatively 
influence cell function because they present as a more two dimensional (2D) attachment surface 
for individual cells [21]. Chondrocytes seeded on nanofiber meshes show better chondrogenesis 
than on larger fiber scaffolds [75]. 
High degrees of porosity and pore interconnectivity are essential factors in the design of 
scaffolds, because they allow for initial cell or cell–carrier substance impregnation into and 
through the scaffold, further cell–cell interactions, mass transfer of nutrients and metabolites, and 
tissue growth [32]. Highly porous substrates provide for more cell attachment (about four times) 
than less porous substrates and result in more cartilage tissue formation [76]. Although this 
might be due to a greater chance of nutrient and metabolite transfer in more porous scaffolds, the 
exact factor(s) responsible for higher cell spreading and ECM production in the highly porous 
substrate are not known. Practically speaking, there is a compromise between porosity and 
mechanical properties of the scaffold, where the degree of stiffness tends to decrease as porosity 
 22 
 
increases [77]. As a result, scaffolds should be designed to provide an interconnected pore 
network with enough overall porosity while maintaining sufficient strength and stiffness [69,78]. 
Sponge scaffold designs generally have higher porosities than fibrous scaffolds [57], although 
the porosity of fibrous scaffolds can be precisely controlled in the fabrication process [61]. 
Woven scaffolds have compact structures with low porosity (70% [79]) and limited 
interconnectivity [21], which may cause inhomogeneous cell seeding and tissue growth as well 
as reduced nutrition transfer throughout the scaffold [46,80,81]. Gradient structures with varying 
porosities might allow tailoring of both mechanical and architectural properties with minimal 
compromise.  
Pore interconnectivity can influence the ability of a scaffold to support chondrogenesis as 
well as the quality of formed tissue, even in scaffolds with similar porosities [57,82]. 
Interconnected structures with open pores are more capable of facilitating homogeneous cell 
seeding and better nutrient dispersion throughout the construct [21]. Lack of sufficient pore 
interconnectivity can cause inhomogeneous chondrogenesis, with cartilage formation only evident 
on the peripheral boundaries of TE constructs [83,84]. Sponge scaffold architecture is largely 
controlled by the fabrication process rather than design parameters [85], and thus there is no 
control over the interconnectivity of the pores. A comparison of 3D sponge and organized 
fibrous scaffolds shows that the sponge scaffold contains random pores with tortuous paths, a 
lower average pore size (about five times smaller), and a higher specific area [57]. In addition, 
sponge architectures have a higher chance of pore blockage (filtration effect) than fibrous 
architectures. As the diffusion coefficient of a structure is directly proportional to porosity and 
inversely proportional to tortuosity, diffusion of nutrients is less in sponge structures than 
organized fibrous structures despite both architectures having similar porosities. This difference 
may not result in different cartilaginous tissue growth in vitro [57]; however, in vivo 
implantation revealed more chondrogenesis in the organized fibrous scaffold that had a denser 
and more homogeneous structure. These results demonstrate the effect of scaffold architecture as 
well as the importance of considering differences between in vitro and in vivo environments 
when designing scaffolds. 
The design of pore distribution using natural cartilage as a model has also been 
investigated in oriented porous polymer scaffolds [86], fiber-reinforced scaffolds [87], and 
gradient pore size structures [61]. In the latter study, growth of cartilaginous tissue in fibrous 
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scaffolds with three different fiber spacings along the length of scaffold (large to small spacing 
from bottom to top) was investigated for mimicking the zonal structure of natural cartilage. 
Results indicate that an anisotropic scaffold architecture can promote inhomogeneous tissue 
formation; however, it cannot produce zonal cartilage matrix similar to natural tissue. Different 
parameters in the architectural design of a scaffold may not have similar effects on all 
components of engineered cartilage, and different combinations of these parameters may 
differently influence cartilage tissue formation. For instance, scaffold architecture and pore size 
may not influence the formation of collage type II [57,66] and total collagen content [67]. 
However, chondrocyte proliferation and GAG content are improved in scaffolds with small pore 
sizes (<20 µm) (more cell–cell interaction) [65]. Thus, it is important to investigate how the 
various components of scaffold architectural design influence the individual biological properties 
of the engineered cartilage construct. Table 2.1 summarizes some of the architectural properties 
of scaffolds, with ranges of associated values for two commonly studied designs (sponge and 
fibrous) in cartilage TE applications.  
In contrast to solid scaffolds, hydrogels do not provide much flexibility for creating 
structures with defined internal architectures. Few efforts have been able to develop 
architecturally designed hydrogel scaffolds [88–91] and, therefore, the effect of architectural 
parameters on chondrogenesis, as has been considered for solid scaffolds, is yet to be 
determined. However, the significant influence of other hydrogel scaffold design parameters, 
such as macromere molecular weight and wt % concentration [92,93], as well as the structure of 
the polymer network (e.g., mesh size) [94–96], on the synthesis and distribution of engineered 
cartilage ECM has been investigated. Higher wt % concentration of HA hydrogels can better 
upregulate collagen type II and proteoglycan content [92]. However, the higher density of the 
hydrogel network impedes the distribution of deposited ECM, which interferes with the 
mechanical properties of the formed tissue construct [93]. The structure of the hydrogel network, 
controlled by the polymer chemistry and gelation mechanism [94,96,97] can dictate the spatial 
distribution of formed ECM by influencing the diffusion of nutrients and the degradation profile. 
To engineer a functional cartilage tissue construct, a fine balance among these design parameters 
must be achieved. A review of design aspects for hydrogel scaffolds along with examples of 
successful hydrogel systems for impregnation of chondrocytes are given in Nicodemus and 
Bryant [97]. 
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Table 2.1 Typical architectural properties of sponge and fibrous scaffold structures. 
Scaffold 
Avg. Pore 
size (µm) 
Porosity 
Surface area 
(mm2/mm3) 
Interconnectivity Fiber size References 
Sponge 50–500 48%–95% 55.6 
<100% 
(low cut off value*) 
-- [37,98–102] 
Fibrous 
Macro fibers 
Micro/nano fibers 
100–1650 
20–80 
48%–87% 
84%–90% 
16.5 
-- 
100% (high cut off value) 
-- 
30–250 µm 
60–100 µm 
[21,34,61,70, 
85,103–106] 
*cut off value; fraction of total pores that are 100% interconnected. 
2.1.3.3 Mechanical properties  
The load-bearing nature of the joint environment in which the engineered 
scaffold/construct will be implanted must be considered when designing the mechanical 
properties of the scaffold. Design considerations with respect to mechanical strength will depend 
on whether the scaffold will be used in vitro or in vivo. If the scaffold will be implanted into an 
articular joint in vivo shortly after fabrication, its mechanical characteristics should ideally match 
those of natural cartilage to support the loads encountered in the joint. The peak force applied to 
knee cartilage during normal physiological loading ranges from 1.9 to 7.2 times body weight [107], 
which corresponds to about 0.84 to 3 MPa for a 70 kg person [108]. If the scaffold is designed to 
initially promote engineered tissue growth in vitro before implantation in vivo, it may not require 
the same level of mechanical strength as natural cartilage. This is because the scaffold will largely 
act as a supportive environment to help formation of the tissue construct. Rather, the newly formed 
tissue or neocartilage–scaffold construct (partially developed cartilage) must achieve the required 
mechanical properties to replace the damaged tissue in vivo [5].  
In addition to the initial strength of the backbone material, architectural properties can 
play an important role with respect to the overall mechanical properties of the scaffold. The 
dynamic stiffness of 3D fibrous scaffolds [57] is higher than 3D sponge scaffolds, and close to 
that of bovine articular cartilage [85] and human knee cartilage [109], even when both scaffolds 
are made of exactly the same material. Poly-l-lactide acid (PLLA) sponge scaffolds (300 µm 
pore sizes and 90% and 95% porosities) and fibrous scaffolds (1 mm pore sizes and 85% 
porosity) can all exhibit mechanical properties (compression Young’s modulus) similar to that of 
natural cartilage [110]. 
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Mechanical properties of scaffolds are also influenced by the variation of architectural 
parameters, such as porosity [69,111], pore size [70,111], pore shape [112,113], fiber diameter 
[1], and fiber spacing [85]. Fibrous scaffolds with different macropore and macro/micropore 
porosities have varying mechanical properties [69]. El-Ayoubi et al. [69] demonstrated the 
design of scaffold architectures that result in similar mechanical properties to bovine articular 
cartilage and a good environment for cell attachment and activity. Sponge scaffolds with 
macropores ranging from 300 to 500 µm have varying mechanical properties, with those of 
lower porosity best resembling the performance of rabbit articular cartilage in compression and 
stress relaxation tests [111].  
The effect of pore size on the mechanical properties of woven chitosan-HA copolymeric 
fibrous scaffolds was studied by Yamane et al. [70]. Chondrocyte-seeded scaffolds with the 
smallest pore size (100 µm) had a larger compression modulus than scaffolds with 200 or 400 
µm pore sizes. However, after 28 days of cultivation, the scaffolds with the smaller pore sizes 
had reduced compression moduli while the two others (specifically 400 µm) had increased 
compression moduli and significantly enhanced ECM production. Thus, the scaffold with the 
larger pore size presents a better environment for developing a stronger tissue substitute. 
Increased ECM content can also be accompanied by improved mechanical properties [114,115]. 
The influence of pore shape on the mechanical properties of cartilage TE scaffolds [112,113] and 
constructs [113] as well as chondrogenesis [116,117] has also been studied. Chondrocytes 
produce more robust ECM (higher sulfated GAGs) in the presence of ellipsoidal pores than 
cubical pores. Jeong and Hollister [113] show that a 3D spherical pore-shaped scaffold enhances 
chondrogenic activity compared to cubical pore shapes. When the porosity and surface area of 
the scaffolds were kept similar, increased chondrogenesis in spherical pore-shaped scaffolds was 
attributed to the lower permeability, subsequent higher cell aggregation and GAG retention, and 
lower oxygen tension within the scaffold. The significant influence of a pore shape on scaffold 
mechanical properties (i.e., stiffness and nonlinearity) and in vivo-generated cartilage tissue 
constructs has also been demonstrated [113]. Scaffolds with pore size gradients [61] or oriented 
structural parameters [46] exhibit associated anisotropic mechanical properties, which can be 
employed to mimic anisotropic biomechanical properties of natural articular cartilage. These 
observations demonstrate the importance of simultaneously considering different factors for 
achieving the most appropriate design for cartilage TE scaffolds.  
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Hydrogel scaffolds have intrinsically weak mechanical properties for in situ placement in 
cartilage. Although architectural properties, similar to those used for solid scaffold design, may 
not be used for modifying hydrogel properties, other strategies have been investigated for 
improving the initial mechanical properties of hydrogels; this includes mixing with other 
molecules or polymers [118–121], using cross-linking agents [122], and changing macromere 
chemistry, molecular weight, and polymer concentration [96,121,123]. In the latter two studies, 
the compression modulus of the scaffolds created ranged from 0.005 to 2.6 MPa, comparable to 
that of healthy human articular cartilage. However, these modification methods can introduce 
chemical toxicity and impair nutrient diffusion [124]. Hydrogels with low initial mechanical 
properties can promote the formation of constructs with high mechanical strength (i.e., 
compressive and dynamic modulus) compared to hydrogels whose mechanical strength is 
initially higher [93]. As a result, design considerations for the initial mechanical properties of 
hydrogels should be balanced with parameters that control the synthesis of tissue ECM.  
The design of TE scaffolds for cartilage repair should also consider mechanical 
compression, tensile, and shear properties to achieve functionality similar to natural cartilage. 
However, scaffolds in most studies have been designed and tested with respect to one or two 
mechanical properties at the expense of others. Compression properties have received more 
attention in scaffold mechanical design than tensile and shear properties. 3D-woven structures 
made of polymeric biocompatible yarns [46,70] demonstrate considerable improvements in some 
mechanical properties, such as nonlinear, anisotropic mechanical properties, as well as high 
tensile strength and stiffness. One potential research area for the mechanical design of scaffolds 
is the investigation of the optimum architecture for improved mechanical properties. A study of 
the molecular/cellular structure and organization of the human body’s 
musculoskeletal/cytoskeletal system shows that the specific architectural framework of a 
structure (e.g., a tensegrity structure) can maximize its strength, flexibility, and structural 
integrity with minimum employed mass [125]. Such framework architectures could be 
investigated with respect to TE scaffolds for cartilage applications.  
Overall, the design of scaffolds with adequate mechanical strength is challenging. Currently 
available cartilage TE scaffolds still require mechanical property improvements, as mostly remain 
inferior to natural human cartilage with respect to supporting the loads at the damaged site. 
Moreover, excellent mechanical properties of TE scaffolds do not guarantee the growth of cartilage 
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tissue substitutes with mechanical properties similar to natural cartilage. To date, the mechanical 
properties of most engineered hyaline cartilage substitutes remain largely inferior to natural 
cartilage [68,126–129]. For instance, mechanically stimulated agarose disks with seeded cells 
had an aggregate modulus of 0.1 MPa (0.1–2.0 MPa for natural cartilage) [68], and agarose and 
chitosan constructs cultivated for 20 days had compression moduli of 0.028 and 0.011 MPa, 
respectively [130], both of which are lower than values for native cartilage (Table 2.2). Although 
scaffolds with sufficient mechanical strength can protect the healing site and may indirectly 
influence the quality of neocartilage, numerous factors should be considered with respect to the 
regeneration of native-like engineered cartilage in terms of mechanical properties. Furthermore, 
changes in mechanical properties during in vitro culture or after in situ implantation are very 
important considerations for scaffold design. Such changes are closely linked to the degradation 
rate and profile of the scaffold in vitro or in vivo. This relationship has been explored to advance 
designs that consider changes in scaffold mechanical properties in culture or during in vivo 
healing time. Time-dependent mechanical properties have been modeled during degradation 
based on the change in microstructure and/or material properties of the scaffold [131]. A profile 
of change in scaffold mechanical properties has also been designed [132] based on a proposed 
profile of degradation [48]. Consequently, the variation of scaffold mechanical properties while 
in vitro or in vivo can be controlled/customized using factors that govern the degradation 
process. Table 2.2 shows the range of some biomechanical properties for natural human cartilage 
and cartilage TE constructs. Different mechanical tests (e.g., compression, tensile, and shear 
tests) have been used to evaluate the mechanical function of TE cartilage scaffolds, constructs, 
and natural cartilage. These mechanical properties have been described in detail and the 
associated testing procedures for cartilage TE applications have been comprehensively reviewed 
in Little et al. [133]. 
Table 2.2 Biomechanical properties of natural human cartilage and cartilage tissue engineering 
constructs with associated ranges.  
Mechanical properties  
Healthy human 
articular cartilage 
References 
Cartilage TE 
construct 
References 
Tensile Young’s modulus (MPa) 5–25  [134–136] 0.089–400 [34,46,137,138] 
Ultimate tensile stress (MPa) 15–35 [139,140] 5.27–85 [34,46,137] 
Compression Young’s modulus (MPa) 0.24–0.85 [141–143] 0.005–5.9 [46,70,123] 
Complex shear modulus (MPa) 0.2–2.0 [144] 0.023–0.11 [46,145] 
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2.1.3.4  Degradation properties 
Scaffold degradation is an important aspect in the design of TE scaffolds as it can affect 
the formation and/or functionality of new tissue, as well as the response of host tissue [146]. 
Ideally, the rate of scaffold degradation should be proportional to the rate of tissue formation to 
ensure sufficient mechanical support at the defect site until the new tissue can fully assume load-
bearing function [48]. The implementation of this strategy is practically challenging. The 
degradation properties of scaffolds depend on and can be modified by variables including 
biomaterial type and composition [18], surface chemistry [147], scaffold local environment 
[132], and architecture [148]. These factors can be used in the design of scaffolds to customize 
their degradation behavior during cartilage tissue growth in vitro or in vivo. Manipulation of the 
scaffold material has been a common strategy to control degradation behavior. The degradation 
behavior of naturally-derived scaffolds is largely influenced by the intrinsic properties of the 
material, over which there is very limited control. Some strategies used for controlling the 
degradation rate in naturally derived solid/hydrogel scaffolds include change of material 
deacetylation degree [5,149], chemistry [150], molecular weight, wt % concentration [151,152], and 
combination with other polymers [94]. For polymeric scaffolds, strategies such as alteration of 
polymer/copolymer composition and molecular weight [153,154], crystallinity [155], and 
incorporation of additives [155] have been undertaken to modify degradation behavior. Local 
environmental parameters such as temperature and pH are also factors that affect material 
degradation [155,156] by accelerating/decelerating hydrolysis processes. Mechanical loading 
(i.e., dynamic loading) also accelerates degradation of scaffolds in vitro [157], which is an 
important factor to be considered with respect to the design of scaffolds for in vivo cartilage TE 
applications. 
Architectural properties affect the degradation of polymeric scaffolds [158–160], with 
scaffolds of higher porosity or smaller pore sizes degrading more slowly than those with lower 
porosity or larger pore sizes. This is attributed to the greater thickness of pore walls and the 
associated earlier autocatalysis hydrolysis inside the struts [156], and domination of bulk 
degradation over surface degradation. Although the exact involvement of each degradation 
mechanism has not been quantitatively determined, both pore wall thickness (bulk degradation) 
and surface area (surface degradation) of the scaffold should be considered with respect to 
scaffold degradation. For hydrogels, the structure of the gel, namely the mesh size of the cross-
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linked network, influences the degradation profile [161], with highly cross-linked hydrogels 
(smaller mesh size) exhibiting longer degradation times. The difference between scaffold 
degradation behavior in in vitro and in vivo microenvironments [162–164] indicates the 
importance of considering the properties of the actual in vivo microenvironment (e.g., the 
presence of enzymes) when strategies for scaffold degradation control are developed for cartilage 
TE applications.  
2.1.4 Fabrication of designed scaffolds 
Creation of TE cartilage scaffolds can be as challenging as scaffold design. The fabrication 
process must generate a scaffold with a reproducible architecture, which can function as designed for 
a specific period of time in the load-bearing environment of a joint (if implanted shortly after 
implantation) [32,48]. The choice of manufacturing method can influence different characteristics 
of the scaffold, including structural architecture, mechanical properties, biocompatibility, and 
biochemical properties (cell/bioactive agent incorporation) [165]. 
Current fabrication techniques include solvent casting, particulate leaching, melt molding, 
phase separation, freeze-drying, and gas foaming [48,58,166]. Some methods, such as freeze-
drying, can generate porous scaffolds containing both small (e.g., 15 to 35 µm) and large (>200 
µm) pore sizes [167,168]. Using these conventional techniques, scaffold properties can only be 
controlled by process and equipment parameters rather than design parameters [85]. Thus, 
scaffold architectural design parameters (e.g., pore size, geometry, interconnectivity, 
distribution) cannot be precisely controlled or customized. Extensive use of highly toxic solvents 
and extreme processing conditions (e.g., high temperature, pressure) in most of the current 
fabrication methods [48] are disadvantages for advanced designs and strategies, such as 
incorporation of viable cells and bioactive molecules during scaffold fabrication (termed 
biofabrication) [165]. Detailed information along with the pros and cons associated with these 
current techniques are summarized by Hutmacher [48] and Sachlos and Czernuszka [169]. 
Textile technologies, including classical nonwoven textile and electrospinning, are other 
methods for fabrication of highly porous scaffolds from polymer fibers. Electrospinning methods 
build scaffolds from micron/submicron fibers that are similar to the size of collagens in the ECM 
of cartilage [34]. Briefly, the electrospinning process involves creations of an electrically 
charged jet of polymer that is ejected across a high voltage electric field. The spinning polymer 
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fibers lay randomly on a grounded collecting screen to create a scaffold. These fine-fiber-based 
electrospun structures can have better mechanical properties than other fiber-based scaffolds 
[34,170,171], such as similar tensile properties to human cartilage [171]. Although electrospun 
scaffolds can have superior stiffness and tensile strength, more studies are required to test their 
mechanical performance (e.g., compression, shear strength) in both dry and hydrated conditions. 
Some advantages and limitations of electrospinning techniques that should be considered in 
designed-based scaffold fabrication are summarized in Table 2.3. In terms of design-based 
scaffold fabrication, electrospinning has the capacity to create meshes with aligned nanofibers 
that resemble the anisotropic structure and mechanical properties of cartilage tissue [172–174]. 
Although electrospinning methods can create oriented fibers, to date the anisotropy of the 
electrospun fibers is only controllable in one direction; therefore, scaffolds with greater 
architectural complexity (e.g., gradient structure, spatially controlled properties) cannot be easily 
created. Focused melt electrospinning has introduced some improvements by enabling deposition 
of patterned nanofibers [175], which could be advanced to fabrication of 3D scaffolds with more 
complex, designed structures for cartilage TE. Melt electrospinning has also been successfully 
tested for direct deposition of nanofibrous polymers onto the cells in vitro [176], which has the 
potential to be improved for biofabrication of scaffolds with incorporated cells and/or bioactive 
molecules for cartilage TE applications. 
Additive manufacturing (AM) techniques, also known as rapid prototyping (RP), is a  
computer-controlled fabrication technique that enables reproducible fabrication of scaffolds with 
designed internal and external architecture [32,169]. In brief, the scaffold model, designed or 
customized (i.e., based on medical images of defect area) by computer-aided design (CAD) 
software, is physically built layer by layer using selective materials as specified by a computer 
program [32,48]. Two main categories of AM techniques used for cartilage TE include 
extrusion-based (e.g., melt/dissolution plotting [57,177,178]) and particle/polymer bonding (e.g., 
stereolithography [179], selective laser sintering [180]). The main advantages of the AM 
techniques in strategic TE of cartilage include developing scaffolds with a range of designed 
mechanical and architectural properties, including copolymer composition, porosity, and pore 
geometry with high precision [85,181–183]. These capabilities of AM approaches have made 
strategic study of the cellular response to scaffold architectural design possible [61,184–186]. 
Some modern AM techniques, such as 3D printing, 3D plotting, sterolithography, and laser-
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assisted systems, can be adopted to operate at biocompatible conditions [187], which make them 
good candidates for biofabrication of scaffolds with incorporated viable cells and/or bioactive 
molecules. Hydrogel-based scaffolds with designed patterns of encapsulated cells have been 
fabricated with AM techniques [89–91,188]. Designed patterns of growth factors immobilized to 
a biomaterial have also been precisely printed using an AM technique (i.e., inkjet printing) to 
study cellular response to engineered bio-guidance [189]. AM techniques have also been used to 
integrate nano-/micro-scaled features into scaffolds [69,190]. Microspheres or nanoparticles 
loaded with bioactive materials have been blended with backbone materials and dispenses by 
AM to make TE scaffolds [190]. These capabilities are of special interest for strategic cartilage 
TE because they can provide precise, design-based fabrication in biocompatible processing 
conditions. AM and indirect AM [191] techniques also have the potential to be integrated with 
other approaches for developing scaffolds with additional features and functionalities. For 
example, conventional porogen leaching and advanced AM techniques have been integrated to 
create scaffolds with both macro- and micro-features [69,192]. 
3D plotting techniques (Figure 2.4) have become more common in TE [69,193,194] 
because a wide range of biomaterials (e.g., from polyester polymers to cell-/bioactive-laden 
hydrogels) can be employed during fabrication [195,196]. This is desirable for developing and 
studying complex scaffolds that have enhanced mechanical and biological functions for cartilage 
TE. Some of the important merits and demerits of 3D plotting for designed-based scaffold 
fabrication are listed in Table 2.3. Although theoretically possible, few studies have investigated 
the potential for building biomimetic designs and complexities into cartilage TE scaffolds using 
these fabrication techniques. In particular, the capability of 3D plotters for biofabrication of 
cartilage TE scaffolds (incorporating cells/bioactive molecules during fabrication) has received 
limited attention, yet could alleviate the low efficiency, nonuniform cell seeding issue that 
usually requires the additional step of dynamic seeding or culture [197–199]. Updated reviews of 
AM systems for TE of scaffolds, along with their detailed advantages and disadvantages, are 
available in the literature [187,200,201]. Some of the recent strategic designs of scaffolds 
investigated for cartilage TE using advanced fabrication techniques are reviewed in the following 
section. 
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Table 2.3 Merits and demerits of electrospinning and bioplotter fabrication techniques for 
design-based scaffold fabrication. 
Merits and 
demerits  
Electrospinning Bioplotter-additive manufacturing 
Merits 
 Fine fibers (25–100 µm), ECM-like structure (good 
for cellular activities) [34,106] 
 Use of minimum amount of material [202], 
minimizing material–cell/tissue interaction [171] 
 Potential biofabrication capacity [106,203] 
 Capable of incorporating multiple polymers 
[204,205] 
 Reproducible fabrication [69,209] 
 Computer controlled 
 Building of designed, specified 
structures; patient-specific grafts 
[169,209] 
 Processing the widest range of 
biomaterials: hydrogels to polymer melts 
and hard substances [85,196] 
 Design-based biofabrication capacity 
[195] 
Demerits 
 Densely packed structure, small pore size, 
nonuniform cell infiltration/tissue formation 
[206,207] 
 Need of postfabrication process, e.g., direct perfusion 
[105] and dynamic culturing [173,208] 
 Limited design-based architectural/properties 
 Limited at high spatial resolution 
[69,192] 
 
 
Figure 2.4 Schematic diagram of a 3D plotter additive manufacturing fabrication technique 
(Image courtesy of Envisiontec GmbH [210]). 
2.1.5 Strategic scaffold designs for cartilage tissue engineering 
Recent efforts have been directed toward developing more functional, biomimetic scaffolds 
using designed structures, combined strategies, advanced fabrication techniques, and/or novel 
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methodologies. This review focuses on the two strategies of hybrid and zonal TE scaffolds for 
cartilage repair. 
2.1.5.1 Hybrid scaffolds 
Hydrogel and solid polymer backbone materials have advantages and disadvantages with 
respect to cartilage TE. However, the use of both materials in hybrid scaffolds can result in 
unique synergistic properties for better engineering of cartilage. In such hybrid designs, the 
polyester solid material provides a reinforcing skeleton for mechanical strength and the hydrogel 
provides a cell supportive/delivery matrix within the scaffold [1,28]. Composed of two essential 
components, hydrogel–solid hybrid scaffolds resemble the biphasic nature of articular cartilage 
(water and solid phases) and might be an effective strategy for TE cartilage repair. The 
superiority of hybrid scaffold over hydrogel- or solid-only scaffolds for cartilage TE has been 
demonstrated. Some reported advantages of hydrogels within solid scaffolds include retaining 
cells in the 3D, cell-friendly environment of the hydrogel, even distribution of cells in the solid 
scaffold pores, preventing cells from floating out of the scaffold, confining growth factors within 
the scaffold for better interaction with cells [211], and retaining the initial geometry (shape) of 
the scaffold. Synthetic PLGA mesh has been combined with chondrocyte-embedded fibrin glue 
to both preserve cell phenotype and provide controllable scaffold degradation properties [212]. The 
accumulation of GAGs after four weeks was 2.6 times more than in a pure PLGA scaffold [5]. 
Composite PLGA/cell-embedded alginate scaffolds enhanced expression of collagen type II 
[213]. An in vivo study of a cell-seeded collagen (type I)/PLGA scaffold showed homogeneous 
distribution of morphologically stable (round shape) cells and collagen type II formation [214]. 
Other similar examples in cartilage repair include combinations of PGA/alginate [215], 
PLA/alginate [216], PLGA/HA [217], and PLGA/fibrin [162,218].  
Different approaches and designs have been investigated for creating hybrid scaffolds. 
Here, the most recent different designs for hybrid scaffolds in cartilage TE are reviewed. 
Infiltration of hydrogels into solid scaffolds has been very popular in cartilage TE. In brief, the 
method takes a solid scaffold framework and then loads it with hydrogel, which may or may not 
contain cells and/or bioactive molecules. The base solid framework is typically fiber/textile 
[87,112,212], sponge [162,211,216,218], or rapid prototyped structures [219]. The hydrogel 
loading procedure may be as simple as dropping the hydrogel cell suspension onto the solid 
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scaffold and then molding the hybrid scaffold, or just seeding the solid scaffold with a hydrogel 
cell suspension [220]. Jung et al. [220] hybridized a synthetic poly (L-lactide-co-ε-caprolactone) 
(PLCL) polymer with chondrocyte-embedded fibrin gels (FG) and hyaluronan (HA) hydrogel. 
The porous solid framework was created by press-molding, salt leaching, and then freeze-drying 
of the PLCL-NaCl mixture. The chondrocyte-hydrogel suspensions were incubated in the PLCL 
scaffolds quickly after preparation. The solid PLCL framework (85% porosity and 300–500 µm 
pore size) possessed rubber-like elasticity, which could deliver stimulating mechanical signals to 
the cells. The round cellular morphology of the chondrocytes was properly retained in the 
inoculated hydrogels. Hybrid scaffolds made with higher viscosity hydrogels (i.e., FG and HA) 
exhibited the highest cell adhesion efficiency among other created hybrid scaffolds. Overall, 
these observations indicate how the design of hydrogel properties can affect the scaffold 
biofunctionality. An eight-week in vivo study showed formation of a well-developed, 
homogeneously distributed cartilage construct that had comparable compression properties 
(0.57–0.77 MPa) to natural articular cartilage (Table 2.2) [220]; the fabrication method used did 
not allow any design-based control over the structural organization of the formed tissue, and 
ECM formed in the randomly distributed pores of the PLCL scaffold [220] (Figure 2.5A). 
Vacuum-assisted infusion of hydrogel/cell–hydrogel biomaterials is another approach that 
provides uniform infiltration of hydrogels into solid scaffolds (i.e., dense structures) [46]. 
Moutos [46] hybridized an agarose/fibrin hydrogel with 3D woven PCL or PGA scaffolds 
(porosity of 70%~75%) using a vacuum-based infusion technique (Figure 2.5B). The design of a 
woven reinforcing component significantly improved the initial mechanical properties (tensile 
and compression) of the hybrid scaffold to within the range of natural articular cartilage. The 
structural design of the hybrid scaffold provided biomimetic mechanical properties including 
anisotropy, viscoelasticity, and tension-compression nonlinearity. The hydrogel component was 
observed to improve viscoelastic creep behavior and stiffness. However, the highly intense 
design of the solid framework resulted in the accumulation of ECM around the perimeter of the 
hybrid scaffold (Figure 2.5B) and lower mechanical properties in the engineered construct [46].  
Tanaka et al. [110] systematically studied the effect of design (architecture and 
composition) on the functionality of atelocollagen/synthetic polymer hybrid scaffolds. Two 
groups of sponge and nonwoven fibrous poly-L-lactide acid (PLLA) scaffolds were fabricated, 
with each design created at different pore sizes and porosities (Figure 2.5C). Chondrocyte-
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embedded atelocollagen was injected into the porous solid scaffolds, incubated for gelation, and 
then the scaffolds subcutaneously implanted in vivo. Retention of the cell–atelocollagen mixture 
was highest in the scaffolds with the highest pore sizes and porosities. Sponge scaffolds show 
higher retention of the hydrogel than fibrous scaffolds, mainly due to their generally higher 
porosity, at 90%–95% compared to 85%–90%. The hybrid scaffold designs that demonstrated 
superior accumulation of collagen type II and GAGs include sponge-based scaffolds, with a pore 
size of 0.3 mm and porosity of 95%, and fibrous-based scaffolds, with a pore size of 1.5 mm and 
porosity of 88%. Collagen type I was generally higher in fibrous-reinforced vs. sponge-
reinforced constructs. Accumulation of macrophages was also observed on and around the 
polymeric part of the hybrid scaffolds [110]. Unfortunately, the mechanical properties of the 
hybrid scaffolds and TE constructs were not investigated despite this information being of great 
value for cartilage TE applications. One limitation of fibrous-reinforced scaffolds is the large 
fiber size (smallest achievable diameter of 1 mm), which inhibits fabrication of scaffolds with 
higher porosities and consequently inhibits formation of larger tissue volumes. Advanced AM 
fabrication techniques can address this issue through higher achievable resolutions [110]. 
Kawazoe et al. [221] developed a PLGA-collagen hybrid scaffold for cartilage repair that 
was specifically designed to prevent the cells from leaking out of the scaffold during seeding. 
The design included a bilayered, cup-shaped mesh membrane of PLGA filled with collagen 
sponge (freeze-dried collagen) (Figure 2.5D). Knitted and woven PLGA meshes, with big and 
small interstices, respectively, were glued to each other to maintain the 3D structure of the 
collagen (to prevent shrinking) and protect against cell leakage. The developed hybrid scaffold 
had comparable mechanical properties (e.g., compression Young’s modulus) to articular 
cartilage and was successful in preventing cell leakage, having a cell seeding efficiency four 
times higher than a nonhybrid scaffold. This and similar hybrid scaffold designs [114,222,223] 
still require postfabrication cell seeding, which may involve noncontrollable/-reproducible cell 
infiltration and distribution.  
Dai et al. [214] developed three designs of hybrid PLGA-collagen scaffolds for cartilage 
TE: a knitted PLGA mesh with collagen sponge in its interstices (called THIN), a knitted PLGA 
mesh with 3 mm collagen sponge on one side (called SEMI), and a knitted PLGA mesh with 
3mm collagen sponge on both sides (called SANDWICH) (Figure 2.5E). Scaffolds were seeded 
with chondrocytes after fabrication and transplanted in vivo. Cell seeding efficiencies were 
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higher in SEMI and SANDWICH designs than the THIN design. Two to eight weeks after 
transplantation, cartilage-like tissues that formed in SEMI and SANDWICH designs were thicker 
and higher in GAGs and collagen type II than in the THIN design. The maximum achieved 
Young’s modulus and stiffness was associated with the SEMI design; 54.8% and 68.8%, 
respectively, of that of natural cartilage [214]. This indicates how the initial design of the hybrid 
scaffold can affect the mechanical properties of the engineered construct. No significant 
difference was reported between the mechanical and biochemical properties of the constructs 
formed by SEMI and SANDWICH designs.  
Comparison of the appearance of the tissue formed in different hybrid scaffold designs 
(Figure 2.5) shows the influence of scaffold design on the structural organization of formed 
tissue. Despite the number of hybrid scaffolds tested for cartilage TE, few studies have 
investigated the development of hybrid scaffolds with reproducible solid and hydrogel 
components throughout the scaffold. More specifically, the customized spatial distribution of 
hydrogels and/or cells and varying the composition of hydrogels throughout hybrid scaffolds, 
have not yet been investigated for cartilage TE.  
Recently, hybrid scaffolds with controlled spatial distribution of hydrogels and solid 
polymers have been developed using advances in fabrication techniques. Although these studies 
were not specifically aimed at cartilage TE, they shed light into potential advances that could be 
achieved in cartilage TE. Lee et al. [225] combined AM and electrospinning fabrication 
techniques to develop hybrid scaffolds from PCL and collagen biomaterials. Melted PCL was 
plotted in two layers of perpendicular strands and then collagen nanofibers electrospun on top of 
the PCL strands. This pattern was repeated to make a 3D hybrid scaffold (Figure2.6A), which 
was later seeded with cells. This hybrid scaffold showed better mechanical properties (tensile 
Young’s modulus) and biological activity than a pure PCL scaffold. Although not tested by Lee 
et al. [225], electrospinning could be used to incorporate viable cells during fabrication [203] 
and, therefore, achieve the design of a biological hybrid scaffold. 
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Figure 2.5 Different designs of hybrid scaffolds developed for cartilage TE:  
(A) PLCL-FG/HA [220,224]; (B) woven PGA/PCL-agarose/fibrin [46];  
(C) PLLA-atelocollagen [110]; (D) PLGA-collagen [221]; and (E) PLGA-collagen [214]. 
Shim et al. [196] employed a multihead deposition system to create a hybrid scaffold from 
synthetic polymers and hydrogel. A mixture of PCL-PLGA was deposited in three layers 
(nonperpendicular pattern), then hydrogel (hyaluronic acid, gelatin, and atelocollagen) infused 
into the canals created between the solid strands. The same pattern was repeated to produce a 3D 
hybrid scaffold (Figure 2.6B). Using this fabrication technique, the dispensing position of both 
synthetic polymer and hydrogel inside the scaffold was exactly controlled. Shim et al. [196] also 
used this fabrication process to make one layer of a hybrid scaffold with a cell-laden hydrogel. 
The viability of the dispensed cells was 97.8% and 94.8% at 4 and 10 days after dispensing, 
respectively, which indicates that cell printing may not affect cell viability. Due to limitations of 
the fabrication process, only one cell-embedded layer was included in the hybrid scaffold (Figure 
2.6B). Practical challenges of the fabrication process that may influence the biological integrity 
of the hybrid scaffold were not addressed, including use of toxic organic solvents during 
fabrication.  
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Schuurman et al. [195] created 3D hybrid scaffolds from CAD models using PCL and a 
cell-embedded alginate hydrogel, demonstrating the feasibility of making hybrid scaffolds with 
customized shapes, internal architectural designs, and depth-varying hydrogel materials (Figure 
2.6C). Viability of cells in this type of hybrid scaffold, three days after fabrication, was reported to 
be within the same range as those in a nonprinted, hydrogel-only scaffold. The Young’s modulus 
of the developed hybrid scaffold was within the range of natural articular cartilage. The results of 
these studies confirm the feasibility of using advanced fabrication techniques to develop 
multiphase hybrid scaffolds with controlled and designed distribution of cells, hydrogel, and 
synthetic materials. These strategies and fabrication techniques could be employed for developing 
more functional cartilage TE scaffolds that have customized biological and mechanical properties.  
 
Figure 2.6 Controlled deposition hybrid scaffolds: (A) PCL-electrospun collagen [225]; (B) 
PCL/PLGA-hydrogel [196]; and (C) PCL-alginate [195]. 
2.1.5.2  Zonal scaffolds 
The exceptional mechanical functionality of natural articular cartilage can be attributed to 
the distinctive organization of cartilage into four zones from the articular surface down to 
subchondral bone. As discussed in the introduction, the variation in cell morphology and ECM 
matrix composition/structure across these regions is believed to be a key factor in the mechanical 
A
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functionality of the cartilage. One problem with current engineered cartilage constructs is the 
absence of normal cell and ECM zonal organization, which is critical to natural cartilage 
function. Recently, researchers have attempted to replicate this zonal variation in scaffold design 
to improve the functionality of the resulting TE cartilage constructs. Cartilage TE scaffolds with 
a zonal design, as described by Klein et al. [21], can be categorized into either scaffold-free 
(cell-based) or scaffold-based approaches. The scaffold-based approach may use zonal solid, 
hydrogel, or hybrid scaffolds. Some efforts have been made to design scaffolds that promote 
engineered cartilage with zonally specific structure/function.  
In a scaffold-free approach, zonal chondrocytes, which have been isolated from different 
zones of natural cartilage, are zonally layered to replicate the normal zonal organization of cells. 
This approach can induce cartilage ECM with a structure on the upper surface similar to the 
superficial zone of natural cartilage [115,226,227]. Self-assembling fabrication techniques [228] 
could potentially facilitate scaffold-free approaches for zonal cartilage TE. Although the initial 
mechanical properties of such cell-based structures are low, strategies can be taken to improve 
the mechanical properties of the self-assembled TE constructs [228–231]. Advances in AM 
technology (i.e., bioprinting self-assembly) [232] could significantly contribute to the design and 
customization of physical/biochemical properties of assembled structures. One limitation of 
zonal cell-based TE is the difficulty in isolating cells from separate zones in articular cartilage, 
especially in human cartilage [61]. 
Zonally varying structural/biochemical designs in solid scaffolds is another approach for 
replicating cartilage zonal organization. Oriented nanofibrous scaffolds can induce cartilage 
tissue with oriented mechanical and cellular properties similar to the superficial zone of natural 
cartilage [233]. Cartilage TE scaffolds with designed zonally varied physical parameters (no 
variation in biological properties) [61] can mimic the anisotropic distribution of cells but not the 
zonal ECM organization. Natural and synthetic hydrogels with zonal-varying properties have 
also been investigated for cartilage zonal TE [234–239]. Zonal chondrocytes have been 
successfully expanded/cultured separately in hydrogels for zonal cartilage TE [238,240,241]. 
Zonal hydrogel scaffolds with a spatial gradient of embedded chondrocyte concentration [43] or 
type (zonal chondrocytes) [242,243] have been developed using a multilayer scaffold design. 
The interaction between superficial and deep/middle zone chondrocytes in a bilayer scaffold 
design resulted in depth-varying cellular activity and heterogeneous ECM formation. A depth-
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dependent compression modulus [242] and enhanced mechanical properties (shear and 
compression strength) [243] have been observed in zonal constructs when compared to single-
layer hydrogel scaffolds. Nguyen et al. [239] designed a hydrogel with zonally varying 
biochemical composition that can drive mesenchymal stem cells into zone-specific chondrocytes 
and promote zone-specific chondrogenesis similar to natural cartilage. The developed hydrogels 
[239] are intended to be incorporated into a layered hydrogel scaffold for zonal cartilage TE. In 
this type of zonal scaffold, the hydrogel for each layer is prepared separately and then assembled 
to make a multilayer, zonal scaffold. One limitation of this approach is the delamination of 
distinct layers by shear stress of applied loads. Efficient layering strategies, which ensure 
sufficient integration/stability of these heterogeneous biomimetic gels, are required to address 
this issue.  
In a very recent study, Fedorovich et al. [88] investigated the use of AM fabrication 
technique for making cell-laden heterogeneous (layered) hydrogel scaffolds for cartilage TE. 
Two different hydrogel layers with different cell types were successfully fabricated into a 3D 
zonal scaffold. Hydrogel scaffolds designed with varying architectural (i.e., fiber spacing, angle, 
and porosity) and mechanical properties (i.e., elastic modulus) have been successfully fabricated 
and tested both in vitro and in vivo [88]. A method has also been developed for engineering 
multiphase structures with controlled and designed properties in each phase, as well as at the 
interfaces [244]. More specifically, multiple phases of collagen fibers, the density and size of 
which were modulated by varying collagen concentration and gelling temperature, were 
integrated into an engineered structure. Using this technique, significant adhesion strength was 
achieved at the interfaces of the multiphase construct [244], which could be important for layered 
cartilage TE design.  
Hybrid scaffolds have also been designed and created to promote the formation of a zonal 
cartilage–bone interface (continuous gradations in formed ECM) [88,245,246]. A review of 
current strategies for developing TE osteochondral (bone–cartilage) grafts is given by O’Shea 
and Miao [247]. The effectiveness of bioreactors and mechanical loadings for stimulating the 
deposition of zone-specific cartilage ECM in TE scaffolds has also been demonstrated [248–
250]. A thorough review of zonal cartilage TE strategies can be found in Klein et al. [21,251]. 
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2.1.6 Conclusions and recommendations for future research 
During the last 20 years, significant advances have been made in cartilage TE with 
respect to scaffold biomaterials, design, and fabrication. Hopes have been increased with respect 
to the development of a tissue engineering-based treatment for osteoarthritis, as well as cartilage 
lesions in young patients. This review discussed design considerations along with techniques 
used for fabrication of designed scaffolds for cartilage TE. Progress and advances in two 
strategic designs of hybrid and biomimetic zonal scaffolds were also reviewed. Although 
encouraging progress has been made, the major challenge in TE cartilage repair remains the 
insufficient resemblance of engineered cartilage to natural hyaline cartilage, in terms of 
biochemical composition, structural organization, and biomechanical properties [252]. To 
systematically improve this limitation using bioengineered scaffolds, strategic scaffold designs 
should be developed and investigated toward creating more functional cartilage TE constructs. 
One approach could be to learn from previous designs, with the mechanisms and/or factors that 
are currently inhibiting successful formation of functional cartilage tissue investigated and 
addressed in scaffold design and/or therapeutic strategies. Another approach is to develop and 
investigate biomimetic scaffold designs using knowledge from natural cartilage tissue systems 
and/or the healing process. This could include introduction of biological (e.g., bioactive 
molecules/cells) and structural (e.g., ECM-like architecture) complexities, similar to natural 
cartilage, into the scaffold design. Using the available advanced fabrication techniques, highly 
complex and designed scaffolds with a biomimetic distribution of cells and/or bioactive 
molecules within the scaffold could be created and investigated for design-based functional 
cartilage TE. Furthermore, different designs that have been successfully developed could be 
integrated and combined into new scaffold designs to achieve improved functionality for better 
cartilage TE. A current example of this approach is hybrid scaffolds with a hydrogel formulation 
designed for successful chondrogenesis and a solid framework designed for sufficient 
biomechanical functionality and formed tissue affinity. Hybrid scaffolds with biomimetic (e.g., 
zonal) designs are another interesting option to be investigated for cartilage TE; the solid 
framework structure and cell–hydrogel formulation could be designed to vary at different zones 
of a hybrid scaffold to achieve biomimetic zonal properties and signals. Biomimetic zonal 
cartilage TE is still in its infancy and more work in the development of design and fabrication 
methods is required to obtain zonally tailored TE scaffolds that promote zonal cartilage tissue 
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formation. Furthermore, whether or not a biomimetic zonal design will actually result in 
functional (mechanically and/or biologically) engineered cartilage, as compared to a nonzonal 
TE strategy, remains to be determined [21]. 
Although available advanced fabrication techniques have several benefits and capabilities, 
limited work has been done to investigate scaffolds designed with built-in biological/structural 
properties for cartilage TE; this should be conducted in future cartilage TE studies. More 
complex scaffold designs may not be easily achieved and studied without sophisticated 
fabrication techniques. Advancements in fabrication techniques for facilitating the development 
of precisely designed bioengineered scaffolds are urgently needed. Specifically, programmable, 
multifunctional, computer-controlled biofabrication techniques with higher resolution (i.e., 
smaller fiber diameter and spacing) could significantly contribute to advances in cartilage TE. 
The reproducibility of scaffolds in a sterile, nontoxic environment could reduce the steps 
required for scaffold preparation and thus accelerate the economical transition of cartilage TE 
strategies to clinical applications. Fabrication systems that are able to facilitate this transition, by 
accommodating multiple functions, are of great interest with respect to development and 
commercialization. Some efforts have been made to develop integrated fabrication systems that 
prepare cell-incorporated biological samples [253] or TE scaffolds [254] in a sterile 
environment, including the nanoplotter-laminar flow hood [253] and stereolithography system-
laminar flow hood [254]. Ongoing advances in technology and instrumentation could 
significantly contribute to this task. 
Although the effect of different scaffold properties on chondrogenesis has been widely 
investigated, the exact mechanisms by which these properties affect neocartilage 
structure/composition are not fully understood. Investigating the rationale behind this cause and 
effect relationship will help to efficiently optimize scaffold design parameters and achieve better 
results. Developing mathematical models that can simulate the tissue formation process and 
subsequently relate scaffold properties to engineered tissue properties would be of special 
interest and benefit to scaffold optimization. One shortcoming in the cartilage TE literature is the 
lack of consistent mechanical and biological tests and/or evaluation criteria, which inhibits valid 
comparisons of designs and strategies. Most of the results reported are based on a variety of 
different testing conditions and criteria, and thus the development of standard evaluation 
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protocols for mechanical and biological assessment of cartilage TE constructs will be beneficial 
for the comparison of different studies and the development of better strategies.  
Different results observed from in vivo and in vitro studies of the same scaffold design 
demonstrate the need and importance of in vivo studies for better understanding real-life scaffold 
performance. Published in vivo studies are considerably fewer in number than in vitro studies; 
this issue becomes especially important when meticulously designed scaffolds, based on in vitro 
tests, perform differently in vivo [255,256]. Because the in vivo environment is where the 
scaffold will finally perform [21], cartilage TE studies should move toward more in vivo 
experiments. Sterilization techniques and their influence on the integrity of TE scaffolds (e.g., 
scaffold material mechanical properties) should also be given more attention in scaffold design. 
Secure fixation of the engineered construct or TE scaffold in the transplantation site, which will 
be highly load-bearing joint, is another issue that should be considered in the design and/or 
fabrication of TE scaffolds/constructs. Weak or inappropriate implantation may significantly 
affect neocartilage formation, structural organization, integration with host tissue, and its 
remodeling. 
 
2.2 SYNCHROTRON X-RAY IMAGING FOR CARTILAGE TISSUE ENGINEERING 
APPLICATIONS 
2.2.1 Abstract 
Biomedical imaging is crucial to the success of cartilage tissue engineering by providing 
detailed three-dimensional information on tissue-engineered scaffolds and associated cartilage 
growth during the healing process. Synchrotron radiation (SR)-based biomedical imaging is an 
emerging technique for this purpose that has been recently drawing considerable attention. Due 
to the unique properties of synchrotron light, novel SR X-ray biomedical imaging techniques are 
capable of providing information that conventional imaging techniques are not able to capture. 
SR phase-based X-ray imaging techniques use contrast mechanisms different from conventional 
X-ray imaging, which makes them particularly suitable for high resolution biomedical imaging 
of low density materials and soft tissues such as in cartilage tissue engineering applications.  In 
the following, conventional methods used for cartilage tissue engineering assessments and novel 
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SR phase-based X-ray imaging techniques are briefly reviewed. Furthermore, recent applications 
of these SR biomedical imaging techniques to cartilage tissue engineering is discussed.   
2.2.2 Introduction 
The success of tissue engineering (TE) scaffold in repairing cartilage tissue may not be 
verified without appropriate monitoring and assessment techniques. Methods for assessing 
engineered scaffolds and tissue constructs can be generally categorized into invasive and non-
invasive methods. Invasive methods mainly include histological and biochemical analysis, light 
microscopy, and electron optical methods. Non-invasive methods include the techniques that can 
image the tissue or structure in situ (in the body) without the need for excising the specimen 
from the body. Examples of non-invasive evaluation methods are the currently used clinical 
diagnostic imaging techniques such as magnetic resonance imaging (MRI), ultrasound, X-ray 
and computed-tomography (CT) imaging. Non-invasive assessment methods are important from 
two perspectives. First, obtaining better understanding of the long term repair process in situ can 
improve current TE approaches towards more effective strategies. However, the in situ condition 
under which the de facto process of TE repair occurs in animal or human bodies is almost 
impossible to replicate in the lab environment. As such, development of assessment methods that 
can enable obtaining such de facto information non-invasively during longitudinal animals or 
humans in vivo studies would be highly beneficial. Secondly, the conventional invasive methods 
cannot be used for assessments of future clinical human trials. Therefore, developing robust non-
invasive assessment methods for future clinical tissue engineering applications is inevitable.  
2.2.3 Conventional assessment methods 
Conventional assessment methods in TE, such as histological analysis, light microscopy, 
and electron optical methods are destructive, involved with invasive analysis and complex 
preparation procedures. Light microscopy methods used for characterization of the biological 
structures have the disadvantage of low penetration depth that inhibits their application for 
analysis of opaque structures [257]. The most developed confocal and multiphoton microscopy 
methods [258, 259] allow imaging of structures with a depth less than 100 and 400 µm, 
respectively. Larger depth of structures can be imaged by serial sectioning technique, which is 
invasive, destroys the volumetric structure, do not allow complete reconstruction of 3D structure, 
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and also prevents in-depth quantification of structural details [257]. Electron optical methods-- 
scanning electron microscope (SEM) and transmission electron microscope (TEM)--provide high 
resolution images at the nanometer scale. However, due to the limited penetration depth these 
methods are only able to resolve peripheral information and/or volumetric information of small, 
thin, and highly detailed samples [257, 260]. Furthermore, required specimen preparations such 
as fixation and dehydration can alter the organization of tissue constructs and impose artifacts in 
images [257, 261]. The invasive nature of the histological techniques requires scarifying of 
animal models at intermediate timepoints during longitudinal in vivo studies in order to excise 
the tissue construct or repaired tissue for further assessments. Such invasive procedure interrupts 
the repair process, make the long term in vivo studies inefficient and uneconomical with potential 
individual-dependent, variable results. 
The conventional assessment techniques cannot be used for future clinical human trials 
which will, consequently, make the evaluation and approval of TE therapeutic strategies 
challenging. Therefore, the TE field demands development of non-invasive methods for non-
destructive, volumetric, qualitative, and quantitative assessments of TE scaffolds and constructs 
in situ throughout the repair process. Common non-invasive clinical imaging methods used for 
cartilage diagnosis include MRI, ultrasound, and conventional radiographic X-ray imaging. MRI 
can provide image resolution of  <50 µm [262]. Through newly developed modalities, MRI has 
also enabled imaging of the cartilage matrix structure [263] as well as qualitative and 
quantitative assessments of soft tissue regeneration [264]. However, MRI has shown limitations 
for non-invasive tissue engineering assessments such as lower image resolutions than X-ray 
imaging, being applicable to small animal imaging only [264], and requiring exogenous contrast 
materials for large animal imaging [265]. Furthermore, MR-based techniques mainly enable 
assessment of new tissue growth and fall short in imaging and evaluating polymeric tissue 
scaffolds in situ [264]. Ultrasound imaging provides information about the surface of the 
cartilage and have limited resolution and ability to resolve inner structure of the cartilage [266, 
267]. Ultrasound imaging of the cartilage is also limited by the geometry and location of the 
articular cartilage because the sound head cannot resolve non-straight signals [266]. Ultrasound-
based non-invasive evaluation methods for cartilage tissue engineering assessments are based on 
comparison of acoustic properties of the natural cartilage tissue, newly growth tissue, or 
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hydrogel scaffold [268-271]. The capability of these techniques for in vivo TE assessments has 
not been reported in the literature. 
X-ray has high penetration depth and better image resolution than MRI and ultrasound 
[272]. Theoretically, it has a resolution between optical and electron microscopy [257]. This 
makes X-ray imaging a potential candidate for non-invasive assessment of TE 
scaffolds/constructs and regenerated tissue in large animal models and human patients in vivo. 
Conventional X-ray radiography is based on absorption contrast mechanism in which cartilage as 
a soft tissue is invisible; cartilage and soft tissues are mainly constitute of low X-ray-absorbing 
elements of hydrogen, oxygen, carbon, and nitrogen. Soft tissue scaffolds and constructs are 
made of comparably low density materials that are not visualizable in absorption-based X-ray 
imaging.  Therefore, clinical radiographs cannot be used for assessment of cartilage tissue and 
low density TE scaffolds. To overcome this issue, researchers have tried to either use contrast 
agents, such as heavy metals for enhancing the absorption contrast [273-276], or develop new X-
ray imaging techniques to improve the image contrast [277-281]. The use of contrast agents 
(staining) may impose cytotoxicity issues [282], artifact effect, and non-uniform staining of the 
tissue/biological construct [283], and, as such, are not optimal for longitudinal in situ TE 
assessments. 
2.2.4 Synchrotron X-ray imaging  
Synchrotron radiation (SR) X-ray is produced from charged particles (i.e. electrons) 
accelerated in a storage ring. The electron particles are initially ejected from an electron gun by 
electric field and speed up in a linear accelerator. The particles are then further accelerated to 
near the speed of light in a booster ring before being transferred to storage ring. In the storage 
ring, bend magnets cause the electrons to change direction and this results in a change in their 
velocity vector and consequently the radiation of synchrotron light. The produced X-ray has 
advanced properties such as high photon flux over large range of energies, high brilliance, small 
angular beam divergence, high level of coherence, and capability of monochromatization 
compared to conventional X-ray tube sources [284, 285]. These properties of the synchrotron X-
ray have resulted in development of advanced biomedical imaging techniques [277-281] with 
superior imaging capabilities [286, 287] and potential for TE applications such as non-invasive 
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and longitudinal delineation of TE construct morphometry, neotissue growth, construct 
degradation kinetics, and host-implant interface dynamic [288-290].  
2.2.5 Phase-based X-ray imaging 
When X-ray enters an object, its propagation behavior through the object material is 
described by a dimensionless number called complex refractive index (n) and is defined as: 
𝑛 = 1 − 𝛼 − 𝑖𝛽     2.1 
where α is the refractive index decrement (typically 10-6 for hard X-rays) and β is the absorption 
index (typically 10-11 for hard X-rays in soft tissues). The real part of the index n, 1-α, is referred 
to as refractive index, which indicates the phase velocity and for hard X-ray energy range (10-
100 keV) is very close to (but less than) 1.  The absorption index (β) indicates attenuation of the 
X-ray photons as they propagate through the material. In conventional X-ray imaging, e.g. 
clinical radiography, the imaginary part of the complex refractive index, iβ, is used as the source 
of absorption contrast. However, in phase contrast imaging the contrast mechanism relies on the 
variations of the real part of the complex refractive index, 1-α (the phase shift), that is several 
orders of magnitude larger than the imaginary part. Using the phase shift variations as the source 
of contrast, the interface of microstructures and soft tissues constitutes of similar low density 
materials is imaged without using exogenous contrast agents [291-293]. Based on different 
implementations of this principle, several phase contrast X-ray imaging techniques have been 
developed [277-281, 285, 294]. Here three phase-based imaging techniques of inline phase-
contrast imaging (PCI), diffraction enhanced imaging (DEI), and analyzer based imaging (ABI) 
are reviewed. 
2.2.5.1 Inline phase-contrast imaging 
Inline phase contrast imaging (PCI), also called propagation-based imaging, has a simple 
experimental setup similar to the clinical radiograph except using a sample-to-detector distance 
and/or a small effective X-ray source (Fig. 2.7a) [295-297]. When the X-ray travels through the 
object, the phase information of the wave front is disturbed at the interfaces of tissues and 
microstructures that have different refractive index. Such wave disturbance results in a phase 
shift and refraction of the X-ray, which is further developed over a free sample-to-detector 
propagation distance. The detector, then, collects the travelled beam at a distance downstream 
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the object. This is in contrast to conventional absorption-based radiograph where the emerged X-
rays is collected immediately after the object. The continuous phase variations in the propagated 
X-rays result in photon intensity variation and enhanced contrast at the boundaries of tissues and 
microstructures [295-298]. Phase contrast imaging using conventional X-ray tube source 
involves limitations such as intense attenuation and scattering, which result in poor contrast 
images. Such effect is attributed to the polychromatic nature of the X-ray tube source and the 
employed imaging set up in which the transmitted beam must travel over a distance before 
hitting the detector [299]. Superior properties of SR X-ray beam can make substantial 
improvements in this regard. PCI technique has shown improved contrast compared to 
absorption-based images and has enabled resolving of soft tissue structures without using 
contrast agents [257].  
2.2.5.2 Diffraction enhanced imaging 
Diffraction enhanced imaging (DEI) utilizes contrast mechanisms of X-ray refraction, 
ultra-small angle X-ray scattering (USAXS), and scatter rejection of small angle X-ray scattering 
(SAXS), in addition to the absorption mechanism[261]. A three crystals setup that consists of a 
double crystal monochromator and an analyzer crystal with asymmetric reflection plane is 
employed in this technique (Fig. 2.7b) [277]. The double crystal monochromator selects a 
monochromatic X-ray beam with a small energy bandwidth from the incident polychromatic 
synchrotron beam [300]. The monochromatic X-ray beam transverse the object and is deflected 
at the interfaces of features with varying refractive index. Upon exiting the object and hitting the 
analyzer crystal, the X-rays that align within an acceptance angular bandwidth of the analyzer 
will be reflected off the analyzer to the detector with an angle-dependent modulation in the 
photon intensity given by analyzer rocking curve (RC). This mechanism along with the rejection 
of any photon that falls out of the angular acceptance window of the analyzer RC--scatter 
rejection effect--result in an enhanced contrast at interfaces and boundaries of features in a pure 
refraction image. Implementation of DEI system involves collecting two sets of images at two 
opposing (low and high) angles of the RC (e.g. at half maximum reflectivity angles), and then 
extracting the apparent refraction and absorption images from the two collected images. 
Currently, implementation of the DEI technique is mainly possible with the nearly 
monochromatic and highly collimated X-ray beam of synchrotron. However, DEI method can 
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also be implemented using any other X-ray source that can produce similar level of X-ray 
intensity [301]. Development of a table-top DEI system in laboratory (with X-ray tube source) 
has been reported in the literature for the imaging of cartilage tissue [302]. 
2.2.5.3 Analyzer based imaging 
Analyzer-based imaging (ABI) is a version of DEI technique [303] that uses the same 
three crystals setup as DEI, however, only one set of images is collected at one side of the 
analyzer RC (e.g. half maximum reflectivity at high or low angle side). Similar to DEI, the 
contrast mechanism involves the slightly refracted X-ray beam that exits the sample and is 
amplified by the analyzer crystal, which, thereby, generate intensity variations that enhances the 
boundaries contrast. Unlike DEI, ABI system does not give pure refraction image, however, 
easier implementation, shorter imaging time, amplified contrast signal, and scatter rejection 
properties, enhance the potentials of this technique for live animal imaging [303].  
 
Figure 2.7 Schematic diagrams illustrating the image acquisition setup of (a) inline PCI and (b) 
DEI [304] 
X-ray source
a. 
b. 
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2.2.6 Computed tomography imaging 
Computed tomography (CT) [305] is a unique technique for non-destructive, three-
dimensional (3D) imaging of an object. It employs a series of 2D images, collected at different 
angles around the object, to produce cross-sectional images-virtual slices- without physical 
sectioning of the object. Reconstruction of CT slices resolve detailed spatial structures that are 
superimposed and not distinguishable in projected 2D images. The reconstructed slices can be 
stacked to produce 3D volume of the imaged object, which allows non-invasive qualitative and 
quantitative characterization of the specimen. Furthermore, combining CT modality with high 
resolution imaging emerged micro-CT (µCT) imaging systems [306] that when implemented 
with advanced X-ray sources can enable CT imaging at resolutions as high as <1 µm [307]. 
These capabilities have increased the popularity of µCT imaging for many medical and industrial 
research applications [308, 309]. Non-invasive property of CT imaging is particularly of interest 
for assessments of tissue engineering scaffolds [299, 308, 310-315] and regenerated tissues, such 
as bone [309, 316-319]. Being a computational method, quantification of numerous 
microarchitectural parameters of scaffold, such as material volume, surface area, strut width, 
pore size, pore network, and interconnectivity have become possible using µCT imaging [308]. 
Such quantitative architectural information is very valuable for assessing degradation behavior of 
tissue scaffolds and constructs, and evaluating mechanical properties and fluid dynamics in the 
engineered construct using solid and fluid mechanical testing and finite element modeling 
(FEM). 
One of the limitations associated with the conventional CT system at high resolution (1-
50 µm pixel size) is beam hardening effect that is caused by the polychromatic X-ray beam that 
contain lower energy X-rays. In other words, lower energy X-rays are readily attenuated in the 
sample and result in higher exposure time at the sample center (beam hardening), higher 
radiation dose, and difficult image segmentation/thresholding [308]. Superior properties of the 
SR X-ray such as high photon flux (typically about 108 photons/s), high brilliance, small angular 
beam divergence, and the ability to obtain monochromatic beam offer higher quality and more 
efficient CT imaging than conventional CT imaging. These advantages enable improved spatial 
resolution, high signal-to-noise ratio, faster acquisition time, and less beam hardening artifacts 
[320-326]. Combining advanced properties of CT modality, SR X-ray, and the phase-based 
imaging techniques would enable development of robust non-invasive imaging systems that have 
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more sensitivity to soft tissues and low density scaffolds for quantitative and qualitative TE 
assessments in situ.  
2.2.7 Synchrotron phase-based imaging applications in cartilage tissue engineering 
The high water content and low density of cartilage tissue produce negligible X-ray 
attenuations that limits visualization of cartilage using conventional absorption-based X-ray 
imaging techniques [307, 327]. MRI is commonly used to examine the cartilage and to identify 
damages and loss of the tissue without contrast media [328]. Nevertheless, the poor spatial 
resolution of MRI and inability to resolve specific tissue types when compared with synchrotron-
based imaging techniques is the bottle-neck of this modality [328, 329]. Synchrotron imaging 
techniques were initially attracted by researchers in medical diagnosis field, where superior 
imaging techniques have always been on demand for early and accurate diagnosis of cartilage 
damages and diseases, e.g. detection of osteoarthritis in early stages. As such, most of the 
reported studies in the literature concentrate on the application of synchrotron imaging 
techniques for visualization and characterization of healthy and damaged/diseased cartilage 
tissue and cartilage-bone interface. Very few studies have investigated these techniques for 
cartilage and/or soft tissue engineering assessments, with no report on the in situ applications for 
cartilage TE. Since the bone tissue has high absorption coefficient that enables easier X-ray 
imaging, several studies have explored SR X-ray imaging techniques for quantitative and 
qualitative evaluation of bone TE scaffolds and newly regenerated bone tissue [307, 309, 316-
319, 330]. The results of these studies indicate the feasibility of using such advanced X-ray 
imaging techniques for assessing and characterization of TE scaffolds architectural properties, 
degradation kinetics, regenerated tissue quality, and its integration with surrounding host tissue. 
Similarly, by developing SR X-ray imaging techniques capable of imaging low density materials 
and soft tissues in situ such information could also be obtained for in vivo cartilage TE 
assessment applications. 
2.2.7.1 PCI 
The simplicity of implementation, provision of outstanding contrast of less dense samples 
without using contrast agents, and edge enhancement are notable advantages of inline PCI. Inline 
PCI is a powerful tool for characterization of cell-scaffold matrix, new tissue ingrowth and bone-
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cartilage interface where the refractive indices vary greatly [296, 304, 328]. The combination of 
inline PCI with either CT or µCT has been studied for 3D visualization of the articular cartilage 
[328]. One of such studies was conducted by Ismail and colleagues who used bench-top 
microfocus X-ray source with polychromatic, incoherent X-rays as well as synchrotron coherent 
X-rays for examining the cartilage-bone interface and different zones of cartilage [328]. They 
recorded edge enhancement, especially using synchrotron X-rays that was enough to visualize 
low density cartilage and cartilage-bone interface with transitional zones from articulating 
surface down to subchondral bone [328]. In a similar study, Zehbe et al. [257] used PC-µCT for 
3D qualitative and quantitative characterization of articular cartilage; the 3D rendered images 
revealed information that was superior to that obtained from conventional serial histology (Fig. 
2.8). Using the 3D images, various tissues under physiological and pathological conditions were 
differentiated. In addition, tissues structure and cellular level changes such as spatial cell density, 
shape and orientation of the lacunae inside soft tissues, were quantified without destruction of 
the tissues [257]. Using high resolution PCI, Choi et al. [331] characterized microstructural 
features of healthy cartilage as well as inflammatory and pathological changes in the arthritic 
joint of mice in vivo, also showing results comparable to those of CT or histological analysis. 
Most of the reported studies imaged microstructure of the cartilage and scaffold, visualized early 
signs of cartilage disease, and quantified cellular activities in the scaffolds on excised ex vivo 
biological specimens, as opposed to intact specimens in situ. New techniques and ideas need to 
be explored for expanding similar applications to in situ samples for future in vivo studies.  
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Figure 2.8 Images showing cellular information from the frontal lacuna in the soft tissue of an 
articular cartilage: (a) original slice image from inline PC-µCT ; (b) magnified region of interest 
containing lacuna doublet with chondrocytes in the centres; (c) corresponding SEM image ; (d) 
3D rendering of (c); and (e) quantitative analysis of cell density from inline PC-µCT (adapted 
from [257]). 
2.2.7.2 DEI and ABI 
DEI is capable of scatter rejection, is sensitive to density differences in tissues, can be 
optimized through varying the analyzer angular setting without increasing the radiation dose, and 
provides multiple types of information such as absorption, refraction, and extinction images 
[332].  Hence, this method is promising for the 3D characterization of microstructural properties 
of regions with varying densities, especially in low X-ray absorbing materials such as native and 
tissue-engineered cartilage. DEI has been used to visualize cartilage tissue with appreciable 
(e)
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structural detail in both ex vivo [261, 333, 334] and in situ samples [301, 302, 335]. High levels 
of detail in the cartilage structure, such as the structural organization of collagen fiber bundles 
within the articular cartilage, have been revealed using DEI system [276]. Issever et al. [333] 
reported the visualization of cartilage matrix including changes in hypodensities that were 
strongly hypothesized to be chondrocyte lacunes. Similarly, Wagner et al. [334] used color-
coding DEI to explore the internal structure of healthy and pathological joints. In their study, 
comparison of DEI with MRI showed that the same level of structural detail may be revealed by 
MRI but only after a much prolonged exposure that might not be practical with a patient. 
Muehleman et al. [302] differentiated stages of a cartilage lesion from a normal state to a down-
to-bone erosion state in intact canine joints in situ using a DEI system. The high spatial 
resolution combined with the refraction-based mechanism of DEI enabled visualization of early-
stage cartilage degeneration and defects in intact human knee and ankle joints in situ [302]. 
These results were further confirmed by histological and gross analysis [301].  
AB-PCI was also used for characterization of osteoarthritic and normal cartilage matrices 
both ex vivo and in vivo [303, 336, 337]. In fact, the investigated technique enabled quantitative 
and qualitative characterization of the zonal pattern in the cartilage matrix, zonal thicknesses, 
chondrocyte homogeneity and alignment, and matrix fibrillation (Fig. 2.9b,c) [336]. Coan et al. 
[337] tested this imaging modality on in vivo samples and observed a high level of contrast for 
depicting anatomic structural details and pathological features of an osteoarthritic articular joint 
[337]. Similarly, Li et al. [303] imaged intact human knee and obtained structural details such as 
cartilage tissue, cruciate ligaments, loose connective tissue, menisci, and chondrocalcinosis (Fig. 
2.9a).  
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Figure 2.9 (A) Analyzer-based (AB) imaging of cadaveric human knee joint showing enhanced 
contrast imaging of soft tissues and bone with structural details in situ[303], and CT-AB imaging 
of cartilage specimen ex vivo with zonal structural detail comparable to (c) histological analysis 
[336] 
Researchers have conducted extensive studies in cartilage imaging and diagnosis of 
cartilage disease using DEI and ABI systems. The reported results suggest the potential of these 
techniques for cartilage and other soft TE applications, and for developing non-invasive 
imaging-based assessment methods. DEI can enable visualizing both soft and hard tissues at the 
same time [337], which can give a unique potential in monitoring and assessing scaffold-based 
TE strategies for osteochondral (full thickness) cartilage repair. PCI, DEI, and ABI systems 
demonstrated capabilities in providing information similar to the gross and histological 
assessments of the cartilage tissue [338] that suggest their potential for evaluation of the cartilage 
repair success. Yet, very few studies have explored the potential of the phase contrast imaging 
techniques for non-invasive characterization of cartilage and soft tissue scaffolds [339, 340]. Zhu 
et al. [339] investigated imaging of soft tissue scaffolds in vitro, and compared DEI with 
laboratory-based radiography, SR-radiography, and inline PCI at the same energy. Their results 
showed that DEI offered better structural and microstructural quantification of soft tissues over 
the other three methods because of its ability to reject X-ray scatter [339]. Apple et al. [340] 
showed the capability of µCT phase-based imaging technique using synchrotron and 
conventional X-ray tube sources for non-invasive evaluation of cell-embedded tissue constructs. 
The structure of the tissue constructs and the newly formed tissue were characterized at various 
B CA
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time points during the culture time in a perfusion bioreactors [340]. The majority of the reported 
studies in the literature focused on imaging and characterization of low density TE scaffold in air 
or ex vivo. This indicates that the limitations of the currently investigated methods for in situ 
assessments is yet to be investigated and addressed. As a result, there is a high demand for 
exploring advanced imaging techniques such as SR phase-based imaging for visualization and 
characterization of TE scaffolds and regenerated tissue in situ. This is particularly important for 
verification of these techniques for animal in vivo studies and future clinical applications. 
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CHAPTER 3: 3D BIOPRINTING OF CELL-IMPREGNATED HYBRID CONSTRUCTS FOR 
CARTILAGE TISSUE ENGINEERING  
This chapter has been published as "Izadifar Z., Change T., Kulyk W., Chen X.B., Eames B.F. 
(2015) Analyzing biological performance of 3D-printed, cell-impregnated hybrid constructs for 
cartilage tissue engineering. Tissue Engineering Part C: Methods. Epub ahead of print, In Press". 
According to the Copyright Agreement, "the authors retain the right to include the journal article, 
in full or in part, in a thesis or dissertation". 
3.1 Abstract 
Three-dimensional (3D) bioprinting of hybrid constructs is a promising biofabrication 
method for cartilage tissue engineering, because a synthetic polymer framework and cell-
impregnated hydrogel provide structural and biological features of cartilage, respectively. During 
bioprinting, impregnated cells may be subjected to high temperatures (caused by the adjacent 
melted polymer) and process-induced mechanical forces, potentially compromising cell function. 
This study addresses these biofabrication issues, evaluating the heat distribution of printed 
polycaprolactone (PCL) strands and the rheological property and structural stability of alginate 
hydrogels at various temperatures and concentrations. The biocompatibility of parameters from 
these studies was tested by culturing 3D hybrid constructs bioprinted with primary cells from 
embryonic chick cartilage. During initial 2D culture expansion of these primary cells, two 
morphologically and molecularly distinct cell populations (“rounded” and “fibroblastic”) were 
isolated. The biological performance of each population was evaluated in 3D hybrid constructs 
separately. Cell viability, proliferation, and cartilage differentiation were observed at high levels 
in hybrid constructs of both cell populations, confirming the validity of these 3D bioprinting 
parameters for effective cartilage tissue engineering. Statistically significant performance 
variations were observed, however, between the “rounded” and “fibroblastic” cell populations. 
Molecular and morphological data support the notion that such performance differences may be 
attributed to the relative differentiation state of “rounded” versus “fibroblastic” cells (i.e., 
differentiated chondrocytes versus chondroprogenitors, respectively), which is a relevant issue 
for cell-based tissue engineering strategies. Taken together, this study demonstrates that 
bioprinting 3D hybrid constructs of PCL and cell-impregnated alginate hydrogel is a promising 
approach for cartilage tissue engineering. 
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3.2 Introduction 
Although significant progress has been made over the last few decades in developing 
tissue engineering strategies for cartilage repair [1], regeneration of cartilage that functions 
similarly to natural cartilage remains a challenging task. The exceptional biomechanical 
functionality of cartilage at the articulating surfaces of skeletal joints in part derives from the 
structural intricacies [2] and the biphasic (solid-liquid) nature of cartilage extracellular matrix 
(ECM) [3]. Resembling a reinforced, highly hydrated material, cartilage ECM provides a 
favourable biological environment, so that impregnated chondrocytes can maintain tissue 
homeostasis, along with a non-compressible, load-bearing function [4-7]. A biomimetic cartilage 
tissue engineering approach creates scaffolds or constructs (i.e., cell-impregnated scaffolds) with 
structural and biological functionality similar to cartilage. Tissue constructs that lack such 
structural and biologically conducive properties can result in inferior performance, particularly 
after in vivo transplantation [8-10]. 
A hybrid cartilage tissue engineering strategy using both cell-impregnated hydrogels and 
polymeric scaffolds is emerging as an effective approach to mimic the biological and structural 
features of cartilage ECM. Hydrogels have many desirable properties for use in cartilage tissue 
engineering. They are highly hydrated and form tissue-like networks [11]. Furthermore, 
hydrogels are prepared easily, can be impregnated with cells, and provide an environment that is 
favourable for retaining the phenotype and morphology of chondrocytes [12, 13]. However, they 
have poor mechanical strength, which impairs their structural functionality for cartilage tissue 
engineering. Polymeric scaffolds, on the other hand, provide the required structural properties 
[14, 15], but they are inferior to the hydrogels in terms of providing a biologically favourable, 
highly hydrated 3D structure similar to natural cartilage matrix [8]. Therefore, combining both 
hydrogel and polymeric components into a hybrid construct can mimic the biologically and 
structurally supportive properties of cartilage, offering promise for optimizing cartilage tissue 
engineering strategies [16-20].  
Conventional hybrid constructs often lack reproducible and/or customized properties, due 
to limitations of the fabrication methods. Conventional approaches, such as free-penetration or 
perfusion-assisted incorporation of hydrogel into scaffolds, do not allow customized cell-seeding 
into the construct, which can affect negatively the distribution and organization of cells and, 
consequently, the quality of regenerated tissue matrix [15, 17, 19]. For example, inefficient cell 
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penetration into the scaffold can lead to formation of cartilage matrix only at the periphery of the 
construct [15]. Indeed, lack of control over the spatial distribution of cells throughout the 
construct can lead to inferior matrix organization and function compared to that of natural 
cartilage [18]. Advanced additive manufacturing techniques, such as three-dimensional (3D) 
bioprinting, can produce custom-designed, computer-controlled hybrid tissue constructs, 
overcoming many limitations of current biofabrication methods [21, 22].  
Three studies show the potential of 3D hybrid bioprinting as a superior fabrication 
technique for cartilage tissue engineering [23-25], but the biological performance of the 
impregnated cells has not been investigated comprehensively, and some critical fabrication 
parameters remain unexplored. Despite some positive results [25], 3D hybrid bioprinting may 
decrease chondrocyte viability, due to thermal stresses from dispensing heated polymers adjacent 
to cell-impregnated alginate [24]. Increases in chondrocyte numbers and cartilage ECM 
production were observed in long-term culture of 3D hybrid constructs, but no images were 
presented  [24] or little cartilaginous matrix was produced [23]. These studies leave open the 
question of whether this fabrication technique affect the impregnated cells in producing enough 
matrix to replace defective cartilage. In addition, the amount of mechanical stresses that cells 
experience during biofabrication is determined by the viscosity of the alginate parameters used 
[26, 27]. Alginate parameters meanwhile can influence long-term biological performance, such 
as proliferation and chondrogenic differentiation. For example, very high alginate concentrations 
resulted in lower biological performance [24, 28, 29], and very low alginate concentrations 
compromise the structural integrity of constructs [30]. Therefore, PCL dispensing temperature 
and alginate rheological properties need to be carefully investigated, and the biological 
performance of impregnated cells, from viability to cartilage differentiation, should be evaluated 
qualitatively and quantitatively over long-term in vitro culture. 
The success of engineered tissue constructs in promoting regeneration of cartilage is 
influenced largely by the type of employed cells [31]. Primary chondrocytes and stem cells are 
the most investigated cell sources for cartilage tissue engineering [32]. Because both cell sources 
offer advantages and disadvantages, there is still discussion and debate on which cell source is 
better suited for cartilage repair strategies. Primary chondrocytes more readily produce and 
maintain cartilage ECM, but they are obtained in low numbers from donor cartilage and do not 
proliferate easily [33, 34]. Stem cells proliferate readily, but they have to be directed carefully 
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towards chondrogenic differentiation [35]. Chondroprogenitors may represent a cell type 
intermediate to stem cells and chondrocytes, for they have the advantage of high expansion 
capability, while maintaining a predisposition to differentiate into chondrocytes [36]. Cartilage 
tissue engineering strategies can be optimized by investigating proliferation and differentiation 
of different cell types (e.g., chondrocytes vs. chondroprogenitors) in 3D biofabricated tissue 
constructs. 
In this study, parameters of a 3D bioprinting technique, including thermal stress of melt-
dispensed PCL and shear stress of dispensed alginate, were evaluated with respect to 
biocompatibility of hybrid cartilage constructs. The biological performance of hybrid constructs 
biofabricated with identified parameters of heat and alginate concentration/temperature were 
investigated during long-term in vitro culture using assays of cell survival, proliferation, and 
cartilage differentiation. To test whether cell source influences the biological performance of 
these constructs, two morphologically distinct cell populations, “rounded” and “fibroblastic”, 
were isolated from primary cultures of embryonic chick chondrocytes. The biological 
performance of each population was very high, verifying the effectiveness of this cartilage tissue 
engineering approach. It is discussed whether differences observed between these cell 
populations may reflect the differentiation state of the “rounded” versus “fibroblastic” cells. 
3.3 Materials and methods 
3.3.1 Materials 
LIVE/DEAD® Viability/Cytotoxicity Kit for mammalian cells (L-3224, Invitrogen, 
USA), anti-collagen type II antibody (II-II6B3—Developmental Studies Hybridoma Bank 
(DSHB), USA), collagen type X antibody (X-AC9—DSHB), Goat anti-mouse IgG-488 
conjugate (A-11001, Millipore, USA), RNeasy Mini Kit (74104, Qiagen, Canada), RT2 Easy 
First Strand Kit (330421, Qiagen, Canada), SYBER master mix (4472908, Life Technologies, 
USA), Acetone (Fisher Scientific, Canada), methanol (Fisher Scientific, Canada), acetic acid 
(Fisher Scientific, Canada), ethanol (Fisher Scientific, Canada), Gibco® fetal bovine serum 
(FBS, 12483-020, Thermo Fisher Scientific, Canada),. The rest of listed reagents and materials 
were purchased from Sigma-Aldrich (Oakville, Canada). Polycaprolactone (PCL) (704105-
Aldrich, Mw 48,000-90,000), alginic acid sodium salt; low viscosity alginate (LVA) (A2158-
Sigma), alginate powder (AP) (180947-Aldrich), medium viscosity alginate (MVA) (A2033-
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Sigma), calcium chloride dehydrate (CaCl2), Dulbecco’s modified Eagle’s medium (DMEM, 
D6429), Stemline® Keratinocyte Medium II-Calcium free (SKM, S0196), phosphate buffer 
saline (PBS), phosphate buffer saline Tween-20 (PBST), HEPES buffer, collagenase type IA, 
trypsin, Hank’s buffered salt solution (HBSS), antibiotic antimycotic (AA; containing penicillin, 
streptomycin, and amphotericin), kanamycin sulfate, glutamine, ascorbate acid, sucrose. 
Ethylenediaminetetraacetic acid (EDTA), Alcian Blue, cacodylate buffer, sodium cacodylate, 
paraformaldehyde, glutaraldehyde, ruthenium (III) hexamine trichloride, normal goat serum, 
normal sheep serum, DMEM/F-12 Ham’s medium (D8437), ascorbate-2-phosphate, insulin-
transferrin-selenium (ITS, 12521). 
3.3.2 Terminology  
Due to variable usage of terms in the literature, it is defined here how a few terms are 
used in this manuscript. “Scaffold” will refer to materials printed without cells, whereas 
“construct” will refer to materials printed with cells. “Hybrid scaffold” will refer to a structure 
printed with two materials (in this case, PCL and alginate), but no cells, while “hybrid construct” 
will refer to a structure with two materials as well as cells. 
3.3.3 Design and fabrication of the hybrid constructs 
Three-dimensional (3D) models of the hybrid constructs were designed to have porous, 
non-woven structure consisting of polycaprolactone (PCL) framework scaffold and an embedded 
alginate hydrogel network in a box-shaped external geometry (Fig 3.1A). The PCL and alginate 
strands were designed to have 1 mm spacing with 0/90o perpendicular pattern in two consecutive 
layers (Fig. 3.1A). The cell-impregnated alginate hydrogel was designed to be placed in the 
desired canals created between the PCL strands in each layer of the construct (Fig. 3.1C). The 
3D computer-aided design (CAD) model of the hybrid construct was made using Magics 
Envisiontec (V13, Materialise, Belgium) software. The 3D hybrid model was then sliced into 
consecutive multiple layers using Bioplotter RP (V2.9, Envisiontec GmbH, Germany) software, 
and loaded to the interface software (VisualMachine BP, V2.2, Envisiontec GmbH, Germany) of 
the 3D-Bioplotter™ system (Envisiontec GmbH, Germany) for construct fabrication (Fig. 3.1B) , 
which was carried out in a sterile biosafety cabinet. PCL beads were loaded to high-temperature 
dispensing head (HTDH), melted and maintained at desired temperature (65-80oC) for 15-20 
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minutes before dispensing. Dissolved alginate solution was loaded to low-temperature 
dispensing head (LTDH) of the machine, maintained at 10oC for 10-20 minutes before 
dispensing. Following the CAD hybrid model, in each layer of the construct the PCL in the 
HTDH was first dispensed with the assigned pattern and then the alginate solution in LTDH was 
dispensed in the created canals between the PCL strands (Fig. 3.1C). This alternative dispensing 
pattern of PCL and alginate was repeated in subsequent layers to build the 3D hybrid constructs 
layer by layer as designed.  
PCL was dispensed through 300 µm metal cylindrical needle (24G) using pneumatic 
pressure of 0.8 MPa at dispensing speed of 1 mm/sec. The alginate solution was dispensed 
through 200 µm conical needle, using 0.01 MPa pressure at dispensing speed of 25 mm/sec. 
Conical needles have been shown to be superior to cylindrical needles in dispensing live cells 
with lower shear-induced cell damage [37]. Since alginate gelation improves its stability and 
structural integrity [38], a partial cross-linking process was adopted throughout the construct 
fabrication. 170 mM CaCl2 aerosol was produced with an ultrasonic nebulizer (MY-520) and 
was applied externally to the dispensing alginate, which takes about 10 seconds for each layer. 
Such partial cross-linking also keeps the construct moist and prevents it from drying during the 
fabrication. The partial cross-linking was followed by a 20 min full cross-linking of the finished 
3D hybrid construct in 100 mM CaCl2 solution to gel the alginate network within the PCL 
scaffold.  
 
Figure 3.1 Design and 3D bioprinting of hybrid constructs with structural and biological features. 
(A) Schematic of designed 3D hybrid construct with alternating strands of PCL and chondrocyte-
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impregnated alginate in each layer, (B) 3D-BioplotterTM system employed for biofabrication of 
designed hybrid constructs, and (C) hybrid biofabrication using pneumatic dispenser heads. 
3.3.4 Characterization of hybrid scaffold fabrication 
Different parameters of the fabrication process, such as materials characteristics and 
processing conditions were investigated to ensure the biocompatibility of the hybrid 
biofabrication for encapsulating cells. To identify a suitable processing temperature of PCL, 
scaffolds were made at different PCL temperatures (65, 70, 75, and 80 ºC) using a pressure of 0.8 
MPa, and the heat distribution on the surface of dispensing PCL strands was monitored with an 
infrared thermal camera (FLIR i3, FLIR systems Inc., CA). Upon dispensing of a 10 mm-long 
PCL strand, infrared (IR) images were collected for analysis. Surface temperature profile along 
the length of the dispensed PCL strand was measured in the collected IR images using FLIR 
Therma CAM Researcher Software (FLIR systems Inc., CA). Prior to collecting images, the 
infrared thermal camera was calibrated with an ice-water mixture (0 ºC).  
Three different sodium alginate stocks; namely, alginate powder (AP), low viscosity 
alginate (LVA), and medium viscosity alginate (MVA), were used for preparing alginate 
solutions (dissolving in dH2O) and testing the fabrication of the hybrid scaffold. The effect of 
temperature on the viscosity of alginate solution (2% w/w) was investigated by using a 
programmable rheometer (Brookfield DV-III Ultra, USA). Alginate temperature was decreased 
from 25-26ºC to 10oC by two degrees at a time and its viscosity was measured. At each 
temperature, at least 10 min wait time was given for the material to uniformly reach the desired 
temperature before viscosity was measured. The effect of temperature on the viscosity of higher 
concentrations of LVA solution (4% and 5%) was also investigated for comparison.  
3.3.5 Cell isolation and culture 
All experiments were carried out according to approved institutional and national 
standards of animal ethics. Primary chondrocytes were isolated from cartilaginous sternums of 
14 day-old chick embryos. Embryonic chick cartilage was used as the cells source because of the 
easy accessibility of large numbers of cartilage-producing cells, and it is a well-characterized 
model for studying the development and differentiation of cartilage cells in different culture 
conditions [39-43] and tissue scaffolds [44-47]. Since monolayer passaging of the primary 
chondrocytes can negatively affect their chondrogenic differentiation capacity [48, 49], 20 to 24 
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embryos were used to obtain sufficient numbers of primary cells without needing to passage 
them (i.e., passage 0). The excised sternums of chick embryos were finely chopped and 
subsequently subjected to digestion in 0.2% collagenase and 0.25% trypsin in HBSS at 37oC and 
5% CO2 for 2 hours with one gentle pipetting at 90 minute. The digestion was stopped by adding 
DMEM and 10% FBS to the digestion medium. The resulting cell suspension was passed 
through a sterile Nitex (70 µm mesh size) and centrifuged at 200g for 10 minutes. The collected 
cell pellets were suspended in culture medium containing DMEM, 10% FBS, 2 mM glutamine, 
0.1 mg/mL kanamycin, 1% AA (100 U/mL penicillin, 0.1 mg/mL streptomycin, 0.25 µg/mL 
amphotericin B), and 0.01 mg/mL ascorbate. The isolated cells were seeded at a population of 
2×106 cells/flask (T-75 flask, VWR, Canada) at 37ºC and 5% CO2 and the medium was changed 
every three days. Of note, the culture medium used for 3D culture of cells in constructs did not 
contain additional growth factors, which are not needed for primary cells from embryonic 
cartilage to differentiate as chondrocytes [50-53], perhaps due to the self-expression of 
chondrogenic growth factors by these embryonic cells [54]. 
Two morphologically distinct cell types, “rounded” and “fibroblastic”, were observed in 
the primary cultures after 7 days of 2D culture in vitro (see Results and Fig. 3.4). Rounded and 
fibroblastic cells were collected separately from the culture at day 10 following the primary 
isolation. To collect rounded cells, the culture medium was gently pipetted up and down two 
times to dissociate any loosely-attached round cells. Then, the floating and dissociated cells were 
harvested and centrifuged at 300g for 10 min to pellet the cells. The remaining fibroblastic cells 
attached to the culture flasks were rinsed with PBS and incubated with 0.25% trypsin solution at 
37ºC for 5 min. Following the incubation, the FBS-containing culture medium (described earlier) 
was added to the flask to neutralize the trypsin. The flask medium was gently pipetted up and 
down to disperse detached cell clumps, which was then centrifuged at 300g for 10 min to pellet 
the cells. Cell number and viability in the collected rounded and fibroblastic cell suspensions 
were determined using hemocytometer and Trypan blue exclusion assay, respectively. 
3.3.6 Biofabrication of cell-impregnated hybrid construct 
Medium viscosity alginate solution (3.5 % w/w) was prepared by stir-bar mixing of 
alginic acid sodium salt in Stemline® Keratinocyte Medium under sterile condition. For each 
cell type, the alginate solution was evenly mixed with cells suspended in fresh culture medium 
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(7:3, alginate volume :cell-suspension volume) using three-way stopcocks to a final alginate 
solution concentration of 2.5% and cell concentration of 5.68×106 cells/ml. The cell-embedded 
alginate was then loaded to the LTDH of the 3D-BioplotterTM machine and the 3D PCL-alginate 
constructs with impregnated cells were dispensed following the hybrid fabrication procedure 
described earlier. During the biofabrication, the temperature of the plotting stage was maintained 
at 10ºC. After crosslinking of the finished cell-embedded hybrid constructs in 100mM CaCl2 in 
4.2 mM HEPES, 0.35M sucrose solution (pH7.4), the constructs were washed in DMEM twice 
for 5 minutes each, and were moved to 12-well culture plates containing DMEM supplemented 
with 10% FBS, 2 mM glutamine, 0.1 mg/mL kanamycin, 0.01 mg/mL ascorbate, and 100 U/mL 
penicillin, 0.1 mg/mL streptomycin, 0.25 µg/mL amphotericin B. The hybrid constructs were 
maintained at 37ºC and 5% CO2 condition with fresh medium change every three days. 
For biological studies, hybrid constructs with two consecutive layers were fabricated and 
used. Furthermore, to better approximate the thickness of human articular cartilage (1.5-2.35 mm  
[55]), multilayer hybrid constructs with six consecutive layers were designed and fabricated 
using cells of the ATDC5 cell line previously employed for cartilage tissue engineering 
applications [56, 57]. ATDC5 mouse cells were purchased from Sigma and were cultured in 
culture flasks containing DMEM/F-12 HAM’s medium supplemented with 5% FBS, penicillin 
(100 unit/ml), streptomycin (100 µg/ml), glutamine (2mM), ascorbate-2-phosphate (0.05mg/ml), 
and 1X ITS+. The medium was changed every two days. Confluent cells after one week of 
culture were collected, re-suspended in serum free DMEM/F-12 HAM’s medium, and mixed 
with alginate (5.6×106 cells/ml in 2.5% alginate solution) for construct biofabrication following 
the procedure described earlier. The hybrid 6-layer constructs were then maintained at 37ºC and 
5% CO2 condition with fresh medium change every three days.  
3.3.7  Cell viability and proliferation assay 
Cell viability assay was conducted in the hybrid constructs using the two-color 
LIVE/DEAD® Kit and fluorescence microscopy. Green-fluorescent calcein-AM dye staining 
identifies live cells with normal intracellular esterase activity, whereas red-fluorescent ethidium 
homodimer-1 (EthD-1) dye staining identifies dead cells with compromised plasma membranes. 
The viability of cells in the hybrid constructs was assayed immediately after biofabrication (day 
0), and at days 1, 3, 7, and 14 of subsequent in vitro culture. At each timepoint, the constructs 
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(n=3) were removed from the culture, washed with DMEM, and stained in 2µM calcein-AM and 
0.5 µM EthD-1 solution in DMEM for 30 min in a 37oC, 5% CO2 incubator. The constructs were 
washed with DMEM twice and imaged using a fluorescence microscope (Nikon, ECLIPSE 
E600, SPOT Insight™ Camera, USA).  
Sequential images at different vertical focal planes were captured to investigate the spatial 
distribution and viability of the impregnated cells within the hydrogel. To quantitatively 
determine the cell viability in the hybrid constructs, the stained cells were released from the 
constructs by dissolving hydrogel matrix with 50 mM EDTA solution (diluted in DMEM) for 30 
min at room temperature while protected from light. Using gentle pipetting, the medium was 
dispersed to give an even cell suspension mixture. Samples (N=3) were taken from the cell 
mixture of each construct and imaged under a coverslip on a standard glass microscope slide at 
5-6 random locations for counting live and dead cells. The cell number in these isolated cell 
suspensions (n=3) was determined using a hemocytometer to indicate proliferation over the 
culture period. The cell viability and proliferation experiment was repeated three times in 
independent experiments and the collected data was used for quantitative viability and 
proliferation analysis.  
3.3.8 Cell differentiation assessments 
Cartilage differentiation of the cells was investigated by assaying glycosaminoglycans 
(GAGs) and Collagen type II (Col2) deposition in the hybrid constructs. Alcian blue staining was 
used to assaym sulfated GAGs at days 1, 7, 14 and 28 following biofabrication. At each 
timepoint, the constructs (n=3) were removed from the culture and washed twice with DMEM. 
The constructs were fixed in acetone and methanol solution (1:1) on ice for 30 minutes and then 
stained with 0.5 % Alcian blue diluted in 3% acetic acid solution (pH=1) overnight. The stained 
constructs were washed once with 25% ethanol in 3% acetic acid and once with 50% ethanol in 
3% acetic acid, and were then imaged using light microscopy. Using ImageJ software [58] the 
amount of Alcian blue-stained matrix in the hybrid constructs was estimated by measuring the 
percentage area of the blue-stained matrix to the total field of view in the alginate of the 
constructs at days 7, 14, and 28 of culture.  
Immunofluorescent staining was performed to detect Col2 or Col10 accumulation within 
the hybrid constructs. The constructs were harvested at days 1, 7, and 14 following 
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biofabrication, washed with DMEM and fixed in cacodylate buffer (200mM sodium cacodylate 
(pH7.4), 20 mM CaCl2, 4% sucrose) contains 2% paraformaldehyde, 2% glutaraldehyde, and 
0.7% ruthenium (III) hexamine trichloride for two hours at 4ºC on a shaking platform. The 
constructs were then washed once in cacodylate buffer, digested with 0.5% trypsin in PBS for 20 
minutes at 37oC for antigen retrieval, and then incubated in blocking buffer (4% normal goat 
serum and 2% normal sheep serum in PBST) for 2 hrs while shaking at room temperature. The 
constructs were then incubated in purified anti-Col2 or anti-Col10 antibody in blocking buffer 
(1:100) overnight at 4ºC while shaking. Next, the constructs were washed 6-8 times with 
blocking buffer over two hours and then incubated with goat anti-mouse IgG-488 conjugate in 
blocking buffer (1:1000) at 4ºC overnight. Constructs were then washed in PBST for at least two 
hours before fluorescence microscopy imaging. Histochemical and immunoflurescent staining 
experiments were repeated twice in independent experiments to confirm the obtained results.  
Relative levels of Collagen type I alpha 2 (Col1a2) and Collagen type II alpha 1 (Col2a1) 
transcript expression in cells harvested from the hybrid constructs were investigated using 
quantitative polymerase chain reaction (qPCR) analysis following manufacturer’s protocols. At 
day 0, rounded and fibroblastic cells were released from hybrid constructs, using the same 
procedure described earlier for cell viability and proliferation assays, and total RNA was 
extracted using RNeasy Mini Kit (Qiagen, Canada). For each sample, 100 ng of RNA was 
reverse transcribed into cDNA using RT2 Easy First Strand Kit (Qiagen, Canada). qPCR was 
performed in 20 µl of reaction volume using 1 µl of cDNA products, gene-specific primers, and 
SYBR master mix with 46 cycles of denaturation (30 s, 95ºC), annealing (30 s, 55ºC), and 
extension (30 s, 72ºC) using a StratageneTM Mx3005P qPCR system (Agilent Technologies, Inc. 
USA). Primer sets for chick Col2a1 (Forward: aagggtgatcgtggtgagac, Reverse: 
tcgcctctgtctccttgttt), Col1a2 (Forward: tgaagttggctttgatgcag, Reverse: gggttctttttggagccttc), and 
internal reference Hprt1 (Forward: aagtggccagtttgttggtc, Reverse: ttgtagtcgagggcgtatcc) were 
synthesized by IDT. PCR efficiency was measured as 102% that was in the acceptable range of 
95-110%. Ratio changes in gene expression were calculated using the ∆∆Ct method [59, 60]. 
3.3.9 Statistical analysis of the data  
Collected data are presented as mean ± standard deviation. Statistical significance 
difference among different timepoints and cell types was calculated using one-way or two-way 
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analysis of variance (ANOVA) and Tukey’s multiple comparison test. Differences were 
significant when the calculated P-value was less than 0.05. 
3.4 Results 
3.4.1 Investigating parameters of hybrid construct fabrication for biocompatibility and 
structural integrity  
To assess the level of potential heat stress on cells in adjacent alginate strands during 
hybrid construct fabrication (see Fig. 3.1), surface temperature of printed PCL strands was 
determined using an infrared camera. Although the PCL was dispensed at 65-80ºC, the surface 
temperature of the PCL strands dropped considerably once printed (Fig. 3.2). The temperature 
profiles along the 10 mm length of printed PCL (X axis and marked black line in Fig. 3.2 inset 
images) indicate that the PCL surface temperature dropped to room temperature (25ºC) within 
approximately 10 seconds after printing at 1 mm/sec. When PCL was printed at 65, 70, 75, and 
80ºC, the maximum temperature at the surface of the printed PCL was 33.9, 38.1, 39, and 
42.4ºC, respectively (Fig. 3.2), which was almost half the applied processing temperatures. Since 
cells are cultured at 37ºC, PCL temperatures of 65-75ºC should allow biocompatible printing of 
hybrid constructs with impregnated cells. Because of the lower viscosity and higher flow rate of 
PCL at higher temperatures, 75ºC PCL printing was used for all subsequent experiments of this 
study. 
Stability of the alginate strands during printing is important for maintaining the designed 
structural properties of the hybrid construct. In order to identify parameters by which the stability 
of low concentration alginate could be controlled effectively, alginate viscosity was 
characterized as functions of temperature, concentration, and the polymer chain length of starting 
material. At 2% concentration, medium viscosity alginate (MVA) exhibited significantly 
(P<0.001) higher viscosity than the low viscosity alginates, LVA and AP, at every temperature 
tested between 25ºC and 10ºC (Fig. 3.3). A similar statistically significance (P<0.001) increase 
in viscosity was achieved by increasing the concentration of LVA from 2% to 5% (Fig. 3.3). 
Lowering the temperature from 25ºC to 10ºC significantly (P<0.001) increased alginate viscosity 
at all concentrations tested. However, the viscosity increase in 2% MVA and 4% and 5% LVA 
was 3-8 times larger than that in 2% LVA and 2% AP (Fig. 3.3), which was statistically 
significant (P<0.001). At 2% and 2.5% concentrations, printing of hybrid constructs with low 
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viscosity alginates (LVA and AP) was found to be very challenging, even by lowering the 
alginate temperature and employing partial cross-linking with CaCl2 aerosol during fabrication. 
Low viscosity alginates did not have enough stability to maintain their 3D structures, and the 
alginate strands flattened after printing. However, hybrid constructs printed with 2% and 2.5% 
MVA at 10oC maintained their structural integrity (see Fig. 3.6). As such, higher initial viscosity 
of alginate along with printing at a low temperature can provide a processing condition for 
making stable hybrid constructs with low alginate concentrations [see Appendix A], which is an 
alternative and more biocompatible approach than using high alginate concentrations.  
 
Figure 3.2 Thermal infrared (IR) imaging reveals that temperature decreases rapidly during PCL 
strand printing. Surface temperature profile along the length of printed PCL (L1 in the inset 
images) shows a rapid drop to ambient temperature after printing at (A) 65ºC, (B) 70ºC, (C) 
75ºC, or (D) 80ºC. X axes in the graphs corresponds to the black line (L1) marked along the 
length of printed PCL in the inset IR images. HTDH: high temperature dispensing head. (The 
heat map scale bar was created automatically from the detected range of temperatures in each 
captured field of view). 
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Figure 3.3 Increase of viscosity by temperature decrease in solutions of low viscosity alginate 
(LVA), medium viscosity alginate (MVA), and alginate powder (AP). Asterisks indicate 
statistically significant difference in viscosity from 25ºC to 10ºC for all tested solutions 
(horizontal asterisks), and at every tested temperature between 2% MVA & 5% LVA and 2% 
LVA, 2% AP and 4% LVA at P<0.001. 
3.4.2 Two populations of primary cells were isolated from embryonic chick cartilage 
Two morphologically distinct cell types, “rounded” and “fibroblastic”, were observed in 
primary cultures of embryonic chick sternal chondrocytes after 7 days of 2D culture in vitro (Fig. 
3.4). Rounded cells with spherical morphology floated in the culture medium or were attached 
loosely to the flask bottom (Fig. 3.4B and C, white arrowheads). Fibroblastic cells with flattened 
morphology were attached firmly to the flask bottom and could not be detached by simple 
pipetting (Fig. 3.4B and C, blue arrowheads). Interestingly, fibroblastic cells appeared to give 
rise to rounded cells when cultured after the floated and loosely attached rounded cells were 
removed (Fig. 3.4D-F).  
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Figure 3.4 Two populations of cells were isolated from primary chick cartilage. Primary cells 
isolated from embryonic chick cartilage in 2D culture at (A) day 0 and (B,C) day 7. Panel C is 
higher magnification view of sample in panel B. Dark blue arrowheads point to fibroblastic cells, 
and white arrowheads point to rounded cells. (D) 2D culture at day 10 following removal of 
floated and loosely attached rounded cells. (E,F) Many rounded cells appeared by day 27, 17 
days after removal of floated and loosely attached rounded cells. Panel F shows higher 
magnification view of dashed box in panel E. 
In addition to the morphological differences between rounded and fibroblastic cells, 
molecular analyses indicated they had different gene expression profiles. Quantitative gene 
expression analysis using qPCR was performed to further investigate the difference between the 
rounded and fibroblastic cells. At day 0, immediately after biofabrication, rounded cells were 
observed to have statistically higher Col2a1 mRNA levels than the fibroblastic cells, while 
fibroblastic cells were observed to have statistically higher Col1a2 mRNA levels than the 
rounded cells (Fig. 3.5). Given these morphological and molecular differences, the biological 
performance of rounded and fibroblastic cell populations in 3D hybrid constructs was evaluated 
separately. 
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Figure 3.5 Rounded cells have distinct molecular characteristics from fibroblastic cells. qPCR 
analyses revealed higher levels of Col1a2, and lower levels of Col2a1, expression in fibroblastic 
cells than rounded cells at day 0 of hybrid construct biofabrication. Levels of Col2a1 and Col1a2 
mRNAs are normalized with respect to those in fibroblastic cells. Asterisks indicate P<0.001. 
3.4.3 Rounded and fibroblastic cells demonstrated high viability in hybrid constructs 
Biocompatibility of the PCL temperature and alginate processing parameters identified 
above was measured using a fluorescent cell viability assay. After 3D hybrid construct printing 
(day 0), cells were observed to be distributed uniformly, without formation of cell clumps, 
throughout the alginate strands between the PCL strands (Fig. 3.6). Fluorescent imaging of 
stained constructs at day 0 showed uniform distribution of both live and dead cells throughout 
the alginate portion of the constructs immediately after printing (Fig. 3.7). The absence of 
increased cell death in regions of alginate that were immediately adjacent to the PCL strands 
confirms that the heat produced by melt-dispensed PCL does not harm considerably the viability 
of impregnated cells (Fig. 3.7A-F). No differences in distribution of cells were observed between 
rounded and fibroblastic cells. 
Time course analysis indicated that both rounded and fibroblastic cells maintained high 
viability in hybrid constructs cultured in vitro. At day 0, constructs with rounded and fibroblastic 
cells both showed cell viability of more than 80% (Fig. 3.7G). Cell viability of constructs 
containing fibroblastic cells decreased to 76% by day 7, which was improved to about 85% by 
day 14 (Fig. 3.7G), although these changes were not statistically significant. For constructs with 
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rounded cells, the viability remained high (>80%) throughout the 14 days of culture, slightly 
increasing from days 3 to 14 (Fig. 3.7G), although not statistically significant. From days 1 to 14 
during culture, rounded cells tended to exhibit slightly higher viability than fibroblastic cells, but 
this was only statistically significant on day 7 (Fig. 3.7G). In general, cell viability was high in 
hybrid constructs of both cell types, with a minimum viability of 77%. 
 
Figure 3.6 3D bioprinted hybrid constructs have uniformly distributed impregnated cells within 
the alginate hydrogel. (A) Gross and (B-D) magnified light microscopy views. Panel B is higher 
magnification view of the box in panel A. Dashed arrows point to cell-impregnated alginate 
strands, and white arrowheads point to cells impregnated in the alginate strand. 
 
Figure 3.7 Cell viability was high for both rounded and fibroblastic cells in 3D bioprinted hybrid 
constructs. Uniform distribution of (A) live, (B) dead, (C) live and dead rounded cells, and (D) 
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live (E) dead, (F) live and dead fibroblastic cells in hybrid constructs confirms the harmless use 
of melted PCL in hybrid fabrication. (G) Time course cell viability analysis demonstrates high 
viability for rounded and fibroblastic cells in the hybrid constructs. Asterisk indicates a statistical 
significant difference with P< 0.05. 
3.4.4 Fibroblastic cells had higher proliferation than rounded cells in hybrid constructs  
To ensure that the hybrid construct provided a stable environment for cell proliferation 
during in vitro culture, cell number, cell organization, and the structural integrity of alginate 
were examined. Representative images of hybrid constructs (Fig. 3.8A-F) suggested that the 
number of live rounded and fibroblastic cells increased during culture. Quantitative analyses of 
the number of rounded and fibroblastic cells suggested that hybrid constructs provide a 
conducive environment for maintaining cell proliferation (Fig. 3.8I). Cell numbers steadily rose 
during the culture period for both rounded and fibroblastic cells, each showing a significant 
increase in cell number at day 14 compared to earlier culture times. Rounded and fibroblastic 
cells exhibited similar cell numbers at each timepoint during culture up to day 7, but at day 14, 
fibroblastic cells had significantly higher numbers (3.7-fold increase) than the rounded cells (2.5-
fold increase) (Fig. 3.8I).  
Cell proliferation was associated with the formation of cell clusters during in vitro culture 
of hybrid constructs. Most cells were dispersed individually throughout the alginate strands at 
day 1, but at later timepoints, discernible cell clusters became apparent (inset images in Fig 
3.8A-F). A high resolution (0.83 µm pixel size) confocal image of the rounded cell hybrid 
construct taken at day 28 of culture revealed that most cells were in clusters rather than isolated 
(Fig. 3.8G, H). In addition, both rounded and fibroblastic cells displayed round morphologies 
that typify chondrocytes in native cartilage during in vitro culture of hybrid constructs (inset 
images in Fig.3.8A-F).  
Throughout in vitro culture, the alginate strands retained both external and internal 
structural integrity. Alginate strands persisted in filling the space between PCL strands, 
maintaining the interconnectivity of pores within the hybrid constructs during 28 days of culture 
(Fig. 3.8A-G). At later times of culture (such as day 28), the size of alginate strands (its 
diameter) sometimes appeared to increase, perhaps due to osmotic swelling of the alginate or a 
gradual loosening of the internal microstructure of the hydrogel matrix. In contrast to this latter 
possibility, cells within the alginate strands displayed the same uniform distribution as seen after 
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initial fabrication, suggesting that the internal structure of alginate was preserved during in vitro 
culture. 
 
Figure 3.8 Qualitative and quantitative cell proliferation analyses indicate cell population 
increases in hybrid constructs with time in culture. Live-stained constructs impregnated with 
rounded (A-C) and fibroblastic cells (D-F) at day 1 (A,D), day 7 (B,E), and day 14 (C,F). (G,H) 
Confocal image of green and red stained rounded cells in a hybrid construct at day 28 of culture. 
Inset images and panel H are high magnification view of the cells in the constructs showing cell 
cluster formation in hybrid constructs over time. (I) Fold increases in cell numbers in hybrid 
constructs over time. Asterisks indicate statistically significant difference with P< 0.001. 
3.4.5 Rounded and fibroblastic cells secrete abundant cartilage matrix within hybrid 
constructs 
Abundant Alcian blue and Col2 immunofluorescence staining reflected secretion of the 
two main components of cartilage tissue matrix, glycosaminoglycans (GAGs) and Col2 [61], 
within hybrid constructs during in vitro culture. Alcian blue staining was localized around cells 
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in the alginate hydrogel of the hybrid constructs from both rounded and fibroblastic cells (Fig. 
3.9A-L). Over the culture timepoints, regions of Alcian blue-stained matrix appeared to increase 
in size within both the rounded and fibroblastic cell hybrid constructs. At days 7 and 14, 
fibroblastic cells seemed to produce more Alcian blue-stained matrix than the rounded cells (Fig. 
3.9C,D,I,J). At day 28, the Alcian blue-stained matrix almost filled the alginate strands of the 
hybrid constructs for both rounded and fibroblastic cells (Fig. 3.9E,F,K,L).  
In order to quantitate these observations, the relative area of Alcian blue-positive matrix 
was measured at each timepoint during the culture period, and these measurements confirmed the 
trends observed in the images. Reflecting GAG secretion, Alcian blue-stained matrix increased 
over culture time for both rounded and fibroblastic cells, being significantly higher at day 28 
compared to days 7 and 14 (Fig. 3.9M). Alcian blue-stained matrix significantly increased at day 
14 compared to day 7 for fibroblastic cells. At each timepoint measured, fibroblastic cells 
showed larger regions of Alcian blue-stained matrix than rounded cells, with statistical 
significance at days 7 and 14. Alcian blue-stained matrix accounted for more than 80% of the 
measured area of alginate strands by day 28 in both rounded and fibroblastic cell constructs (Fig. 
3.9M). In total, these data confirm that hybrid constructs provide a favourable environment for 
increased secretion of cartilaginous matrix during long culture periods. 
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Figure 3.9 Increased secretion of Alcian blue-positive matrix in the 3D hybrid constructs over in 
vitro culture time. Alcian blue-stained 3D constructs impregnated with (A-F) rounded and (G-L) 
fibroblastic cells at day 1 (A,B,G, H), day 7 (C,I), day 14 (D,J), and day 28 (E,F,K,L). Panels B, 
E, H, and K are high magnification views of samples in panels A, F, G, and L, respectively. (M) 
Quantitative increase of Alcian blue-positive matrix in 3D hybrid constructs over time in culture 
for rounded and fibroblastic cells. Single asterisk and double asterisks indicate statistically 
significant differences with P<0.05 and P<0.001, respectively. 
Col2 immunostaining demonstrated secretion of Collagen type II matrix around 
impregnated cells of the in vitro-cultured hybrid constructs. Similar to the Alcian blue staining 
results, Col2-stained matrix increased for both rounded and fibroblastic cells over time in culture 
(Fig. 3.10). At day 1 and 7, rounded and fibroblastic cells showed comparable Col2 matrix 
secretion. However, fibroblastic cell hybrid constructs seemed to have larger and more 
continuous Col2-stained matrix than the rounded cells by day 14 of culture (Fig. 3.10D,E,I,J). 
The cells impregnated in the constructs also secreted some Collagen type X (Col10) matrix after 
0
10
20
30
40
50
60
70
80
90
100
Day 7 Day 14 Day 28
A
lc
ia
n
B
lu
e
 s
ta
in
e
d
 m
at
ri
x
(%
 a
re
a)
Culture time
Rounded cells
Fibroblastic cells
100 μm
Fi
b
ro
b
la
st
ic
 c
e
lls
Day 1Day 1 Day 28Day 7 Day 14
R
o
u
n
d
e
d
 c
e
lls B
G
C D E F
H I K
Day 28
200 µm
A
LJ
*
**
**M
**
 106 
 
long term in vitro culture (Fig. 3.11). In summary, these data demonstrate that hybrid constructs 
are permissive for chondrogenic differentiation and secretion of Collagen type II matrix by both 
rounded and fibroblastic cells. 
 
Figure 3.10 Collagen type II (Col2) immunofluorescence staining illustrates increase of Col2-
positive matrix over time in 3D hybrid constructs. Fluorescent images of constructs impregnated 
with rounded (A-E) and fibroblastic cells (F-J) at day 1 (A,B, F,G), day 7 (C,H), and day 14 
(D,E,I,J). The same exposure time was used for panels B-D and G-I to illustrate relative increase 
in Col2 immunostaining during culture. 
 
Figure 3.11 Collagen type II (Col2) and type X (Col10) immunofluorescence staining illustrates 
both (A) Col2-positive matrix and (B) some Col10-positive matrix in the 3D hybrid constructs. 
(C) Hypertrophic cartilage of developing limb in embryonic chick (HH35) was used as a positive 
control for Col10 immunostaining. (D) DIC image of HH35 chick section, and (E) overlay image 
of panels C and D demonstrate abundant Col10 in hypertrophic cartilage of the developing 
embryonic chick limb. 
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3.4.6 Biofabrication of cartilage hybrid constructs can be scaled up successfully 
To confirm that this biofabrication method can be scaled up to make biologically 
functional constructs with a thickness approximating that of mature cartilage, 6-layer constructs 
were printed, and cell viability and matrix production were evaluated. For these experiments, the 
common chondrogenic cell line, ATDC5 [56, 57], was used. High cell viability and Alcian blue 
staining at days 14 and 28 of culture demonstrated that this hybrid biofabrication method can be 
scaled up to create multilayer constructs that maintain high cell viability and secretion of GAGs 
(Fig. 3.12, and data not shown). Cross section views further confirmed the biocompatibility of 
the PCL printing temperature. Similar to the two-layer hybrid constructs (Fig. 3.8A-G), uniform 
distribution of cells within the alginate throughout the thickness of six-layer constructs verified 
the integrity of the alginate hydrogel 3D structure during in vitro culture (Fig. 3.12). These 
results demonstrate not only the successful up-scaling of this biofabrication method, but also 
illustrate its versatility on multiple cell sources. 
 
Figure 3.12 Six-layer hybrid constructs with impregnated ATDC5 cells also demonstrate good 
biofunctionality. Cross section views of six-layer constructs revealed promising biological 
performance by (A) live (green) and dead (red) cell viability assay, and (B) Alcian blue-positive 
matrix at day 14. Cross section of the PCL strands and the outline of the transverse PCL strands 
that make the 0/90º pattern in the stacked layers are seen in panel B. 
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3.5 Discussion 
Identifying parameters of biofabrication that enable reproducible results, while ensuring 
biocompatibility, is critical to future clinical applications of tissue engineering. Recently, the 
sophisticated tissue engineering strategy of 3D bioprinting live cells into hybrid constructs has 
been attracting more attention, since it can generate customized structural and biological 
functions. Also, this biofabrication method is automated, hands-free, and economical, showing 
promise to improve cartilage tissue regeneration and facilitate clinical translations. The 
feasibility of using 3D bioprinting for cartilage tissue engineering had been shown by limited 
studies [23-25], and this study confirmed and significantly expanded the promising potential of 
this technique. Parameters of a hybrid biofabrication process that employs melt-dispensed PCL 
polymer and chondrocyte-impregnated alginate were identified to enable biocompatible 
impregnation of cells and allow maintenance of the construct’s structural integrity [see Appendix 
A]. Throughout culture periods of four weeks, impregnated cells were distributed uniformly, and 
high cell viability was observed (Figs. 3.7,8). Although PCL was dispensed at high temperatures, 
there was a relatively fast (within seconds) and large decrease of temperature at the surface of the 
dispensed PCL strand (Fig. 3.2), presumably because the small size of the strands accelerated the 
cooling process. The high observed cell viability during biofabrication of hybrid constructs may 
result from this rapid cooling, since there was no spatial correlation between dead cells and 
dispensed PCL (Figs. 3.7,12) 
Reproducible and biocompatible 3D printing of structurally stable hydrogels remains a 
challenge. The PCL scaffold provides mechanical properties to the hybrid construct [25], with 
the goal of withstanding loading of the joint after in situ implantation, yet still allowing some 
transfer of applied mechanical stimuli to the cells in the alginate. In the absence of any external 
loading, such as in the experiments reported here, the PCL scaffold likely does not affect the 
biological behaviour of cells encapsulated in alginate. The performance of the PCL scaffold in 
transferring customized mechanical stimuli (modulated by the PCL architectural design) to the 
cells in the alginate is recommended to be investigated in the future studies. Despite mechanical 
support from PCL, the alginate strands in hybrid constructs also need to exhibit some level of 
stability after fabrication in order to maintain the customized design properties. Crosslinking the 
hydrogel before dispensing can improve biofabrication [38], but the crosslinking process is 
progressive, leading to changes in hydrogel viscosity over time. This introduces undesirable, 
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time-dependent variability to the fabrication process, making the pre-crosslinking method less 
reproducible. The more common approach of using higher concentrations of alginate (e.g. 3.5%-
10% [24, 38, 62]) also benefits its structural stability, but suffers from limitations on 
biocompatibility. Cells are subjected to increased shear stress during printing [26, 27], and 
increased alginate concentrations may provide a less favourable biological environment for some 
cells [24, 28, 29]. In this study, suitable biofabrication parameters were identified to avoid these 
limitations. A combination of alginate processing temperature and initial viscosity was found to 
improve printability at low concentrations (2% and 2.5% w/w) without any pre-crosslinking (Fig. 
3.6). This finding should assist tissue engineering strategies that require low hydrogel 
concentrations for biological reasons [63]. 
To evaluate the biological performance of hybrid constructs, two distinct cell populations 
isolated from embryonic chick cartilage were assayed for cell viability, proliferation, and 
secretion of cartilage ECM components during lengthy periods of in vitro culture. The “rounded” 
and “fibroblastic” cell populations were identified in 2D primary cultures based upon 
morphology (round versus elongated) and adhesive affinity to the culture flask (floating/easily 
detached versus firmly attached) (Fig. 3.4). After bioprinting into 3D hybrid constructs, these 
cell populations continued to demonstrate some differences (i.e., timecourse of proliferation and 
secretion of cartilage ECM) (Figs. 3.8-10), but they both showed high overall biological 
performance (Fig. 3.7-10). 
Focussing first on similarities in the in vitro performance of two distinct cell populations 
in hybrid constructs, both rounded and fibroblastic cells displayed high viability and abundant 
secretion of cartilage ECM (Figs. 3.7, 9 & 10). Cell viability was over 80% for up to 14 days of 
culture. Also, abundant Alcian blue staining and Col2 immunostaining in both cell populations 
(Figs. 3.9,10) reflect secretion of the two major components of cartilage ECM, GAGs and 
Collagen type II [61], further demonstrating the promising biocompatibility of this 3D 
biofabrication method. While the majority of impregnated cells appear to maintain a non-
hypertrophic, cartilaginous phenotype throughout the examined culture period, a few cells 
expressed Col10 after long culture time (Fig. 3.11). Col10 expression is characteristic of deep 
and calcified layers of articular cartilage [64-66], so future work must be done to regulate layer-
specific gene expression in engineered cartilage constructs. These are critical results for 
therapeutic applications of cartilage tissue engineering, since culturing tissue constructs in vitro 
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for a period of time may allow cells to initiate lineage-specific (e.g., chondrocyte) cellular 
activities prior to in vivo implantation [34, 67]. 
Differences in biological performance of the rounded and fibroblastic cells in hybrid 
constructs are presumed to rise from intrinsic differences between the two cell populations, since 
similar results were obtained in many independent experiments. These results raise the general 
issue of the importance of selecting among alternative cell sources for tissue engineering 
applications. Rounded and fibroblastic cells showed differences in the timing of cell proliferation 
and secretion of cartilage ECM (Figs. 3.8-10). A dramatic increase in proliferation of fibroblastic 
cells compared to rounded cells was observed at later timepoints of 3D hybrid construct culture 
(Fig. 3.8). Also, statistically larger regions of Alcian blue-stained matrix appeared in fibroblastic 
cells than in rounded cells at days 7 and 14 of culture (Fig. 3.9), and fibroblastic cell constructs 
appeared to contain larger areas of Col2-positive matrix than the rounded cells at day 14 of 
culture (Fig. 3.10). Together, these data suggest that fibroblastic cells secrete abundant cartilage 
ECM earlier than rounded cells, but they also maintain capacity for proliferation longer than the 
rounded cells. Both of these features seem beneficial for therapeutic applications of cartilage 
tissue engineering, and call for an understanding of the mechanistic basis for these observations.  
Despite the fact that both rounded and fibroblastic cells were isolated from the same 
source (embryonic cartilage), I propose that differences in their biological performance in 3D 
hybrid constructs are explained by the idea that they are at different states of chondrocyte 
differentiation. Rounded cells have typical chondrocyte morphology [68], suggesting that they 
may be differentiated chondrocytes. On the other hand, fibroblastic cells have a morphology that 
is that is typical of many cell types, including stem cells [69]. Given their origin from embryonic 
cartilage, the fibroblastic cells may be undifferentiated cartilage stem cells (chondroprogenitors) 
or dedifferentiated chondrocytes. While dedifferentiation of primary cells is common in 2D 
culture [70, 71], two functional observations support the assertion that fibroblastic cells are 
cartilage stem cells. Chondroprogenitor cells maintain capacity for cell division [36], and 
fibroblastic cells demonstrated increased cell proliferation. Also, asymmetric division of 
progenitor cells give rise to differentiated cells [36, 72], and fibroblastic cells appeared to give 
rise to rounded cells during 2D culture (Fig. 3.4). Interestingly, when rounded cells were cultured 
in a 2D environment, some cells attached to the substrate and formed fibroblastic morphology 
(data not shown), indicating that some rounded cells still have the potential to dedifferentiate and 
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attach to the tissue culture plate. Similar behaviour of cartilage cells in 2D culture has also been 
observed in human [73], murine [74, 75], and chick [76, 77] primary embryonic chondrocytes. 
Moreover, the continued proliferation of the rounded cells in the 3D constructs (Fig. 3.8) 
suggests that they may not be fully-matured, post-mitotic chondrocytes, which have low 
proliferation capability [78, 79]. In fact, their proliferative capability is similar to transiently-
amplifying chondrocytes that are organized into columns of the developing growth plate [79, 
80]. Finally, molecular data support the idea that rounded cells are chondrocytes and fibroblastic 
cells are chondroprogenitors (Fig. 3.5). qPCR analyses directly after 3D bioprinting showed that 
rounded cells had significantly higher expression of Col2a1, a marker of differentiated 
chondrocytes [61, 81, 82], while fibroblastic cells expressed significantly higher levels of 
Col1a2, a marker of undifferentiated mesenchymal cells [83, 84].  
In total, these functional and molecular data suggest that chondroprogenitors may serve as 
a better cell source than differentiated chondrocytes in cartilage tissue engineering, since they 
produce cartilage ECM quicker and proliferate more. Such speculation needs to be supported by 
rigorous molecular characterization (e.g., transcriptomics) and clonal cell analyses, but would 
inform a critical, unresolved issue for therapeutic applications of cartilage tissue engineering. 
Which among the two common cell sources is best: chondroprogenitors from mesenchymal stem 
cells, or primary chondrocytes isolated from differentiated cartilage [36, 85-88]?  
To be clinically relevant, biofabrication methods must work with a variety of cell sources 
and also be capable of making constructs that match the size of the tissue to be replaced. The 
cartilage tissue engineering method developed in this study satisfied these objectives. Good 
biological performance in hybrid constructs was observed using three different cell types and 
sources: rounded and fibroblastic cells from primary embryonic chick cartilage, as well as a 
mammalian chondrocytic cell line, ATDC5. While these cells do not have direct application to 
large animal and human studies, the primary cell isolation method used here from embryonic 
chick is similar to that used to isolate primary chondrocytes from larger animals and human 
tissues [89]. Future applications of this hybrid biofabrication method should be explored using 
primary chondrocytes and mesenchymal stem cells from adult tissues. Furthermore, the hybrid 
biofabrication method demonstrated good performance when scaled up from two-layer (480 m) 
to six-layer (1.4mm) constructs (Fig. 3.12). These six-layer constructs approximate the average 
thickness of human articular cartilage (e.g. [55]). Future applications of this hybrid fabrication 
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method may improve engineering of cartilage and other tissues. Complex structural and 
biological properties could be designed into constructs that mimic the zonal characteristics of 
articular cartilage [21, 31]. Such biomimetic tissue constructs may promote more natural ECM 
formation [90, 91].   
In addition to cartilage tissue engineering, the developed biofabrication method could 
improve functionality of many different soft and hard engineered tissues (such as tendon, 
ligament, bone and tooth) that require synergistic components with customized properties [92, 
93]. Advanced biofabrication technologies build the foundations for hands-free, automated, 
aseptic, and economic tissue engineering methodologies that are required for large-scale clinical 
trials [94-96]. 
3.6 Conclusions 
In this study, a 3D printing-based biofabrication technique was developed successfully for 
making custom-designed, hybrid constructs from polymer and cell-impregnated hydrogel. 
Demonstrating the potential for advanced cartilage tissue engineering, this hybrid biofabrication 
enabled promising biological performance (viability, proliferation, and cartilage ECM secretion) 
of three different cell types (two primary embryonic cell populations and an established 
chondrocyte line). Statistically significant differences in biological performance of two 
morphologically distinct cell populations isolated from embryonic chick cartilage were discussed 
in relation to the strategy of using differentiated vs. progenitor cells in tissue engineering. The 
hybrid biofabrication method described here can be used to develop sophisticated, biomimetic 
tissue constructs with more complicated structures and functions. 
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CHAPTER 4:  COMPUTED TOMOGRAPHY DIFFRACTION ENHANCED IMAGING FOR 
IN SITU VISUALIZATION OF TISSUE SCAFFOLDS IMPLANTED IN CARTILAGE 
This chapter has been published as "Izadifar Z., Chapman LD, Chen X. (2014) Computed 
tomography diffraction-enhanced imaging for in situ visualization of tissue scaffolds implanted 
in cartilage. Tissue Engineering Part C: Methods. 20(2): 140-148". According to the Copyright 
Agreement, "the authors retain the right to include the journal article, in full or in part, in a thesis 
or dissertation". 
4.1 Abstract 
Long-term in vivo studies on animal models and advances from animal to human studies 
must rely on non-invasive monitoring methods. Synchrotron radiation (SR)-diffraction enhanced 
imaging (DEI) has shown great promise as a non-invasive method for visualizing native and/or 
engineered tissues and bio-microstructures with appreciable details in situ. The objective of this 
study was to investigate SR-DEI for in situ visualization and characterization of tissue 
engineered scaffolds implanted in cartilage. A piglet stifle joint implanted with an engineered 
scaffold made from polycaprolactone was imaged using SR computed tomography (CT)-DEI at 
an X-ray energy of 40 keV. For comparison, in situ visualization was also conducted with 
commonly-used SR CT-phase contrast imaging (PCI) and clinical magnetic resonance imaging 
(MRI) techniques. The reconstructed CT-DE images show the implanted scaffold with the 
structural properties much clearer than those in the CT-PC and MR images. Furthermore, CT-
DEI was able to visualize microstructures within the cartilage as well as different soft tissues 
surrounding the joint. These microstructural details were not recognizable using other imaging 
techniques. Taken together, the results of this study suggest that CT-DEI can be used for non-
invasive visualization and characterization of scaffolds in cartilage, representing an advance in 
tissue engineering to track the success of tissue scaffolds for cartilage repair. 
 
4.2 Introduction 
Articular cartilage is a specialized tissue that covers the ends of the bones in diarthrodial 
joints of the body and facilitates their movements within the joint. Articular cartilage lesions 
from traumatic joint injuries in children and young adults as well as cartilage degeneration 
resulting from osteoarthritis (OA; present in ~70% of the population aged 65 years and older [1]) 
are serious health problems throughout the world. Unfortunately, the natural healing ability of 
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human articular cartilage is very limited. Available clinical treatments for cartilage repair also 
have limited success [2] since they do not result in long-term correction of cartilage pathologies 
[3]. Tissue engineering (TE) aims to replace or repair damaged articular cartilage with an 
engineered tissue and, as such, holds great promise for joint repair. Most tissue engineering 
strategies employ 3-dimensional (3D) scaffolds made of biocompatible materials incorporated 
with viable cells and/or bioactive molecules to promote new tissue generation and functional 
recovery. To this end, the visualization of the scaffolds, once implanted in animal models or 
human patients, is essential to track their success. For this, scaffold visualization methods such 
as biomedical imaging play a significant role.   
At the current experimental stages of cartilage TE, conventional histological and imaging 
techniques, such as light microscopy, scanning electron microscopy, transmission electron 
microscopy, and confocal laser microscopy, are typically used to visualize and study the success 
of the tissue engineered scaffolds. These conventional methods are destructive and involve 
invasive analysis, for which the animal model must be sacrificed. For long-term animal studies, a 
large number of animals are required for sacrifice throughout the experiments, which makes in 
vivo studies expensive and complicated. Furthermore, as TE strategies will eventually advance 
from animal to human studies, non-invasive visualization of scaffolds and new tissue generation 
becomes essential. Although a large number of TE studies have been targeting cartilage tissue, 
the development of non-invasive monitoring methods with application to cartilage tissue 
engineering has received limited attention.  
Diffraction enhanced imaging (DEI) is an X-ray imaging technique that has shown great 
promise for non-destructive, quantitative, and qualitative visualization of soft tissues with 
detailed internal structures. DEI contrast is based on the refraction of X-rays, rather than 
absorption/attenuation as they travel through the object being imaged. This makes DEI a suitable 
technique for imaging TE scaffolds and constructs as well as soft tissues (e.g., cartilage) that 
have very low X-ray attenuation. The main advantage of DEI is that the images can be captured 
non-invasively and without any exogenous contrast agents. DEI is capable of resolving 
histological and structural details of articular cartilage [4-7], which are not easily visible using 
conventional imaging techniques based on absorption contrast. Cartilage consists of ~80% water 
and, as such, is invisible in conventional radiographs. This is also true for TE scaffolds and 
constructs made from low density materials [4, 8]. Magnetic resonance imaging (MRI) and 
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ultrasound are two additional, well-known medical imaging techniques. However, they exhibit 
some inherent limitations or disadvantages for imaging soft tissues and low density materials 
such as cartilage [9], including the limits on spatial resolution and the types of tissues/structures 
that can be resolved. Consequently, investigation of alternative non-invasive imaging techniques 
(such as DEI) that can overcome these limitations is greatly needed.  
With its higher spatial resolution than MRI, synchrotron radiation (SR)-DEI offers 
considerable promise for providing detailed information of tissues and microstructures [10]. In-
line phase contrast imaging (PCI) [11] is one SR X-ray imaging method based on similar, but 
simpler than DEI, principles and thus offers easier imaging modality. Because of its simplicity 
and ability to visualize microstructural details in various biological tissues and TE scaffolds [12, 
13], PCI has been commonly used in tissue engineering. However, in most reported studies DEI 
and PCI have been used for imaging TE scaffolds in the in vitro or non-in situ-like conditions. 
Examples include imaging of dehydrated TE scaffolds in air [12, 13] and in thin tissue 
representative medium [8]. Although these studies demonstrate the potential of these techniques, 
their capacity for real in vivo TE studies has not been investigated and reported yet. Planar or 2-
dimensional (2D) DEI and PCI have recently been investigated for visualization of low-density 
TE scaffolds embedded in muscle tissue with a sample thickness of up to 4 cm [8]. As the tissue 
sample becomes thicker (more than 4 cm) visualization of scaffold may become questionable by 
using these 2D imaging techniques. With the advance of computed tomography (CT), it is 
rational to combine these imaging techniques with CT to potentially overcome this limitation 
with improved capacity for visualization of TE scaffolds in thick tissue samples or in situ. To the 
best of the authors’ knowledge, to date there have been no studies reported in this regard. As 
such, the objective of this study was aimed at investigating CT-DEI for visualization and 
characterization of TE cartilage scaffolds in situ, compared to CT-PCI and clinical MRI, so as to 
identify the most appropriate imaging technique for use in non-invasive and serial in situ 
monitoring of TE cartilage repair. 
4.3 Materials and methods 
4.3.1 Scaffold fabrication 
The scaffold used in the present study was designed with a porous structure and then 
fabricated on a 3D-Bioplotter (Envisiontec GmbH, Gladbeck, Germany). The Bioplotter is a 
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three-axis, computer-controlled additive manufacturing system that can build 3D scaffolds from 
a variety of biomaterials. Poly-ε-caprolactone (PCL) (Mw 48,000-90,000, Aldrich, Saint Louis, 
MO, USA) was chosen for the scaffold fabrication due to its wide applications to cartilage tissue 
engineering. PCL was melted at 65 °C in the high-temperature dispensing head of the Bioplotter 
and was subsequently dispensed through a metal needle with an internal diameter of 400 µm 
under a pneumatic pressure of 0.75 MPa (Fig. 4.1A). Scaffolds were fabricated by dispensing 
melted PCL strands in multiple layers with a strand spacing of 1 mm and a 0°/90° pattern of 
successive layers (Fig. 4.1B). The scaffold was originally fabricated with an overall size of 10 
mm × 10 mm × 1.7 mm and was then trimmed to 4 mm × 4 mm × 1.7 mm for implantation. 
 
Figure 4.1 (A) Scaffold fabrication by using pneumatic dispenser head and (B) 3D scaffold with 
five layers of PCL strands. 
4.3.2 Sample preparation 
Pig joints are usually used for in vivo cartilage tissue engineering studies [14] because 
they better simulate human conditions than small animal models. In this study, the piglet stifle 
(knee) joint was selected to investigate the non-invasive imaging. Dissected stifle joints of four-
week-old cadaver piglets were prepared at the Vaccine and Infection Disease Organization 
(VIDO, Saskatoon, Canada). For each sample, a full thickness articular defect (4.5 mm × 4.5 mm 
× 2-2.5 mm depth) was created in the lateral femoral condyle cartilage of the knee and a scaffold 
as prepared above was then implanted into the created defect area and covered with a piece of 
periosteum layer [14], which was concurrently harvested from the proximal femur (Fig. 4.2), to 
mimic the actual surgical procedure used in animal and clinical studies. During the implantation 
surgery, joint cavity fluid was released and as a result, air was entered the joint cavity and the 
surrounding soft tissues. It is noted that the trapped air may misrepresent in vivo conditions and 
A B
10 mm
10 mm
2 mm
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cause artifacts in the images. As such, the trapped air must be removed from the joint samples 
prior to being imagined. For this, joint samples were placed in a sample holder filled with 
Dulbecco’s phosphate buffered saline, which was then placed in a vacuum desiccator for 10-15 
min to remove trapped air. It is noted that in live animal/clinical studies, the trapped air may be 
gradually absorbed and removed from the site via the vascular system/blood circulation 
postsurgery, and then replaced with synovial and body fluids.  
 
Figure 4.2 Surgical approach used for implanting TE scaffolds in the lateral femoral condyle 
cartilage of the knee in dissected piglet joints. 
4.3.3 Synchrotron based imaging 
Imaging was performed at the Biomedical Imaging and Therapy bend magnet (BMIT-
BM) beamline of the Canadian Light Source (CLS, Canada). A highly collimated X-ray beam 
was produced by a bend magnet (1.354T) and monochromatized at 40 keV photon energy by a Si 
(4,4,0) double crystal monochromator. It is noted that the photon energy is determined by the 
thickness of tissue sample being imaged, i.e., thicker the sample is, higher photon energy is 
required. Based on the previous studies [8, 15], 40 keV photon energy and the analyzer reflection 
plane of Si (4,4,0) were selected and expected to be able to visualize the samples as prepared in 
this study. A Photonic Science detector (St. Geoirs, France) with an effective pixel size of 37 
µm× 37 µm was employed to collect the images, which was selected based on the balance 
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between the area of interest in the sample and the image resolution, as well as the availability of 
detectors at the CLS. For each sample, CT images were acquired by rotating it 180° around an 
axis perpendicular to the incident beam with an angular scanning increment of 0.072°. During 
the process of imaging, both the beam and detector were stationary and the detector acquisition 
system was synchronized with the sample angular scanning. The size of the scanned region (field 
of view) at the detector was 4 mm (vertical) × 74 mm (horizontal). The time required for imaging 
one sample was 4.9 h for CT-DEI and 1.7 h for CT-PCI. The principles behind both CT-DEI and 
CT-PCI are outlined as follows. 
4.3.3.1 CT-DEI  
DEI can dramatically increase the contrast of X-ray images by utilizing a crystal analyzer 
that enables contrast mechanisms of refraction, ultra small angle x-ray scattering (USAXS), and 
scatter rejection of small angle x-ray scattering (SAXS) in addition to the absorption mechanism 
[5]. When the X-rays travel though the sample, they are refracted at the interfaces of organized 
features/structures in the tissue through angles of a few microradians. The analyzer placed 
between the object and the detector (Fig. 4.3) uses its angle-dependent reflectivity, or rocking 
curve (RC), to tune the diffraction of refracted, transmitted X-rays off the analyzer to the 
detector. At the detector, this is translated into enhanced contrast at the interface of features 
having different densities from their surroundings. A detailed description of the DEI method can 
be found in [16]. To obtain DEI refraction images, two sets of images were taken: one on the low 
angle side (the low-angle image (L)) and one on the high angle side (the high-angle image (H)) 
of the half maximum point of the analyzer RC (Fig. 4.3). On each side of the RC, tomographic 
images were acquired by taking 2500 projection images from angular scanning. For 
normalization of images, flat field (beam without sample) and dark field (without beam) images 
were also taken at both sides of RC. Refraction angle images were then calculated using the 
following equation [16]:  
∆𝜃𝑍 =
𝐼𝐻𝑅(𝜃𝐿)−𝐼𝐿𝑅(𝜃𝐻)
𝐼𝐿(
𝑑𝑅
𝑑𝜃
)(𝜃𝐻)−𝐼𝐻(
𝑑𝑅
𝑑𝜃
)(𝜃𝐿)
     4.1 
where ΔθZ is the intensity in the refraction angle image, R(θ) is the analyzer reflectivity, θ is the 
analyzer angle, and IH and IR are the intensity of the images taken on high-angle side (θH) and 
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low-angle side (θL), respectively. Obtained refraction images were then processed using 
SYRMEP software (Elettra Synchrotron Facility, Trieste, Italy) to create CT slices, which were 
then 3D rendered using Avizo® software (VSG, Burlington, USA). 
 
Figure 4.3 Schematic of the DEI set up at the Canadian Light Source used for imaging TE 
scaffolds in piglet joints. Embedded graph shows the analyzer rocking curve, in which X-ray 
reflectivity from the analyzer is a function of incident angle. 
4.3.3.2 CT-PCI 
PCI exploits X-ray refraction at the edges of different features to provide higher image 
contrast. In in-line PCI, this is made possible by providing a free space between the sample and 
the detector so that the refracted, transmitted X-rays can freely propagate and interfere to 
develop informative phase-shifted signals at the detector. Synchrotron radiation provides high 
coherence X-rays, which is essential to enhancing the quality of PC images. Briefly, the X-rays 
travel through the object, with the phase information of the beam disturbed by interfaces of 
features inside the sample that have differing refractive indexes. The phase variation propagated 
in the free sample-to-detector distance is converted into intensity variation at the detector to 
visualize the structural features in the object. For PCI of the pig joint samples, a sample-to-
detector distance of 85 cm was used. Multiple (3000) images were acquired by rotational 
(angular) scanning of the sample. Flat field and dark field images were also taken for 
normalization. Tomographic slices were reconstructed following the same procedure as for CT-
DEI. 
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4.3.3.3 Magnetic resonance imaging (MRI) 
MRI of joint samples was performed at the MRI Center, Royal University Hospital, 
Saskatoon, Canada. The MRI imaging system was a 3T Siemens MAGNETOM® MRI Skyra 
(Muenchen, Germany), with XQ gradients and 48 channels. T2-weighted spin-echo sequence 
was used for taking the image and the imaging receiver employed was a hand/wrist 16 channel 
high resolution receiver coil with a “clamshell design”. By using MRI, the time required for 
imaging one sample was 4 min. Images obtained by MRI were processed by using Numaris/4 
software (syngo MR D11, Muenchen, Germany). 
4.4 Results  
4.4.1 Scaffold characterization 
Images of the PCL scaffold fabricated for implantation are shown in Fig. 4.4. The grid 
structure and morphology of the PCL scaffold are visible from stereo microscope (Ancansco, 
Canada) image at 2x magnification (Fig. 4.4A). The size of the fabricated scaffold in the z 
direction is indicated in the isometric view of the scaffold taken by digital camera (Fig. 4.4B). It 
is noted that the computer-controlled fabrication technique employed in the present study allows 
for reproducibility of scaffolds with the designed structure and properties, thus limiting the 
variability of samples for imaging. 
 
Figure 4.4 Images of the fabricated PCL scaffold by a stereo microscope at 2x magnification (A) 
and a digital camera (B). 
1.7 mmB
A
1 mm
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4.4.2 Planar diffraction enhanced imaging 
Using the DEI technique, absorption images were obtained along with refraction images. 
As expected, the absorption image did not provide enough contrast for visualizing the low 
density scaffold and surrounding tissue microstructures. Consequently, the refraction image, 
which achieves its contrast solely from refraction of X-rays, is of interest in this study and is 
exclusively discussed below (referred to as the DE images).  
A planar refraction image obtained from the projection DEI of the sample shows a 15 cm 
long sagittal view of the joint (Fig. 4.5). The planar refraction image was acquired to compare 
the visibility of the cartilage scaffold in situ using 2D imaging modality to tomographic imaging. 
A weak grid profile of the scaffold can be recognized in the planar DE image (Fig. 4.5); 
however, the contrast is obviously not sufficient for clear visualization. The limited contrast of 
the scaffold image may be due to the nature of 2D imaging, in which superposition of 
information over the thickness of the sample can hinder distinct differentiation of the scaffold 
structure. As expected, quantitative characterization of scaffold structural properties was also not 
possible in 2D-DEI. Furthermore, the images of the scaffold that show its grid structure (e.g., 
Fig. 4.5) can only be acquired in limited projection shots, i.e., at specific spatial/angular positions 
of the scaffold and the joint itself, but this is inconvenient and impractical. CT imaging can 
overcome these limitations by producing volumes of data that are used to generate 3D images of 
the sample.  
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Figure 4.5 Sagittal image of the pig joint using 2D-DEI; the white arrow points to the implanted 
scaffold in the lateral femoral cartilage. Asterisk (*) indicates the growth plate in a growing joint. 
The arrowheads show the periphery of a plastic tube placed at the vicinity of the implantation 
site to direct air bubbles out of the joint. 
4.4.3 Computed tomography diffraction enhanced imaging 
A volume image was reconstructed from the CT-DEI of the sample. The refraction image 
of a representative slice (Fig. 4.6) shows a profile through the cartilage of lateral and femoral 
condyles as well as surrounding soft tissues (e.g., skin, muscle, fat). The interfaces of different 
soft tissues as well as microstructures of the skin and the infrapatellar fat pad can be identified in 
the DE image (Fig. 4.6A). In the enlarged image showing the condyles (Fig. 4.6B), a cross-
sectional view of the PCL scaffold is clearly recognizable in the lateral femoral cartilage. The 
PCL strands and their 0°/90° grid pattern of the scaffold structure are clearly visible in the image. 
Notably, the enhanced contrast at the edges of the strands makes the scaffold contour visible and 
distinguishable from surrounding low-density tissues. In addition to the implanted scaffold, the 
DE images show the information on tissue features, including the morphological or structural 
features of the cartilage (e.g. different appearance of the cartilage tissue in the inner area of the 
femoral condyle) and the vascular channels within cartilage (Fig. 4.6B and 4.9A).   
A 3D rendered image of stacked tomographic slices created a volume image of the joint 
with a thickness of 4 mm about the region of implantation (Fig. 4.7). The surfaces of the condyle 
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cartilage at an axial view of the joint are visible (Fig. 4.7A), with the recognizable structural 
pattern of the implanted scaffold (Fig. 4.4A) clearly depicted in the lateral condyle cartilage. 
Branches of vascular channels throughout the lateral condyle cartilage are also easily identified 
in the 3D rendered image. The vascular branches in the medial condyle cartilage are visible in 
other views. While the cartilage vascular system is most evident in young growing joints, these 
images show the obvious potential of DEI for visualizing detailed microstructures in soft tissues. 
An enlarged 3D rendered image of the scaffold (Fig. 4.7B) provides a clear image of the scaffold 
structure in which some structural properties, such as strands and pore sizes, can be 
quantitatively characterized. This is of special interest for in vivo evaluation of the degradation 
and mechanical properties of scaffolds during the repair process. For example, one can employ 
finite element models that use measurable structural parameters as input for simulations that 
evaluate changes in scaffold mechanical properties with time [17]. Interestingly, even the 
surgical suture that was used for suturing and closing the inner site of incision was visualized in 
the DE image (Fig. 4.7B). Furthermore, the soft periosteum tissue layer used to cover and fix the 
scaffold in place was visible in the CT-DE images (Fig. 4.7C). These are features that can hardly 
be visualized at this detailed level, if at all, using other imaging techniques. Fig. 4.7A shows the 
presence of some air bubbles in the joint, which produces strong contrast against other 
anatomical features imaged in the joint. Although the vacuum dessicator removed the majority of 
air bubbles from the joint, some remain due to the limited vacuum duration and the formation of 
bubbles from boiling of the joint sample in the vacuum. The streak artifact that is seen around the 
scaffold in Fig. 4.6 and Fig.4.7 are caused due to a small copper wire used for quickly locating 
the scaffold in the joint for the CT scan.  
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Figure 4.6 Representative tomographic DE image of a pig knee joint implanted with a TE 
scaffold in the cartilage (image pixel size 37 μm): (A) axial full cross section image of the joint 
with different soft tissues identified and (B) magnified area of interest clearly showing the profile 
of the implanted scaffold in the lateral femoral condyle cartilage. Note the enhanced contrast at 
the edges of the scaffold strands, interfaces of different soft tissues, and contours of vascular 
channels.  
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Figure 4.7 Volume rendered DE image of the joint at the site of implantation: (A) axial view of 
the cartilage surface at lateral (*) and medial (×) femoral condyles, implanted scaffold, and 
vascular channels in a young growing joint (indicated by arrows), (B) magnified image of the 
implantation site shows the grid structure of the scaffold with measurable strand and pore sizes 
and details including the sutures used in the surgery; and (C) grafted periosteum layer covering 
and fixing the scaffold in place at the site of implantation. 
4.4.4 DEI compared to PCI and MRI  
The three imaging techniques—CT-DEI, CT-PCI, and MRI—were compared with respect 
to visualization of the PCL scaffold in cartilage in situ (Fig. 4.8). Slices through the joint at the 
site of implantation were obtained for CT-PCI (Fig. 4.8A) and CT-DEI (Fig. 4.8B). Although the 
two images represent the same axial view of the joint, the scaffold cannot be perceived in the PC 
image; however, the DE image clearly shows a profile of the scaffold structure. Structural 
features in the cartilage and surrounding soft tissues that can be recognized in the DE image (Fig. 
4.8B) are not visible in the PC image (Fig. 4.8A). This includes the contours that clearly 
distinguish the condyle cartilage from surrounding tissues, interfaces that differentiate various 
soft tissues, and in-cartilage vascular channels. The PCI-induced contrast can apparently only 
visualize and differentiate bulk features inside the sample (e.g. fat against non-fat soft tissues) 
and not the fine features required for visualizing microstructures (e.g., the TE scaffold). 
Consequently, the tested PCI system is unable to provide the information required for imaging 
and studying TE scaffolds for cartilage repair in situ.  
The MR image was taken at a resolution of 310 μm pixels. A representative MRI slice 
shows a cross section through the condyle cartilage and the location of scaffold implantation 
(Fig. 4.8C). The scaffold profile cannot be identified in the MR image and only the contour of 
the defect created in the cartilage can be depicted. Expectedly, soft tissues such as cartilage, 
muscle, fat, and skin are visualized and differentiated in the MR image; however, the scaffold is 
not visible. In fact, the defect area filled with the scaffold is seen as a void black spot in the MR 
image, which means that insufficient signal has been produced by the scaffold to make it visible 
at the detector. Overall, CT-DEI is the most capable method for in situ visualization of scaffolds 
in cartilage among the three imaging methods for comparison. 
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Figure 4.8 Comparison of (A) CT-PCI, (B) CT-DEI, and (C) clinical MRI techniques for 
visualizing TE scaffold implanted in the lateral femoral cartilage of piglet knee joint. Yellow 
arrows show the location of the implanted scaffold. Both PC and DE images were taken at a 
resolution of 37 µm pixels, while MR image taken at a resolution of 310 µm pixels. 
4.4.5 Radiation dose 
Based on the obtained results, the CT-DEI method evaluated is the most appropriate for 
visualizing and studying TE scaffolds in thick samples such as knee joints. To extend the 
application of this imaging method to in vivo studies on live animal models or even future 
clinical human studies, the ionizing radiation dose received by the sample during CT-DEI must 
be optimized. The irradiation absorbed by the sample is defined as the deposited energy per mass 
of material in which the radiation is deposited, and is usually characterized by the rate of 
radiation dose at the surface of the object where the largest dose occurs. The surface dose rate is 
calculated using  
𝐷(̇ 𝐸𝑝ℎ) =
?̇?𝑜𝐸𝑝ℎ
𝐴
 
𝜇
𝜌⁄
𝑎𝑏𝑠
,    4.2 
where 𝐷(̇ 𝐸𝑝ℎ) is the rate of surface absorbed dose in gray [Gy] or [J/kg], 𝐸𝑝ℎ [eV] is the photon 
energy, ?̇?𝑜 is the number of photons that hit the object surface area of A [cm
2] per second, and 
𝜇
𝜌⁄
𝑎𝑏𝑠
 [cm2/g] is the energy absorption mass attenuation coefficient.  
A B C
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Different tissues and organs respond differently to ionizing radiation based on their 
radiosensitivity. To account for these differences, a second radiation exposure metric is defined 
as 
?̇?𝑒𝑓𝑓 = 𝑊𝐹 × 𝐷(̇ 𝐸𝑝ℎ),    4.3 
where Deff is the effective dose rate in sieverts (Sv) and WF is a weighting factor related to the 
risk for a particular tissue or organ. Tissue weighting factors associated with different tissues and 
organs are recommended in the annals of International Commission on Radiological Protection 
(ICRP). The reported effective dose is usually used for measuring the potential detriment or risk 
to the radiosensitive tissue. The rate of absorbed surface dose, 𝐷(̇ 𝐸𝑝ℎ), to the sample imaged by 
CT-DEI was calculated at 0.34 mGy/s. Considering the total scanning time, the absorbed dose 
received by the joint sample during the X-ray scan was 6 Gy and with the cartilage tissue 
weighting factor of 0.01, the total received effective dose was 60 mSv.  
4.5 Discussion 
The results of this study reveal the feasibility of CT-DEI for in situ visualization of a PCL 
scaffold implanted in pig knee cartilage, which is a critical step to track the scaffold success in 
the in vivo applications. The combination of CT and DEI technique was found essential for in 
situ imaging of the scaffolds embedded in thick samples, thus providing a powerful tool for 
quantitative evaluation of changes in scaffolds during the tissue repair processes. In the present 
study, cartilage tissue was imaged with appreciate morphological and structural properties by 
using CT-DEI. As such, CT-DEI could be employed for studying the success of TE cartilage 
repair in situ by tracking scaffold changes as well as neotissue regeneration. The descriptive 
information with respect to the cartilage tissue morphology revealed that DE images can also be 
used for evaluation of the quality of neocartilage as compared to native cartilage. In addition, the 
CT-DEI presented in the present study was performed without the use of contrast agents or 
materials. Other methods may be able to provide visual information on the scaffold, but would 
require the use of contrast materials. In addition to extra work required for scaffold preparation, 
these contrast agents may also have negative impact on the function of scaffolds and surrounding 
tissues even after the scaffold completely degrades (i.e., the residual artifact). 
In addition to the cartilage tissue targeted in the present study, DEI revealed informative 
details on the morphology and microstructure of other soft tissues, such as skin, fat, and muscle 
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(Fig. 4.6A) as well as transverse ligament, anterior cruciate ligament, and menisci (Fig. 4.9A) (in 
which the striation and the fibrous texture of the ligaments are clearly visible). Notably, these 
structural features may not be imaged easily, if at all, using clinical imaging techniques. Also, it 
is noted that CT-DEI has the capacity to image hard tissue. For example, Figure 9B is an axial 
image of the joint, revealing the cartilage and proximal end of the tibia bone; interestingly, the 
spongy/porous structure of the bone is also visible (Fig 4.9B-inset). Simultaneous imaging of 
both soft and hard tissues demonstrates the promising potential of CT-DEI for tissue engineering 
applications involving a variety of different tissues. This ability is attributed to the non-
absorptive, refraction-based contrast mechanism of DEI. One application of this capability in 
cartilage TE is to monitor and study the repair at the bone-cartilage interface, which involves 
both soft and hard tissues.  
 
Figure 4.9 Tomographic DEI slices at two different vertical locations of the joint: (A) 
visualization and differentiation of various soft tissues with some structural details and (B) 
imaging of both soft (cartilage) and hard (bone) tissues in a DE image, with the inset showing the 
level of structural detail of the bone tissue. 
Compared to CT-DEI, CT-PCI has its limit to visualize scaffolds embedded in thick 
samples as illustrated in the present study. One main factor in the in-line PCI contrast mechanism 
is the free propagation of distorted X-rays throughout the sample-to-detector distance. A greater 
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distance could improve the capability of PCI for visualizing microstructures inside the sample. 
Low density microstructures such as the implanted TE scaffold and microvascular channels 
produce small deflections/distortions in the X-rays as they hit the boundaries of the features. The 
small X-ray phase disturbance induced can propagate and develop over a sufficiently long free 
space for the features to be visualized at the detector; otherwise, the non-developed phase 
information of the beam cannot be used to construct the image of the microstructure (e.g., 
scaffold) at the detector. For this study, a sample-to-detector distance of 85 cm was achievable at 
the time of experiment in the BMIT-BM experimental hutch; however, the results (Fig. 4.8A) 
indicate that this sample-to-detector distance was not suitable for visualizing the scaffold inside 
the cartilage. Longer distances might improve the ability of PCI to image scaffolds in situ, and 
this should be investigated in future experiments. In addition to the free propagating distance, the 
effective image resolution (i.e., pixel size) has influence on the capability of the PCI technique. 
A higher spatial resolution (smaller pixel size) could potentially improve the ability of PCI to 
visualize fine microstructures (i.e., scaffolds), particularly for the cases where a larger sample-to-
detector distance is not possible or practical. By doing so, fine distorted phase information (i.e., 
the one associated with the scaffold structure) could be detected and used for image construction. 
Although it is theoretically possible to increase image resolution through a longer scanning 
exposure time, this can dramatically raise the radiation dose received by the sample. For 
instance, doubling the spatial resolution (decreasing pixel size by half) requires up to a sixteen-
fold increase in the exposure time. This means that imaging of scaffolds with the PCI system 
might be achievable but at the cost of higher radiation doses, which is not suitable for live animal 
imaging experiments.  
In the MRI system, the presence of water and variations in the amounts in different tissues 
and microstructures are essential for visualization. More precisely, MR imaging is based on the 
resonation of mobile protons (hydrogen nuclei-H+) to generate electromagnetic signals using 
magnetic and radio frequency fields. Protons residing in various tissues/structures resonate at 
different frequencies, based on the amount of constituent water, and will thus generate different 
signals. The produced signals are detected by a receiver and used to construct the MR image, 
which reveals various types of tissues and microstructures. As such, mobile hydrogen nuclei are 
the source of signal in MRI. The implanted TE scaffold was made of a polyester polymer of 
PCL, (C6H10O2)n, which has hydrogen atoms in its structure. However, constituent protons are 
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immobilized in the polymer structure (due to strong coupling) and cannot be imaged as easily 
using MRI as water-containing tissues. The short-lived signals generated by the protons in rigid 
polymeric materials make their MR imaging difficult. Consequently, no informative 
electromagnetic signal was received from the scaffold to construct its profile in the MR image 
(Fig. 4.8C). The only useful information that can be obtained from this MR image is the signal 
void representing the area in which the scaffold was implanted. In other words, only the external 
geometry of the implanted scaffold can be visualized in the MR image if the scaffold completely 
fills the defect geometry, as noted by Stuckey et al. [18]. To improve the signal, strategies such 
as using a larger magnetic field (e.g., 7T), longer scan time (to accumulate the signals), special 
pulse sequences (i.e., SPRITE), and elevated temperature in the material [19] may be used. 
Although these strategies might improve imaging of solid polymeric materials, they may 
introduce complexities and inefficiencies with respect to the imaging of live animals or humans. 
The radiation dose received by the samples in the CT-DEI technique was evaluated from 
imaging photon energy of 40 keV and detector resolution of 37 µm in the present study. This 
radiation dose obtained is tolerable for live animals, making it suitable for in vivo applications. 
Notably, lower radiation dose CT-DEI can also be achieved through different strategies. 
Increasing the imaging photon energy (𝐸𝑝ℎ) can decrease the dose rate at the sample by reducing 
the photoelectric (PE) component of the energy absorption coefficient ( 
𝜇
𝜌⁄
𝑃𝐸𝑎𝑏𝑠
∝
1
𝐸𝑝ℎ
3 ) [8]. 
Therefore, performing CT-DEI at higher energies is one strategy for reducing the radiation dose 
received. Photon energy of 40 keV was the maximum available at the CLS BMIT-BM beamline 
that allowed imaging at a sufficient photon flux. Higher photon fluxes can facilitate CT-DEI of 
the sample at shorter scanning times (faster imaging), which can also considerably reduce the 
absorbed radiation dose. Both higher photon energies and higher photon fluxes could be 
achieved by SR X-rays generated by a superconducting wiggler insertion device. Faster scanning 
will make the CT-DEI method even more convenient for applications to live animals. With the 
commissioning of the BMIT-ID beamline at the CLS, these strategies can be investigated in the 
future.  
Higher imaging energy may be disadvantageous for all forms of X-ray imaging techniques 
including PCI and DEI due to the reduced ability to stop X-rays in the detector and the decreased 
resolution that can occur because of the thick phosphors required in the detector.  Additionally, 
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the increase in photon energy can result in blurring of the image and deterioration of the image 
quality [8], as higher photon energies increase the X-ray scattering inside the object. However, 
this problem is prevented in DEI by the analyzer rejecting Compton scattered X-rays that are off 
the angle and energy of the RC. Consequently, the DEI method is almost scatter free [16], and 
the increase of photon energy needed to lower the dose rate does not compromise image quality. 
This property becomes particularly advantageous when imaging large, thick samples is of 
interest, because this requires an X-ray photon energy sufficient to penetrate throughout the 
sample and reach the detector. Other strategies that lower the absorbed radiation dose in CT-DEI 
include reducing the required scan time through imaging a smaller area of interest, lowering the 
exposure time, and using higher efficiency detectors. This strategy is now being pursued by the 
authors for developing a lower dose DEI-based imaging method for visualization and monitoring 
of tissue engineering scaffolds in live animal models. DEI is currently carried out using a 
synchrotron radiation X-ray source due to its advanced properties (e.g., high photon flux, large 
range of selectable-energies, high brilliance, small angular divergence, high level of coherence, 
and monochromatic beam) compared to conventional X-ray sources [20, 21]. Although the same 
photon flux is not yet achievable without synchrotron sources, studies have been pursued to 
transfer DEI technology to a desktop X-ray imaging setting [22]. 
4.6 Conclusion 
Non-invasive monitoring methods that can track the success of TE scaffolds in situ during 
repair processes are essential to the future development of TE strategies. In an effort to develop 
such a method for soft (i.e., cartilage) tissue engineering, CT-DEI was investigated in this study 
for the visualization and characterization of PCL scaffolds implanted in the knee cartilage of a 
dissected pig joint. CT-DEI clearly visualized the implanted PCL scaffold, including 
characterizable structural properties that were not visible in CT-PC and MR images. The contrast 
mechanism of DEI combined with the CT modality at sufficient X-ray energies enabled 
successful in situ imaging of low density PCL cartilage scaffolds. In addition, CT-DEI also 
demonstrated its robust capability for distinctly visualizing various soft tissues as well as hard 
bone tissue with microstructural detail. The present study reveals that information on TE 
scaffolds, once implanted, as well as the surrounding tissues can be captured by means of CT-
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DEI, showing its promise for in vivo studies in live animals and eventually for human clinical 
studies.  
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CHAPTER 5: LOW-DOSE PHASE-BASED X-RAY IMAGING TECHNIQUES FOR IN SITU 
SOFT TISSUE ENGINEERING ASSESSMENTS 
This chapter has been published as "Izadifar Z., Honaramooz A., Wiebe S., Belev G., Chen X.B., 
Chapman L.D. (2016) Low-dose phase-based X-ray imaging for in situ soft tissue engineering 
assessments. Biomaterials. 82: 151-167” and has been accepted for publication as “Izadifar Z., 
Honaramooz A., Wiebe S., Belev G., Chen X.B., Chapman L.D. (2015) Data of low-dose phase-
based X-ray imaging for in situ soft tissue engineering assessments. Data in Brief”. According to 
the Copyright Agreement, "the authors retain the right to include the journal article, in full or in 
part, in a thesis or dissertation". 
5.1 Abstract 
In tissue engineering, non-invasive imaging of biomaterial scaffolds and tissues in living 
systems is essential to longitudinal animal studies for assessments without interrupting the repair 
process. Conventional X-ray imaging is inadequate for use in soft tissue engineering due to the 
limited absorption difference between the soft tissue and biomaterial scaffolds. X-ray phase-
based imaging techniques that derive contrast from refraction or phase effects rather than 
absorption can provide the necessary contrast to see low-density biomaterial scaffolds and tissues 
in large living systems. This paper explores and compares three synchrotron phase-based X-ray 
imaging techniques—computed tomography (CT)-diffraction enhanced imaging (DEI), -analyzer 
based imaging (ABI), and -phase contrast imaging (PCI)—for visualization and characterization 
of low-density biomaterial scaffolds and tissues in situ for non-invasive soft tissue engineering 
assessments. Intact pig joints implanted with polycaprolactone scaffolds were used as the model 
to assess and compare the imaging techniques in terms of different qualitative and quantitative 
criteria. For long-term in vivo live animal imaging, different strategies for reducing the imaging 
radiation dose and scan time—reduced number of CT projections, region of interest, and low 
resolution imaging—were examined with the presented phase-based imaging techniques. The 
results demonstrated promising capabilities of the phase-based techniques for visualization of 
biomaterial scaffolds and soft tissues in situ. The low-dose imaging strategies were illustrated 
effective for reducing the radiation dose to levels appropriate for live animal imaging. The 
comparison among the imaging techniques suggested that CT-DEI has the highest efficiency in 
retaining image contrast at considerably low radiation doses. 
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5.2 Introduction 
As tissue engineering aimed at repairing damaged tissues and organs continue to advance, 
more sophisticated assessment and monitoring techniques are required to evaluate and/or 
optimize the success of outcomes. The information on the functionality, tissue regeneration, 
interaction, and integration of engineered constructs with the host tissue post-implantation is 
essential to the in situ evaluation of various therapeutic tissue engineering strategies. Such 
evaluation or assessment is critical for the strategies seeking approval for clinical application to 
patients; the approval process typically involves extensive and comprehensive longitudinal in 
vivo studies on large animal models and clinical trials on patients. Notably, conventional 
biochemical evaluation techniques (e.g., histochemical analysis), which have been widely used 
for various in vitro and in vivo studies, are invasive and destructive due to the need to sacrifice 
animals during the repair process for ex vivo analysis. As such, they are inadequate for use in 
clinically relevant and long-term in vivo studies. Furthermore, conventional ex vivo techniques 
cannot provide de facto and dynamic information about the in vivo repair process, which is the 
key to developing better regeneration strategies. Most importantly, such invasive assessment 
techniques have to be relinquished with the advance from animal to human studies. Therefore, 
the development of non-invasive assessment techniques with applicability to longitudinal live 
animal studies and eventually to human trials is urgently needed.  
Biomedical imaging techniques such as magnetic resonance imaging (MRI) and X-ray 
imaging are forerunner candidates for non-invasive tissue engineering assessments. MR-based 
techniques have been explored for non-invasive monitoring in soft (i.e., cartilage) tissue 
engineering applications [1], but are currently limited to small animal models [1] or require 
exogenous contrast agents for applications to large animals [2]. Furthermore, MR-based 
techniques mainly focus on the evaluation of tissue growth [1] and have limitations with respect 
to in situ imaging and evaluation of polymeric tissue scaffolds [3]. With the discovery of 
synchrotron X-ray source that has superior brilliance, coherence, and a monochromatic (single 
energy) beam, robust phase-based X-ray imaging techniques have emerged [4-7] and led to 
breakthroughs in biomedical X-ray imaging of soft tissues and low density microstructures [8-
14]. Phase-based X-ray imaging techniques rely on refraction-based and phase shift contrast 
mechanisms instead of absorption-based mechanisms that do not facilitate imaging of low 
density materials. In addition, synchrotron phase-based X-ray imaging techniques have the 
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advantages of being free of contrast agents, providing high imaging resolution (down to 1-2 µm), 
using a high penetrating beam, and featuring highly sensitive imaging mechanisms. As such, 
synchrotron phase-based X-ray imaging offers great potential for non-invasive, longitudinal 
monitoring and assessment applications in large animal and human soft tissue engineering. 
Although the potential of X-ray phase-based imaging techniques and their capabilities for soft 
tissue engineering have been shown [3, 15, 16], these techniques are relatively new to the field 
and several issues remain to be addressed, particularly for use in longitudinal in vivo large animal 
and human studies.  
Synchrotron diffraction-enhanced imaging (DEI), analyzer-based imaging (ABI), and 
propagation-based inline phase contrast imaging (PCI) techniques have been investigated for soft 
tissue imaging [17-19], particularly for cartilage and joint tissues [12, 20-26]. Recently, these 
imaging techniques have been drawing considerable attention in soft tissue engineering 
applications [3, 16, 21, 27-30]. Other phase-based X-ray imaging techniques such as edge-
illumination and grating based imaging have also proven great potential for soft tissues [31-38] 
and low-density materials imaging [39-42]. It is noted that relatively high resolution imaging of 
large biological samples requires high X-ray energies and big field of view. This can makes the 
application of grating-based interferometry and edge-illumination techniques more challenging 
than DEI, ABI, and propagation-based PCI for non-invasive large animal tissue engineering 
assessments. As such, DEI, ABI, and inline PCI are currently more applicable than other phase-
based imaging techniques to large animal imaging applications. Application of the DEI 
technique to cartilage tissue engineering assessment [3] suggested the necessity of computed 
tomography (CT) modality for successful and informative in situ imaging of engineered tissue 
scaffolds. Compared to non-CT modalities, however, CT requires collection of multiple 2D 
images; this often results in a longer scan time and a higher ionizing radiation dose that could 
prohibit widespread use of newly developed X-ray imaging techniques for live animal and 
human studies. Although some recent studies have tried to address these issues [31, 43-45], the 
performance of various imaging techniques for clinically relevant in vivo studies involving 
imaging of large biological objects at safe doses, as compared in terms of imaging quality, 
radiation dose, and scan time, has not been explored and documented in the literature. Such 
comparison study provides a platform of different non-invasive assessment techniques for soft 
tissue engineering, which will greatly facilitate more realistic longitudinal and comprehensive in 
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vivo studies with clinically translatable results that will advance tissue engineering technologies 
towards clinical patient trials and therapies.  
In this study, synchrotron CT-DEI, CT-ABI, and inline CT-PCI (with different 
propagation distances) were investigated with respect to their potential as non-invasive X-ray 
monitoring techniques for soft tissue engineering applications. By exemplifying a cartilage tissue 
engineering application, the capabilities of these phase-based imaging techniques and their 
practical aspects for longitudinal in vivo large animal studies were examined and compared. This 
included evaluation and comparison of the techniques in terms of imaging features of importance 
to tissue engineering assessments, scan time, and level of radiation dose delivered. To reduce the 
scan time and radiation dose, three strategies of reduced number of CT projections, region of 
interest, and low resolution imaging were investigated and compared with the three imaging 
techniques. Imaging quality and quantitative contrast of visualized structural features were 
further probed to identify the most suitable and efficient imaging technique for application to 
longitudinal in vivo animal studies with the potential for possible extension to human trials. 
5.3 Materials and methods 
5.3.1 Sample preparation 
The samples used in this study were prepared by following the procedure developed in 
my previous study [3]. Briefly, scaffolds were designed with a porous structure featured by a 
strand spacing of 1 mm and a perpendicular (0°/90°) pattern of strands in successive layers and 
fabricated from polycaprolactone polymer (Mw 48,000-90,000; Aldrich, St. Louis, MO, USA) 
on a 3D Bioplotter (Envisiontec, Germany). Polycaprolactone was melted at 75 °C in a cartridge 
of the Bioplotter and then dispensed through a 22G (400 µm ID) needle under a pneumatic 
pressure of 0.75 MPa on the Bioplotter stage layer by layer to form a three dimensional (3D) 
scaffold. The fabricated scaffolds were implanted into the lateral femoral condyles of stifle joints 
dissected from four-week-old cadaver piglets (prepared at the Western College of Veterinary 
Medicine (WCVM) and the Vaccine and Infectious Disease Organization (VIDO), Saskatoon, 
Canada, under the animal use protocol # 20110071 approved by the University of Saskatchewan 
Animal Research Ethics Board). In each joint, an osteochondral defect (4.5 × 4.5 × 2-2.5 mm 
depth) was created and filled with the polycaprolactone scaffold and covered with a piece of 
concurrently harvested periosteum tissue to fix the scaffold in place; this procedure was similar 
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to the one commonly used in the in vivo implantation of cartilage tissue constructs in animals 
[46]. The implanted intact joints with all surrounding tissues (including skin) were submerged in 
Dulbecco’s phosphate buffered saline (DPBS) and placed under vacuum for 10-15 min to 
eliminate any air that might have entered the joint cavity during the surgery. It is noted that any 
trapped air in the joint may cause artifacts in the images and does not represent the actual status 
of the joint in a living system. 
5.3.2 DEI, ABI, and extended-distance PCI 
DEI, ABI, and extended-distance PCI were performed at the Biomedical Imaging and 
Therapy-bend magnet (BMIT-BM) beamline [47], Canadian Light Source (CLS), Canada. The 
experimental optical setup followed the protocol reported in my previous study [3]. Briefly, for 
DEI and ABI an analyzer crystal is placed between the object and detector (Fig. 5.1A) so as to 
induce refraction-based contrast, ultra-small angle X-ray scattering (USAXS), and scatter 
rejection of small angle X-ray scattering (SAXS). The analyzer crystal is used to convert the 
change in X-ray refraction angle, caused by interfaces of different microstructures in the tissue, 
into a change in X-ray photon intensity at the detector, thus resulting in enhanced contrast at the 
interfaces of features with different densities. Owing to the small X-ray refraction angles (down 
to a few microradians), the enhanced image contrast allows for visualizing and distinguishing 
low density microstructures from surroundings. To perform DEI and ABI, a highly collimated, 
monochromatic 40 keV X-ray beam was produced using a Si (4,4,0) double crystal 
monochromator to illuminate the sample after passing through 0.221 mm aluminum and 0.276 
mm copper filters. The narrow reflective bandwidth of the Si (4,4,0) reflection plane was used in 
the analyzer crystal and monochromator to allow larger changes in photon intensity upon 
changes in refraction angle and thus produce sharper contrast at interfaces. The beam height at 
the sample in the DEI and ABI setups was 4.5 mm. 
In DEI mode, two sets of images were taken, at the high and low angle sides of the 
analyzer rocking curve (RC) at 50% reflectivity angles. The collected images contain contrast 
from both absorption and refraction mechanisms. Refraction images, which only contain the 
contrast from diffraction, were extracted using  
∆𝜃𝑍 =
𝐼𝐻𝑅(𝜃𝐿)−𝐼𝐿𝑅(𝜃𝐻)
𝐼𝐿(
𝑑𝑅
𝑑𝜃
)(𝜃𝐻)−𝐼𝐻(
𝑑𝑅
𝑑𝜃
)(𝜃𝐿)
 ,     5.1 
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where ΔθZ is the intensity in the refraction angle image, R(θ) is the analyzer reflectivity, θ is the 
analyzer angle, and IH and IR are the intensity of the images taken on the two sides (high-angle 
side, θH and low-angle side, θL) of the RC. In ABI mode, only one set of images was collected at 
50% reflectivity of the high angle side of the RC and used to reconstruct the CT slices.  
To perform inline PCI, the sample was placed 5.9 m from the detector and illuminated by 
a 40 keV energy synchrotron X-ray beam produced using a Si (2,2,0) double crystal 
monochromator and filtered through a 1.04 mm aluminum filter. The beam was then collected at 
the detector after it exited and traversed the free propagation distance (Fig. 5.1B). At the BMIT-
BM beamline, the free propagation distance is adjusted by moving the sample upstream or 
downstream the X-ray beam, while the detector is kept at a fixed position downstream of the 
hutch. The X-ray beam has a vertical and horizontal divergence of 0.2 and 10 miliradians, 
respectively. Thus, the beam height at the sample in the PCI varies with the propagation distance. 
For the extended propagation distance used in this study the beam height was 3.4 mm at the 
sample location, while the beam height at the detector position was roughly 4.6 mm, which 
produces a magnification of 1.35 in vertical direction.  In all imaging techniques, the imaged 
field of view was limited by the beam height at the sample in the vertical direction and the 
detector size in the horizontal direction, which led to 74 mm (horizontal) × 4.5 mm (vertical) in 
DEI, ABI, and PCI, and 74 mm × 3.4 mm in extended-distance PCI. Because the scaffold height 
was smaller than the vertical beam sizes, no vertical scanning was needed for any of the imaging 
techniques.  
The phase contrast signal in PCI system stems from the fact that, when the X-rays travel 
through the object, their phase information is disturbed at the interface of features having 
different refractive index. Upon leaving the object, the disturbed phase information develops 
across the X-ray beam front as it propagates through the free distance before hitting the detector 
(Fig. 5.1B). Because the propagation distance directly affects the edge-enhanced phase contrast 
signal [48-50], the maximum available propagation distance of 5.9 m was evaluated and 
compared to that of 0.85 m, which is commonly used in the PCI setting at the BMIT.  
The phase contrast images collected contain both absorption and phase information. A 
phase retrieval technique [51, 52] was employed to obtain phase information from the images 
collected by amplifying the phase contrast fringes to background noise and retrieving 
quantitative results [53]. The phase-retrieval algorithm of the phase-attenuation-duality Paganin 
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algorithm (PAD-PA) [54], which was developed for single propagation distance PCI and for 
samples with weak absorption and phase-attenuation duality [55, 56], was employed in this 
study. Phase retrieval was performed using phase-sensitive X-ray image processing and 
tomography reconstruction (PITRE) software [53], in which the PAD-PA algorithm is 
implemented and the phase-retrieved image is reconstructed using [53]:   
𝜑𝜃(𝑥, 𝑦) = 𝐹
−1 {
𝐹[
(𝐼𝑍,𝜃−1)
2
⁄ ]
(𝛼 𝛽⁄ )
−1
cos 𝑋+sin 𝑋
},    5.2 
𝑋 = 𝜋𝜆 𝑍 (𝑢2 + 𝑣2),    5.3 
where φθ (x,y) is the phase at the tomography rotation angle θ and at coordinates x and y in the 
image; F and F-1 are the forward and backward Fourier transform operators, respectively; Iz,θ is 
the photon intensity at sample-to-detector distance z and rotation angle θ; α is the X-ray 
refractive index decrement; β is the absorption index; λ is the X-ray wavelength; and u and v are 
Fourier conjugate coordinates of x and y, respectively. In the present study, the values of α and β 
were chosen as the ones for water, α = 0.144×10-6 and β = 0.0658×10-9, given the fact that the 
joint imaged largely comprises of soft and low density tissues (within the space between femur 
and tibia). Nonphase-retrieved extended-distance CT slices were also reconstructed for 
comparison to phase-retrieved images.  
All three imaging systems were coupled with CT modality as recommended for in situ 
imaging of thick intact samples [3]. Due to the fixed X-ray beam used in synchrotron-based 
imaging, CT scanning was performed around the axis perpendicular to the incident beam over 
180° degrees in a step and shoot mode with images collected at the detector. The number of 
projection images collected was in range of 300 to 2500. A Photonic Science detector (St. 
Geoirs, France) with a physical pixel size of 18.5 ×18.5 μm was used to collect the images. 
PITRE [53] and X-TRACT [57]  were used for reconstruction and CT slice reconstructions of 
the DEI refraction and ABI images as well as the extended-distance PCI phase-retrieved and 
non-phase-retrieved images. The intensity signals obtained in the reconstructed CT slices are 
retuned by the filtered back projection algorithm in the reconstruction software in terms of 
refraction angle (ΔθZ) in the DE image, X-ray attenuation coefficient (µ) modified for edge-
enhancement in the AB image and nonphase-retrieved PC image (referred to as the apparent µ), 
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and approximate X-ray refractive index decrement (referred to as the approximate α) in phase-
retrieved PC image-because the phase retrieval algorithm uses the assumption of constant (𝛼 𝛽)⁄  
for the sample composition. 
 
Figure 5.1 Schematic diagrams illustrating the imaging setup for (A) CT-DEI and CT-ABI and 
(B) extended-distance CT-PCI. Inset in (A) shows the reflectivity function in the analyzer 
rocking curve. 
5.3.3 Radiation dose evaluation 
The radiation dose rate delivered in different imaging techniques was obtained using X-
ray radiation dosimeters (Luxel® by Landauer (aluminum oxide dosimeter)). The dosimeters 
measure the shallow dose equivalent, which is the external exposure dose received at the skin or 
at a tissue depth of 0.007 cm over a 1 cm2 area [58]. The rate of radiation dose was then 
calculated from the measured total dose according to  
?̇? =
𝑉
ℎ
 𝐷,      5.4 
where ?̇? is the rate of radiation dose, V is the vertical scanning speed, h is the beam height at the 
sample location, and D is the total received radiation dose measured by the dosimeter. Two 
dosimeters were employed to measure the radiation dose for DEI/ABI (both have the same 
imaging setting despite different data collection procedure) and PCI. Another dosimeter was 
used to measure the background radiation at the CLS site and served as a control. To measure the 
radiation from each imaging setup, the dosimeter was attached to a SolidWater® sheet (4.5 mm 
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in thickness) to simulate radiation back-scattered from the sample to the dosimeter. The 
dosimeter was then vertically scanned through the beam at a speed of 0.1 mm/s for DEI/ABI and 
0.2 mm/s for PCI setups. The vertical beam height was also measured by exposing Linagraph 
Direct Print papers (Kodak, Type 2167 standard) to the X-rays until a beam mark appeared on 
the paper.  
Total dose received by the sample during CT imaging (D) was calculated according to  
𝐷 = ?̇? × ∆𝑡,      5.5 
where ?̇? is the calculated dose rate and ∆𝑡 is the total exposure time. The radiation dose is 
usually reported by two metrics: absorbed dose in Gray (Gy) and effective dose equivalent in 
Sievert (Sv). Typically, the first metric is used by physicists to report the radiation energy 
deposited per mass of material, while the second metric is used by clinicians to report the 
detrimental radiobiological risk of radiation to the exposed tissue or organ. Here, the effective 
dose equivalent is reported in Sieverts converted according to  
𝐷(𝑆𝑣) = 𝐷(𝐺𝑦) × 𝑊𝑅 ×  𝑊𝑇,    5.6 
where D is the absorbed dose, WT is a tissue radio-sensitivity weighting factor, and WR is a 
radiation weighting factor. The value of WR for X-ray photons is 1 [59] and the value of WT for 
cartilage tissue was chosen as 0.01 [59]. Although in the report of International Commission on 
Radiological Protection (ICRP) [59]  the value of WT is not explicitly given for cartilage 
(considered as a negligibly radiosensitive tissue), for being safe the WT value for bone surface 
(0.01) was adopted and used for dose conversions in the present study. 
5.3.4 Low-dose CT imaging 
Three strategies were investigated to reduce the radiation dose received during CT 
imaging: (i) reducing the number of projections in CT imaging, (ii) region of interest (ROI) CT 
imaging, and (iii) lower resolution imaging. These strategies were examined either alone or in 
combination with CT-DEI, CT-ABI, and extended-distance CT-PCI. The number of projections 
in CT imaging was reduced by increasing the angular rotation step of tomography scanning 
stage. A CT scan of 2500 tomographic projections is suggested for standard CT for a field of 
view of about 74 mm (horizontal) × 4.5 mm (vertical) in DEI, ABI, and PCI (74 × 3.4 mm in 
extended-distance PCI) and an image pixel size of 37 × 37 μm [3]. To uniformly reduce the 
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number of tomographic projections collected over the 180° CT, the angular CT steps were 
increased to collect 1250 (50% of the standard number), 900 (36%), 625 (25%), and 375 (15%) 
projections for image reconstruction. Standard 2500 projection CT scans performed with all 
phase-based imaging techniques served as controls. The exposure time per projection was 3.5 s 
for DEI and ABI and 187 ms for PCI and extended-distance PCI. 
Region of interest (ROI) imaging was examined by decreasing the field of view in the 
horizontal direction to 43 mm using slits to achieve a smaller imaging area that mainly covered 
the scaffold implanted site at the joint. By following the standard CT scan procedure, 1800 
tomographic projections were collected to reconstruct the ROI images. The combination of a 
lower number of projections and ROI CT imaging was also investigated by performing ROI CT 
scans of the samples and collecting 900 (50%), 600 (36%), 450 (25%), and 300 (15%) 
tomographic projections. 
The strategy of lower resolution imaging was examined by either performing CT imaging 
at 74 μm and 111 μm pixel sizes or by using a non-averaging sampling algorithm written in IDL 
(Interactive Data Language, Exelis Visual Information Solution, Inc., Boulder Colorado, CO, 
USA) that returns tomographic projections with 74 μm and 111 μm pixel sizes from 2×2 and 3×3 
pixel sample areas of 37 μm pixel size projections. The sampling algorithm selects the signal 
from one of the 4 and 9 pixels to create the 74 and 111 μm pixel size projections, respectively, 
which simulates the actual signal received during CT imaging at 74 and 111 μm pixel size. The 
simple binning of data by averaging or summing the values of the pixels was not used in the 
present study because it leads to improved signal to noise ratio in the simulated projection image. 
Such signal enhancement is inconsistent with a real CT data collection due to the fact that the 
AD conversion in the Photonic Science detector is limited to approximately 11.5 bits. The 
highest imaging resolutions performed in DEI and ABI had a 37 μm pixel size and in extended-
distance PCI had an 18.5 μm pixel size. Imaging at a pixel size of 18.5 μm required a projection 
exposure time of 700-900 ms using extended-distance PCI and 12-16 s using DEI or ABI. This 
was only practically possible with the extended-distance PCI technique. The scan time could take 
up to 12 h for a standard CT-DEI at 18.5 μm pixel size; this is extremely large and impractical 
and therefore was not pursued. The combination of lower resolution and a reduced number of 
projections was tested by reconstructing 3D images using 1250 (50%), 900 (36%), 625 (25%), 
and 375 (15%) projections at 74 and 111 μm pixel sizes. The combination of the three low-dose 
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strategies was also investigated for the imaging techniques that worked well with the individual 
low-dose strategies. 
5.3.5 Image quality assessment 
To evaluate the image quality as well as the effectiveness of the aforementioned low-dose 
strategies, quantitative and qualitative criteria were used in evaluation and comparison of the 
imaging techniques. The criteria examined include image intensity profile, quantitative image 
similarity/correlation to the standard (100% projections) image, contrast to noise ratio, total 
effective dose, total scan time, and qualitative observer image quality score. Quantitative 
analysis was performed on a square-shape area in the images that contained the structured feature 
of the scaffold. An area of the same size at a non-structured region of the image was used as the 
background noise area. The image intensity profile was obtained and compared among images 
for a line drawn across the structured scaffold region. In each technique, the similarity between 
the lower dose images and the standard reference image was represented by the image 
correlation coefficient (R) obtained using the ImageJ correlation plugin [60]. Contrast to noise 
ratio (CNR) was defined as the contrast of a structured region in the image (e.g. scaffold) to the 
noise of the background calculated according to 
𝐶𝑁𝑅 =
𝜎𝑠
𝜎𝑏
,      5.7 
where σs is the standard deviation across the selected structured area and σb is the standard 
deviation of a non-structured background region. The relative CNR values for each image was 
calculated by multiplying the CNR of the reference standard image (100% projections) to the 
image correlation coefficient (R) associated with low- dose image.  In order to enable an 
equitable comparison among the CT-DEI, CT-ABI, and extended-distance CT-PCI techniques, 
the relative CNR values of standard and low dose images were normalized with respect to the 
associated dose and pixel size resolution by 
𝑁𝐶𝑁𝑅 =
𝐶𝑁𝑅×𝑅
𝐷×𝑝𝑥 
 ,     5.8 
where NCNR is the normalized contrast to noise ratio [mSV-1 mm-1], R is the image correlation 
coefficient, D [msV] is the total absorbed effective dose and px [mm] is the image pixel size. To 
produce the error bar, the relative CNR values were obtained from the original structured and 
non-structured square-shape areas (~ 5 mm × 5 mm) and 8 other areas of the same size, but with 
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the center shifted 1 mm in eight directions of the following angles: 0º, 45º, 90º, 135º, 180º 225º, 
270º, 315º. For the observer image quality assessments, a 5-point scoring system was employed 
to describe the image quality, where 5 was “best”, 4 was “optimal”, 3 was “adequate”, 2 was 
“insufficient”, and 1 was “poor”. A clinical radiologist used the scoring scale to grade the quality 
of images in terms of level of visualization and characterization of the implanted scaffold as well 
as different microstructural and anatomical features. The given image quality score (IQS) was 
used to represent the clinically relevant quality of the image. 
5.4 Results 
5.4.1 CT-DEI, CT-ABI, and CT-PCI  
The initial comparison to identify the most suitable phase-based X-ray imaging 
technique(s) for in situ scaffold visualization was performed with images captured by using 
standard CT imaging modality (using 2500 projections) at a pixel size of 37 µm. In the CT-DEI 
and CT-ABI produced images, the scaffolds implanted in cartilage were clearly visualized in situ 
(Fig. 5.2A,B), while not detectable in the PCI with a sample-to-detector distance of <1 m (Fig. 
5.2D).  Increasing the propagation distance for inline PCI was found to be essential for in situ 
imaging of the scaffold and low absorbing soft tissues of the joint (Fig. 5.2C,E). DEI, ABI, and 
extended-distance PCI did not exhibit similar image contrasts, but the contrast mechanism 
employed in each technique was sufficient for resolving the desired low density features with 
appreciable structural detail. All three techniques produced images of the implanted scaffolds 
that included the characteristic lattice structure. Furthermore, distinct interfaces and structures of 
the surrounding soft tissues, e.g., condyle cartilage, meniscus, fibrous ligament, tendon, muscle, 
and fat tissues, were visible in the CT-DE, CT-AB, and extended-distance CT-PC images (Fig. 
5.2A-C, E).  
The DE and AB images showed stronger edge contrast than extended-distance PC images 
at the 37 µm resolution. CNR of the scaffold region was determined as 4.07, 2.13, 1.49, and 1.19 
in the DE, AB, and phase-retrieved and nonphase-retrieved extended-distance PC images, 
respectively, which confirms the contrast difference observed among different methods (Fig. 5.2 
A-C, and E).  Very small and detailed structural features of soft tissues, such as micro-vascular 
channels in the cartilage, bundled fibrous texture of the ligaments and tendon, and loose, non-
oriented fibrous structure of the fat tissue, were identified with more distinct interfaces in the DE 
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and AB images than in the extended-distance PC images (Fig. 5.2A-C, and E). DEI produced a 
sharper edge contrast than ABI due to the ABI’s combined refraction-absorption contrast signal 
(Fig. 5.2F and G). The dual imaging in the DEI technique enabled extraction of a pure refraction 
signal that produced a stronger edge-enhanced contrast with better visualization of small features 
(Fig. 5.2A and F). In extended-distance PCI, the tissue and structural contours were identifiable 
but had less edge-enhanced contrast than DEI and ABI (Fig. 5.2F-H, and J). The nonphase-
retrieved PC image showed less sharp edge contrast than the phase-retrieved PC images (Fig. 
5.2C and E), which appeared to be due to the large background noise that supressed the edge-
enhanced contrast signal in the image profile (Fig. 5.2H and J). In the phase-retrieved PC image, 
the contrast difference between bulk tissues was more recognizable by sudden changes in pixel 
intensity (Fig. 5.2H). For example, the fat tissue is seen as a darker, less absorbing material with 
much lower pixel intensity than muscle and cartilage (Fig. 5.2C and H). The intensity profile of 
the phase-retrieved extended-distance CT-PC images also shows a subtle difference between 
pixel intensity in muscle and cartilage tissues (Fig. 5.2H). Furthermore, the cartilage defect 
cavity implanted with the scaffold and filled with DPBS was distinguishable in the phase-
retrieved extended-distance PC image as a lower density material compared to the surrounding 
cartilage tissue (Fig. 5.2C and H). This subtle bulk density information was not visualized in the 
DE and AB images. The nonphase-retrieved PC image illustrated the low density fat tissue as a 
darker, less absorbing material, but it fell short in revealing the detailed information that was 
depicted in phase-retrieved PC image (Fig. 5.2C, E, H, and J). 
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Figure 5.2 Imaging in situ cartilage scaffold using different phase-based X-ray imaging 
techniques. Reconstructed CT slices from (A) DEI, (B) ABI, (C) phase-retrieved PCI and (E) 
nonphase-retrieved PCI at extended sample-to-detector distance of 5.9 m and (D) PCI at a 
sample-to-detector distance of 85 cm. All images are at a pixel size resolution of 37 μm. Yellow 
arrows point to the implanted scaffold. The intensity profile across the yellow dashed line in the 
(A-E) images is shown in (F–J) respectively. (K) A schematic view of the joint cross section 
with labeled main components. Inset images in panel (K) are the digital planar view (top) and the 
light microscopic cross section view (bottom) of polycaprolactone tissue scaffold.  
5.4.2 Radiation dose of phase-based X-ray imaging 
The radiation doses delivered by the imaging methods considered were 10.31 mGy for 
DEI and ABI and 117.40 mGy for PCI. The calculated rate of radiation dose was 0.2 mGy/s for 
DEI and ABI and 6.43 mGy/s for PCI. The higher dose rate in PCI is due to the higher X-ray 
photon flux reflected from the Si (2,2,0) planes vs. the Si (4,4,0) planes used for DEI. The Si 
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(4,4,0) reflection plane in the DEI and ABI systems provides a narrow reflection bandwidth in 
the rocking curve for higher refraction sensitivity and stronger edge contrast, but this results in a 
lower photon flux and consequently longer scan times and larger exposures.  
The total exposure time for a standard CT scan (2500 tomographic projections), was 
about 4.9 h for DEI, 2.5 h for ABI, and 8 min for PCI. The total dose received by the samples 
during these scans was calculated as 3.4 Gy for CT-DEI, 1.7 Gy for CT-ABI, and 3 Gy for 
extended-distance CT-PCI. Despite their considerably different dose rates, DEI and PCI methods 
have similar total delivered doses due to their large difference in scan times. ABI has a smaller 
dose rate than PCI and shorter scan time than DEI, resulting in a lower total dose than the other 
techniques. Considering the 0.01 tissue weighting factor (WF) for cartilage and surrounding soft 
tissues, the equivalent effective dose rate for CT-DEI and CT-ABI was 2 µSv/s and for 
extended-distance PCI was 64.3 µSv/s. The total equivalent effective dose received by the 
sample was 34 mSv for CT-DEI, 17 mSv for CT-ABI, and 30 mSv for extended-distance CT-
PCI. 
5.4.3 Low-dose CT phase-based imaging  
5.4.3.1 Reduced number of CT projections imaging  
The strategy of reducing the number of projections was investigated by reconstructing the 
CT-DEI, CT-ABI, and extended-distance CT-PCI slices using 50, 36, 25, and 15% of the 
projections collected during a standard CT scan at 37 µm image pixel size. Although the number 
of projections collected was considerably reduced, the CT slices were successfully reconstructed 
with the key features and information preserved. The scaffold structure and the joint soft tissues 
were detectable and characterizable in the DE, AB, and phase-retrieved extended-distance PC 
images constructed using 50, 36, 25, and 15% of the usual number of projections without 
considerable loss of contrast compared to a standard (100%) image (Fig. 5.3A-O). However, 
reducing the number of tomographic projections made the noise signal more recognizable, which 
slightly affected the overall quality of the reconstructed DE, AB, and phase-retrieved extended-
distance PC slices. The noise signal was particularly apparent in the 25 and 15% extended-
distance PC images compared to the corresponding DE and AB images (Fig. 5.3 D, E, I, J, N and 
O). In the nonphase-retrieved extended-distance PCI, reducing the number of projections, even 
by 50%, led to noticeably poor image contrast and quality (Fig. 5.3P-T). The bright area seen in 
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the center of the phase-retrieved image appears to be the start of the ossification center at the 
femoral condyle, which is also more easily visualized in the phase-retrieved image than 
nonphase-retrieved image (Fig. 5.3K-T). Comparing image intensity profile across the structured 
scaffold illustrated the well-preserved image signal in DEI upon reduction of the tomographic 
projections up to 85% (Fig. 5.4A and E-I). In ABI and phase-retrieved extended-distance PCI, 
the coarse changes in the signal associated with more distinct features were observed to be 
sufficiently preserved, while fine changes were to some extent affected as the number of 
projections was reduced (Fig. 5.4B, C, and J-S). The nonphase-retrieved PC image profile shows 
the apparent suppression of the structure signal by the strong noise when the number of 
projections were reduced (Fig.5. 4D, and T-X).  
Furthermore, the image correlation coefficient results confirmed the superior performance 
of DEI compared to other methods by consistently high image correlation coefficient of at least 
0.85 to the standard reference image (100% projections) when the number of projections were 
reduced to 15% (Fig. 5.4Y). The minimum number of projections that can efficiently preserve 
DE image information was 15% CT projections; R dropped considerably at 10 and 5% CT 
projections (Fig. 5.4Y). ABI and extended-distance PCI showed reduced image correlation with 
lowering the number of projections (Fig. 5.4Y). Lower image quality and R values reduced to 
0.5 or less were observed at 15% projections with ABI and phase-retrieved extended-distance 
PCI, and at 50% projections with nonphase-retrieved extended-distance PCI. This appears to be a 
threshold R value below which the image quality and information may be compromised 
considerably (Fig. 5.4Y). The high CNR of the DEI technique along with the high image 
correlations resulted in persistently high relative CNR (>3.9) across lower number of projections 
images (50%-15%) (Fig. 5.4Z). This indicates the robustness of this technique compared to other 
methods with respect to maintaining contrast at a reduced number of projections. ABI showed 
slightly higher relative CNR than extended-distance PCI at 100% projections (2.1 vs 1.5), 
however, the difference diminishes as the number of projections is reduced (Fig. 5.4Z). The 
nonphase-retrieved extended-distance PCI showed the lowest CNR value (1.2) among the 
methods, which reduces to 0.5 at 50% projections and eventually to zero at 15 % projections 
(Fig. 5.4Z).  
Reducing the number of projections substantially lowered the received dose and scan time 
for all three imaging techniques (Table 5.1). For example, reducing the number of projections to 
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15% in CT-DEI reduced the scan time and dose from 4.9 h and 34.5 mSv in standard CT 
imaging to ~45 min and 5.5 mSv, respectively. Similarly, the dose in CT-ABI dropped from 17.2 
to 2.6 mSv and in extended-distance CT-PCI dropped from 30.1 to 4.5 mSv.  The scan times 
dropped to <25 min for CT-ABI and <2 min for CT-PCI (Table 5.1). By reducing the number of 
projections in CT-DEI by 50%, a comparable dose and scan time to standard (100%) CT-ABI is 
achieved while maintaining superior image contrast (Fig. 5.4). The observer image quality 
assessments indicated that the reduced CT projection strategy for all the methods, except 
nonphase-retrieved extended-distance PCI, did not affect the capability of the techniques in 
imaging the implanted scaffold, image quality scores (IQS)>3 (Table 5.1). This illustrates the 
potential of this strategy to reduce time and dose without compromising image contrast. Since 
the nonphase-retrieved extended-distance PCI demonstrated an inferior and insufficient 
capability among other methods for imaging scaffolds at standard and lower projection imaging, 
it was excluded from further intensity profile and observer image quality assessments.      
 160 
 
 
Figure 5.3 Qualitative image comparison in CT phase-based imaging using a lower number of 
projections. (A–E) CT-DEI, (F–J) CT-ABI, and (K–O) phase-retrieved and (P–T) nonphase-
retrieved extended-distance (ext.-dist.) CT-PCI at (A, F, K, P) 100%, (B, G, L, Q) 50%, (C, H, 
M, R) 36%, (D, I, N, S) 25%, and (E, J, O, T) 15% of the standard number of projections. The 
bright spot visible in panels (K–O) corresponds to the start of the ossification center, and are 
better visualized in the phase-retrieved images than the nonphased retrieved images (P–T). 
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Figure 5.4 Quantitative image comparison in lower number of projections CT phase-based 
imaging. Comparison of the image intensity profile across a 4.5 mm white dashed line shown in 
the structured scaffold area of (A, E–J) CT-DE, (B, J–N) CT-AB, (C, O–S) phase-retrieved 
extended distance CT-PCI, and (D, T–X) nonphase-retrieved extended distance CT-PCI (NP-CT-
PCI) as the number of tomographic projections decreases from 100 to 15% of the standard 
number. (Y) Image correlation coefficient(R) with the reference image (100% projection) and 
(Z) relative contrast to noise ratio (CNR) for CT-DEI, CT-ABI, and phase-retrieved and 
nonphase-retrieved CT-PCI with reduced number of tomographic projections.  
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Table 5.1 Total effective dose, scan time, and observer image quality score (IQS) for visualizing 
scaffolds in situ with the strategy of reducing the number of projections in CT imaging.  
% Proj 
CT-DEI  CT-ABI Extended-distance CT-PCI 
Dose* Scan time** IQS  Dose Scan time IQS  Dose Scan time IQS IQS(NP
×
) 
100% 34.5 294.6 5 
 
17.2 147.3 4  30.1 7.8 4 3 
50% 17.2 147.3 4 
 
8.6 73.7 4  15.1 3.9 4 2 
36% 12.4 106.1 4 
 
6.2 53.1 4  10.8 2.8 4 2 
25% 8.6 73.7 4 
 
4.3 36.9 4  7.5 2.0 3 1 
15% 5.2 44.3 3 
 
2.6 22.1 3  4.5 1.2 3 1 
* Total effective dose in (mSv), ** total scan time in (min), 
×
 Nonphase-retrieved 
5.4.3.2 Region of interest (ROI) CT imaging 
Performing the CT scan on a smaller area of the sample that mainly covered the 
implantation site, i.e., ROI imaging, was also found to be an effective strategy for reducing the 
radiation dose and scan time. Reducing the scan area resulted in a smaller number of pixels in the 
field of view and a smaller number of required tomographic projections to be collected in a CT 
scan. In a standard CT scan of the whole joint at 37 µm pixel size, 2500 projections are 
collected; this was reduced to ~1800 projections for a CT scan of the selected ROI. Compared to 
standard images (Fig. 5.3A, F, and K), reconstructed ROI slices did not show any notable 
negative effects on the visualization of the scaffold and surrounding soft tissues (Fig. 5.5A, F, 
and K). Image intensity profile analysis showed similar performance of the techniques at ROI 
imaging as that observed in the reduced number of projection strategy (Fig. 5.6). Intensity profile 
of ROI DE images at reduced number of projections showed the smallest variation from the 
reference standard image (non-ROI, 100% projections) compared to those in ROI AB and phase-
retrieved PC images (Fig. 5.6A-C).  This observation was also confirmed quantitatively by the 
consistently higher R values (>0.85) of ROI DE images than ROI AB and extended-distance PC 
images at reduced number of projections (Fig. 5.6S). Although the image correlation of ROI AB 
and PC images dropped with decreasing the number of tomographic projections, ABI 
demonstrated better R values than extended-distance PCI particularly at 15% projections (Fig. 
5.6S). The considerably higher relative CNR values of ROI DE images than ROI AB and 
extended-distance PC images indicated that DEI maintained high contrast in the ROI imaging 
compared to ABI and extended-distance PCI (Fig. 5.6T). At 25% and 15% projections, R and 
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relative CNR values of ROI PC images drop to relatively low value which reflects the somewhat 
affected image quality observed (Fig. 5.6Q-T). 
 ROI imaging reduced the radiation dose from 34.5 to 24.8, 17.2 to 12.4, and 30.1 to 19.4 
mSv for CT-DEI, CT-ABI, and extended-distance CT-PCI, respectively (Table 5.2). When ROI 
imaging was combined with a reduced number of projections, the delivered dose and scan time 
declined further (Table 5.2). For example, the CT-DEI radiation dose dropped from 34.5 to 24.8 
mSv by reducing the imaging area, and then use of 15% of the standard number of projections 
further decreased the total delivered dose to 4.1 mSv. The observer IQSs for visualizing the 
scaffold remained relatively high at these settings. The reconstructed ROI AB and extended-
distance PC images also maintained sufficient image contrast at a low number of projections for 
visualizing both the scaffold and anatomical features of the joint; however, the subtle structural 
details were less clear in ROI ABI and extended-distance PCI than in DEI (Fig. 5.5).  
 
Figure 5.5 Region of interest (ROI) and CT imaging at reduced number of projections: (A-E) 
CT-DEI, (F-J) CT-ABI, and (K-O) extended-distance (ext.-dist) CT-PCI at (A, F, K) 100%, (B, 
G, L) 50%, (C, H, M) 36%, (D, I, N) 25%, and (E, J, O) 15% of the standard number. 
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Figure 5.6 Quantitative image comparison in ROI and lower number of projections CT phase-
based imaging. Comparison of the image intensity profile across a 4.5 mm white dashed line 
shown in the scaffold area of region of interest (ROI) (A, D–H) CT-DE, (B, I–M) CT-AB, and 
(C, N–R) phase-retrieved extended distance CT-PC images as the number of tomographic 
projections decreases from 100 to 15% of the standard number. The black intensity profiles in 
panels A–C are associated with the standard non-ROI images at 100% projections. (S) Image 
correlation coefficient (R) to the standard image and (T) relative contrast to noise ratio (CNR) 
for ROI CT-DEI, CT-ABI, phase-retrieved CT-PCI, and nonphase-retrieved CT-PCI (NP–PCI) 
with decrease of the number of tomographic projections. 
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Table 5.2 Total effective dose, scan time, and observer image quality score (IQS) for visualizing 
scaffolds in situ with the strategy of reducing the region of interest (ROI) combined with reduced 
number of projections in CT imaging.  
% Proj 
CT-DEI   CT-ABI  Extended-distance CT-PCI 
Dose* Scan time** IQS  Dose Scan time IQS  Dose Scan time IQS 
100% 24.8 212.1 4  12.4 106.0 4  19.4 5.0 4 
50% 11.5 98.3 4  6.2 53.1 4  9.5 2.5 4 
36% 8.6 73.7 4  4.3 36.9 4  6.3 1.6 3 
25% 6.9 59.0 4  3.1 26.6 3  4.8 1.2 3 
15% 4.1 35.4 3  2.1 17.7 2  3.2 0.8 3 
* Total effective dose in (mSv), ** total scan time in (min) 
5.4.3.3 Lower resolution imaging 
To further reduce the radiation dose and scan time, imaging at a lower resolution was 
investigated. Lowering the resolution or increasing the pixel size results in higher photon counts 
per pixel per second, which reduces the required exposure times and thus scan times and 
radiation dose. The scaffold structure as well as anatomical and structural details of different 
surrounding tissues were well preserved in the lower resolution DE and AB images, with 
negligible image quality deterioration compared to standard 37 µm pixel size images (Fig. 5.7 A-
F). In the extended-distance PC images, lowering the resolution resulted in a noticeable 
deterioration of image quality (increased noise, blurred edges and interfaces) compared to DEI 
and ABI at the same resolution (Fig. 5.7 G-I). However, the images still were of sufficient 
quality to visualize the scaffold and anatomical features of the joint. The intensity profile 
analysis showed that the signal changes across the structured feature are well preserved in DE 
images at lower pixel size resolutions of 74 and 111 µm (Fig. 5.8A, and D-F), although a slight 
drop in the intensity level was observed at 111 µm pixel size. The superior performance of low 
resolution DEI was also quantitatively confirmed by the high R values (>0.72) at 100% as well 
as reduced number of projections images (Fig. 5.8M). Lower resolution ABI and extended-
distance PCI captured the coarse intensity changes across the structured region (Fig. 5.8B-L) at 
100% tomographic projections, however, reducing the number of projections dropped the image 
correlation values for both imaging techniques (Fig. 5.8M). Relative CNR values indicated that 
DEI maintained high contrast, compared to ABI and extended-distance PCI, as both image 
resolution and the number of tomographic projections reduced (Fig. 5.8N).  
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Decreasing the image resolution in CT-DEI and CT-ABI decreased the exposure time per 
projection from 3.5 s (at 37 µm pixel size) to 900 ms (at 74 µm pixel size) and 410 ms (at 111 
µm pixel size). In extended-distance CT-PCI, the exposure time per projection decreased from 
776 ms (at 18.5 µm pixel size) to 187 ms (at 37 µm pixel size), 60 ms (at 74 µm pixel size), and 
21 ms (at 111 µm pixel size). For all three imaging techniques, the considerable drop in exposure 
time decreased the radiation dose and the total scan time by approximately four-fold (at 74 µm) 
and nine-fold (at 111 µm) (Table 5.3). Imaging at 74 µm pixel size combined with reducing the 
number of projections further decreased the radiation dose, by 16-fold to <3 mSv at 25% in CT-
DEI and CT-ABI, and by 8.6-fold to 3.5 mSv in extended-distance CT-PCI at 36% (Table 5.3). 
Based on the given observer IQSs, the contrast signal in these settings remained sufficient to 
visualize the scaffold structure (Fig. 5.7 J, L, and N; Table 5.3).  
The scan time (at 74 µm and 25%) was also considerably reduced in DEI and ABI to < 20 
and 10 min, respectively, and in extended-distance PCI (at 74 µm and 36%) to <1 min (Table 
5.3). At 111 µm pixel size, CT-DEI, CT-ABI, and extended-distance CT-PCI can be performed 
at a reduced number of tomographic projections to further lower the radiation dose and scan time 
while maintaining adequate image quality for visualizing the scaffold structure (Fig. 5.7 K, M, 
and O; Table 5.3). Reducing the number of projections to 25% at 111 µm pixel size lowered the 
total delivered dose and scan time in CT-DEI and CT-ABI to 1 and 0.5 mSv and 8.6 and 4.3 min, 
respectively (Table 5.3). The radiation dose and scan time in extended-distance CT-PCI could 
also be reduced to 1.5 mSv and 0.4 s by imaging at 111 µm pixel size and collecting 50% of the 
standard number of tomographic projections while maintaining sufficient detail to reconstruct the 
scaffold structure (Table 5.3). Imaging at the highest image resolution, 18.5 µm pixel size, was 
only practically feasible with extended-distance CT-PCI (the scan time for CT-DEI or CT-ABI at 
18.5 µm pixel size is 16 times longer than at 37 µm pixel size), although the radiation dose was 
very high at 187 mSv. 
The combination of the three strategies can further reduce the dose and scanning time 
without considerably affecting image quality for visualization and characterization of scaffolds 
in situ. This was particularly effective with the DEI technique due to its strong image contrast. 
Region of interest CT-DEI using 25% of the standard number of projections reduced the 
effective radiation dose and scan time to 1.77 mSv and 15 min at 74 µm pixel size and to 0.81 
mSv and 7 min at 111 µm pixel size. Region of interest CT-ABI at 25% of the standard number 
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of projections reduced the effective radiation dose and scan time to 0.88 mSv and 7.5 min at 74 
µm pixel size and to 0.4 mSv and 3.4 min at 111 µm pixel size (image not shown).  
 
Figure 5.7 Comparison of representative images from lower resolution CT phase-based imaging. 
CT-DEI (A–C, J, K), CT-ABI (D–F, L, M), and phase-retrieved extended-distance (ext.-dist.) 
CT-PCI (G–I, N, O) using 100% (A–I), 25% (J–M), 36% (N), and 50% (O) of standard 
projections at 37 μm (A, D, G), 74 μm (B, E, H, J, L, N), and 111 μm (C, F, I, K, M, O).    
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Figure 5.8 Quantitative image comparison in lower resolution and reduced number of projections 
CT phase-based imaging. Comparison of the image intensity profile across a 4.5 mm white 
dashed line shown in the scaffold area of low resolution (A, D–F) CT–DE, (B, G–I) CT-AB, and 
(C, J–L) phase-retrieved extended distance CT-PC images at 37 (D,G, J), 74 (E, H, K), and 
111 μm (F, I, L) pixel size resolutions. (M) Image correlation coefficient (R) to the standard 
100% projections images at 37 μm resolution and (T) relative contrast to noise ratio (CNR) for 
CT-DEI, CT-ABI, phase-retrieved CT-PCI, and nonphase-retrieved CT-PCI (NP-PCI) at 74 and 
111 μm resolutions as the number of tomographic projections decreases from 100 to 15% of the 
standard number.. 
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Table 5.3 Total effective dose, scan time, and observer image quality score (IQS) for visualizing 
scaffolds in situ with the strategy of lowering imaging resolution combined with reduced number 
of projections  in CT imaging.  
CT-DEI 
37 µm 74 µm 111 µm 
Dose* Scan time** IQS  Dose Scan time IQS  Dose Scan time IQS 
100% 34.5 294.6 5  8.8 75.3 4  4.0 34.4 4 
50% 17.2 147.3 4  4.4 37.7 4  2.0 17.2 3 
36% 12.4 106.1 4  3.2 27.1 4  1.4 12.4 3 
25% 8.6 73.7 4  2.2 18.8 3  1.0 8.6 3 
15% 5.2 44.3 3  1.3 11.3 2  0.6 5.2 2 
CT-ABI 
37 µm  74 µm 111 µm 
Dose Scan time IQS  Dose Scan time IQS  Dose Scan time IQS 
100% 17.2 147.3 4  4.4 37.7 4  2.0 17.2 4 
50% 8.6 73.7 4  2.2 18.8 4  1.0 8.6 4 
36% 6.2 53.1 4  1.6 13.6 4  0.7 6.2 3 
25% 4.3 36.9 4  1.1 9.4 3  0.5 4.3 3 
15% 2.6 22.1 3  0.7 5.7 2  0.3 2.6 2 
Ext.-
dist.  
CT-PCI 
18.5 µm 37 µm 74 µm  111 µm 
Dose 
Scan 
time IQS 
 
Dose 
Scan 
time 
 
IQS 
 
Dose 
Scan 
time 
 
IQS 
 
Dose 
Scan 
time IQS 
100% 187.0 48.5 5  30.1 7.8 5  9.6 2.5 4  3.4 0.9 3 
50%     15.1 3.9 4  5.8 1.5 3  1.5 0.4 3 
36%     10.8 2.8 4  3.5 0.9 3  1.2 0.3 2 
25%     7.5 2.0 3  2.4 0.6 2  0.8 0.2 1 
15%     4.5 1.2 3  1.4 0.4 2  0.5 0.1 1 
* Total effective dose in (mSv), ** total scan time in (min) 
5.4.3.4 Lowe-dose CT-DEI vs CT-ABI vs extended-distance CT-PCI 
In order to perform a more reasonable comparison among the methods for identifying the 
more effective low dose imaging settings, the low dose images were compared based on the 
normalized CNR (NCNR) that accounts for the dose and image resolution associated with the 
achieved image contrast. At 100% tomographic projections (standard setting), DEI, ABI, and 
extended-distance PCI demonstrated similar performances. In other words, at standard CT 
imaging all three methods provided comparable image contrast per mm pixel size of the image 
and per mSv delivered dose (Fig. 5.9). This, however, changes as the lower dose strategies are 
applied. The lower dose DEI demonstrates an increase in its performance, higher than other 
methods, as the lower CT projection, ROI, lower resolution, or a combination of these strategies 
are implemented (Fig. 5.9).  At the lowest dose image settings, 15% projections, ROI-15% 
projections, 74 or 111µm-15% projections, the NCNR of DEI demonstrated the largest 
 170 
 
difference from the other methods that indicates its superior performance for the same image 
resolution and amount of delivered dose (Fig. 5.9). Furthermore, ABI demonstrated better 
performance than extended-distance PCI at ROI and reduced CT projection imaging (Fig. 5.9). 
At lower resolution-reduced CT projections imaging, DEI exhibits considerably better image 
contrast than the other methods per mm pixel size and mSv delivered dose (Fig. 5.9B).  
 
 
Figure 5.9 Quantitative comparison of low dose CT-DEI, CT-ABI, phase-retrieved extended-
distance CT-PCI, and nonphase-retrieved extended-distance CT-PCI (NP-PCI) techniques. 
Comparison of normalized contrast to noise ratio (NCNR) for (A) reduced number of CT 
projections and region of interest (ROI) imaging, and (B) lower resolution imaging strategies at 
100, 50, 36, 25, and 15% of the standard number of projections. 
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5.4.4 Imaging low density microstructural features using CT phase-based imaging 
In addition to the implanted tissue scaffold, the phase-based imaging techniques 
investigated here revealed various other soft tissues and microstructural features present in the 
joint. CT-DEI and CT-ABI demonstrated similar visualization of these features at the standard 
setting and, as such, only DE and phase-retrieved extended-distance PC images are discussed 
further. The low density structural features are more readily detectable with a higher level of 
detail in DE axial and sagittal images than those in extended-distance PC images (Fig. 5.10). A 
video of 3D rendered DE images better shows such structural details [see Appendix B]. As 
described in the methodology, the beam height at the sample was smaller in the extended 
distance PCI than DEI and, as such, a smaller vertical view of the joint is seen in the sagittal 
plane of the PC image compared to that in the DE image. If a longer experimental X-ray hutch is 
available, the sample can be placed at the same location as in DEI (or even further away from the 
source) to illuminate a larger area of the object while maintaining the required long sample to 
detector distance.  
Among the low density structures visualized in the CT-DE, CT-AB, and extended-
distance CT-PC image stacks, the following features were identified and evaluated using the 
observer image quality assessments: perimeter of the created defect area, cartilage anatomy 
including its interfaces with surrounding tissues and in-cartilage vascular channels, fat tissue 
perimeters and its loose fibrous structure, perimeters of ligaments and tendons and their bundled 
fibrous structure, muscle tissue, distortion of tissue parenchyma caused during implantation 
procedure, strands of the surgery suture, and the covering periosteum patch (Fig. 10). Image 
quality scores associated with the visualization level of these features at standard and low dose 
imaging modes are given in (Table 5.4). In standard imaging mode, all three imaging techniques 
demonstrated high scores for visualization of different microstructural features. In low dose 
imaging modes, the difference between the techniques becomes more evident. Generally 
speaking, CT-DEI maintained higher IQSs than CT-ABI and extended-distance CT-PCI while 
CT-ABI had higher IQSs than extended-distance CT-PCI for visualizing low density structures 
(Table 5.4). In other words, applying the three strategies to lower the radiation dose had a more 
noticeable effect on the quality of extended-distance PC images than DE and AB images (Table 
5.4). Visualization and characterization of subtle features, such as in-cartilage vascular channels 
or the covering periosteum patch, appear to be more affected by the low dose strategies than the 
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more obvious structures, such as cartilage, fat, and ligament tissues and some of their structural 
characteristics.  
 
Figure 5.10 Visualization of different low density microstructural features in axial and sagittal 
views of 3D reconstructed (A) DE and (B) extended-distance phase-retrieved PC slices of the 
joint. L: lateral, co-L: collateral, M: medial, Ant: anterior, Pst: posterior, Fem: femoral, Tib: 
tibial, Lig: ligament, Msl: muscle, Mncs: meniscus, PCL: posterior cruciate ligament, ACL: 
anterior cruciate ligament, c.s.: cross section. Periosteum was used to cover the scaffold at the 
site of implantation. Anterior and posterior are equivalent to cranial and caudal locations, 
respectively, in animals.   
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Table 5.4 Image quality scoring for in situ visualization of soft microstructural features captured 
by the phase-based CT imaging with low-dose imaging strategies or in their combination. 
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CT-DEI (37 µm) 
         
100%  5 5 5 4 5 5 5 5 5 
50%  4 4 4 4 4 4 4 4 4 
36%  4 4 4 4 4 4 4 4 4 
25%  4 4 4 4 4 4 4 4 4 
15%  3 3 3 3 3 3 3 3 3 
ROI CT-DEI (37 µm)  
        
100% 4 4 4 4 4 4 4 4 4 
50%  4 4 4 4 4 4 4 4 4 
36%  4 4 4 4 4 4 4 4 4 
25% 4 4 3 3 4 4 4 4 4 
15%  3 3 3 3 3 3 3 3 3 
CT-DEI (74 µm) 
         
100%  4 4 4 4 4 4 4 4 4 
50%  4 4 4 3 4 4 4 4 3 
36%  3 4 4 3 4 3 3 3 2 
25%  2 3 3 3 3 3 2 3 1 
15%  2 3 2 3 3 2 1 3 1 
CT-DEI (111 µm) 
         
100% 3 4 4 3 4 4 4 4 4 
50%  3 4 3 3 3 3 3 3 3 
36%  3 3 2 3 3 3 3 3 2 
25%  2 3 2 3 2 2 2 2 1 
15%  2 2 1 2 2 2 2 2 1 
CT-ABI (37 µm) 
         
100%  4 5 4 4 5 4 4 5 4 
50%  4 4 4 4 4 4 4 4 4 
36%  4 4 4 3 4 4 4 4 4 
25%  4 4 4 3 4 4 4 4 3 
15%  3 3 3 2 3 3 3 3 3 
ROI CT-ABI (37 µm)  
        
100% 4 4 4 3 4 4 4 4 4 
50%  3 3 3 3 4 3 3 4 3 
36%  3 3 3 3 3 3 3 4 3 
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25%  3 3 3 3 3 3 3 3 3 
15%  2 2 2 2 2 2 2 2 2 
CT-ABI (74 µm) 
         
100%  4 4 4 4 4 3 3 4 4 
50%  4 3 3 3 3 3 3 4 4 
36%  3 3 3 3 3 3 3 3 3 
25%  2 3 2 2 2 2 2 3 2 
15%  2 1 1 1 1 1 1 2 2 
CT-ABI (111 µm) 
   
 
     
100%  4 4 3 3 3 3 3 4 4 
50%  4 3 3 3 3 3 3 4 4 
36%  3 3 2 3 2 2 2 3 2 
25%  2 2 2 2 2 2 2 3 2 
15%  2 1 1 1 1 1 1 2 2 
Extended-distance CT-PCI (37 µm) 
       
100%  5 4 5 5 4 4 4 4 4 
50%  4 4 4 4 4 4 4 3 3 
36%  4 3 3 4 3 3 3 2 2 
25%  3 2 2 3 2 2 2 2 2 
15%  2 1 1 2 2 2 2 1 1 
ROI Extended-distance CT-PCI (37 µm) 
      
100%  4 3 3 4 4 3 4 4 3 
50%  4 3 3 4 3 3 4 3 3 
36%  3 2 2 4 3 2 3 2 2 
25%  3 2 2 3 2 2 3 2 2 
15%  2 1 1 2 2 2 2 1 1 
Extended-distance CT-PCI (74 µm) 
       
100%  4 3 3 4 3 3 3 3 3 
50%  3 3 2 3 3 2 3 3 2 
36%  3 2 2 3 3 2 3 2 2 
25%  3 2 1 2 2 2 2 2 2 
15%  2 1 1 2 2 2 2 1 1 
Extended-distance CT-PCI (111 µm) 
       
100%  3 3 2 4 3 3 3 3 3 
50%  3 3 2 3 3 2 3 3 2 
36%  2 2 2 2 3 2 2 2 2 
25%  1 1 1 2 2 2 2 2 2 
15%  1 1 1 1 1 1 1 1 1 
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5.5 Discussion 
This study shows the promise of CT-DEI, CT-ABI, and extended-distance PCI for in situ 
imaging of tissue scaffolds implanted in pig knee joints. Phase-based X-ray imaging techniques 
have great utility for soft tissue engineering and diagnosis applications, and being non-invasive 
and in situ make them particularly suitable for longitudinal live animal studies as well as for 
possible clinical translation to human trials. The imaging techniques examined in the present 
study produce image contrast based on the X-ray refractive properties of low absorbing materials 
albeit through relatively different mechanisms. In the PCI technique, the sample-to-detector 
propagation distance was found to be a critical factor for achieving desirable image contrast. A 
large propagation distance (~6 m) was shown to be essential for adequate phase contrast and 
visualization of structural features similar to DEI and ABI. Phase-retrieval processing of the PC 
images was also observed to be beneficial and preferable for visualization and interpretation of 
low density features. 
Although the main features of interest, such as the tissue scaffold and surrounding soft 
tissues, were successfully imaged in all three systems investigated, some differences were 
observed among the reconstructed images. Higher sensitivity of DEI and ABI in imaging small 
structural features, as compared to extended-distance PCI, could be employed to assess details of 
tissue repair processes, such as evaluating the quality of tissue construct integration and/or 
interaction with host tissues. In order to achieve a similar level of details, extended-distance PCI 
requires imaging at higher spatial resolutions, which increases the exposure time, scan time, and 
delivered radiation dose. On the other hand, the capability of extended-distance PCI to visualize 
the difference in the density of bulk materials is particularly applicable to monitoring new 
cartilage tissue formation by assessing its bulk resemblance to natural healthy cartilage tissue 
during the repair process. The contrast in extended-distance PC images constitutes of both phase 
and attenuation signals. Therefore, the interface of low density structures and tissues (from the 
phase component) as well as the bulk density difference of various materials (from the 
absorption component) could be visualized. This is an advantage when both types of information 
are of interest for tissue repair assessment. Although the contrast in ABI is also obtained from 
both refraction and absorption signals, the change in material bulk density is not as clear as in 
extended-distance PCI (Fig. 5.2B and C). This may be due to the higher intensity of the 
refraction signal that conceals the absorption signal in the images. 
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The DEI and PCI techniques also offer the potential for quantitative tissue engineering 
assessment. The X-ray refractive index decrement (α) is a material-specific property that can be 
extracted from phase-based images and used as a characterization parameter for soft tissues and 
engineered constructs. In DEI, the refraction image gives the refraction angle (ΔθZ) that arises 
from gradients of the thickness and/or density of different materials and structures, which, if 
employed along with the geometrical information of the features, can return the refractive index 
of distinct materials. In PCI, the pure phase image that returns the specific refractive indices of 
materials can be obtained by performing inline PCI at two or more propagation distances, and 
then using consecutive phase retrieval analysis to obtain pure phase images with extracted 
refractive indices [52, 61]. Although feasible, this technique is not very practical for live animal 
imaging. Collecting projection images at shorter exposure time may be a possible solution to 
address the increased scan time and radiation dose. However, in case of live animal imaging 
where the propagation distance is adjusted by moving the anesthetized animal rather than the 
detector, the application of multiple distance PC imaging becomes risky due to potential 
complications from animal motion. This issue and increased noise to contrast ratio at shorter 
exposure times make multiple distance PCI less practical for live animal imaging compared to 
DEI and ABI. In this case, DEI is preferable over PCI because with a comparable total does it 
requires two sets of scans, during which the location of the object is not changed.  
To identify the most suitable imaging technique(s) for applications to longitudinal live 
animal studies, factors that influence the practicality and safety of the techniques should be 
evaluated in addition to the quality and level of information obtained. These factors include the 
total delivered dose, the rate at which the dose was delivered, imaging scan time, and the ease of 
performing the imaging technique on a living object. Standard CT-ABI delivered an effective 
radiation dose (17.2 mSv) within the range delivered in a clinical abdomen or pelvic CT scan 
(10-20 mSv [62]), while the effective radiation doses delivered by standard CT-DEI (34.5 mSv) 
and extended-distance CT-PCI (30.1 mSv) were slightly higher than that conventionally 
delivered in a clinical PET/CT scan (25 mSv [62]). However, the report of International 
Commission on Radiological Protection (ICRP) [59] indicates absorbed doses up to ~100 mSv 
are low radiation doses at which no tissues show clinically relevant functional deterioration [63]. 
Furthermore, the available literature and clinical experience with radiation therapy show that 
normal tissues exhibit tolerance to much larger radiation doses. For example, bone, 
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temporomandibular joints, and skin tissues have demonstrated total dose tolerance of up to 52, 
65, and 55-70 Gy, respectively, if irradiated over a 4-10 cm2 area [64]. With a tissue weighting 
factor of 0.01 for bone and skin tissues [59], the effective tolerance dose would be 520, 650, and 
550-700 mSv for bone, temporomandibular joint, and skin, respectively. This is in agreement 
with the annual dose limit suggested by the ICRP, i.e. 500 mSv, for skin, hands, and feet [63]. 
Radiation dose is conventionally fractionated and delivered in bearable portions of 1.8-5 Gy (18-
50 mSv equivalent dose) per day of treatment [64, 65]. These reported tolerance doses are based 
on the standard probability of 5% complications within five years after treatment [66]. Overall, 
the total doses delivered by phase-based CT imaging techniques at standard settings (2500 
tomographic projections at 37 µm resolution) do not appear to be largely concerning or 
impractical, particularly for live animal in vivo studies. Nevertheless, the minimally possible 
radiation dose from these systems is always preferred and encouraged for live object imaging.  
The measured dose rates for CT-DEI and CT-ABI (0.2 mGy/s) and extended-distance PCI 
(6.43 mGy/s) were in a range similar to that delivered during conventional clinical radiation 
therapy. Depending on the size of the target area, therapy radiation doses are delivered at a rate 
between 0.27 and 25 mGy/s [67]. Therefore, the dose rate associated with the phase-based 
imaging techniques in this study appears to be practical for live animal imaging. DEI and 
extended-distance PCI delivered a comparable total dose; however, the dose rate was >30× 
larger in extended-distance PCI than with DEI and ABI due to the different monochromator 
reflection plane used in the PCI system. The Si (4,4,0) planes used in DEI and ABI have a small 
reflection bandwidth that reduces the X-ray photon flux and results in a smaller dose rate. In 
extended-distance PCI, the Si (2,2,0) plane is used to gain a higher photon flux and shorter scan 
time through wider reflection bandwidth, which results in a larger dose rate. If a smaller dose 
rate comparable to that of DEI is of interest for extended-distance PCI, Si (4,4,0) or an 
alternative reflection plane can simply be adopted; however, this comes at the cost of increased 
scan time. For instance, using Si (4,4,0) in extended-distance PCI instead of Si (2,2,0) increases 
the scan time from 7.8 to 83 min. The use of Si (4,4,0) in DEI and ABI was necessary to increase 
the sensitivity to of the contrast mechanism, which is not the case for the extended-distance PCI 
technique.  
Among the three imaging techniques examined, extended-distance CT-PCI had the 
shortest scan time (<10 min), which was 37 times shorter than CT-DEI and 19 times shorter than 
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CT-ABI. Faster imaging is highly preferred for practical implementation and clinical translation 
of techniques for live animal or possible human applications. Moreover, extended-distance PCI 
benefits from a simple imaging setup comparable to conventional clinical radiography, while 
CT-DEI and CT-ABI require more technical apparatus. The less demanding extended-distance 
PCI system makes it a more user-friendly technique with easier translation to clinical X-ray 
sources. The CT-DEI technique requires two sets of CT scans during which the object must 
remain still with negligible to no movement to perfectly align the two sets of CT scans for 
obtaining the refraction image. Maintaining the position of a live object throughout the scan time 
could be practically challenging, although the use of an anesthetic may alleviate such concerns. 
Such motion sensitivity is considerably reduced in the CT-ABI technique by collecting only one 
set of CT scan data. Nevertheless, the long scan time in both standard CT-DEI and CT-ABI 
increases the chance of motion artifact production in the images and also imposes discomfort to 
the living object being imaged. One approach to reducing the scan time is to use a higher photon 
flux X-ray source, such as a synchrotron wiggler insertion device [68]. The associated higher 
flux can reduce the scan time by up to 25 times compared to a bend magnet X-ray source (to <12 
and <6 min for CT-DEI and CT-ABI, respectively). This can make the methods more efficient 
and practical for live object imaging. Overall, extended-distance CT-PCI may be more readily 
implementable to live animal imaging at standard CT scan settings. However, standard CT-DEI 
and CT-ABI could also be adapted for practical live animal imaging with improved X-ray 
sources. 
As discussed earlier, the radiation doses delivered by standard CT-DEI, CT-ABI, and 
extended-distance CT-PCI were in a feasible dose range; however, ICRP [59] requires 
consideration of effective dose reduction to 20-100 mSv [63]. The common dose range of 0.001 
to 25 mSv for clinical X-ray scans has been associated with negligible to moderate risk levels 
[62]. The dose of the phase-based imaging methods investigated here (17-34.5 mSv) is 
associated with the low to upper end of the moderate risk level. To implement these imaging 
techniques in live animal studies and possible human trials, action must be further taken to 
reduce the dose. The low dose imaging strategies investigated in this study successfully reduced 
the radiation doses to a risk level of low (10 mSv) to very low (0.3 mSv), which is comparable to 
most clinical X-ray scans [62] while largely preserving the quality and information in the images 
obtained. By applying the low dose imaging strategies, the impractically-long scan times for CT-
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DEI and CT-ABI were reduced to a range from 5-10 mins to <1 h, which is realistic for 
anesthetized live animals. At the settings with the scan time less than 5 min, imaging human 
patients may also become possible. 
Among the three low dose strategies investigated, reducing the number of projections and 
imaging at lower resolution (111 µm pixel size) were shown to be the most effective. These 
approaches reduced the delivered dose and scan time up to 7 and 9 times, respectively, over 
standard CT-DEI, CT-ABI, and extended-distance CT-PCI. The advantage of these approaches is 
the preservation of contrast and image information despite a significant reduction in image 
resolution and the number of tomographic projections. Although low resolution imaging (74 µm 
pixel size) and ROI imaging strategies also reduced the dose and scan time, their combination 
with reduced number of projections achieved reductions in dose and scan time to suitably low 
levels. In all three phase-based imaging techniques, dose and scan time were reduced up to 10 
times when ROI imaging was performed using 15% of the standard number of CT projections. 
The dose and scan time were also reduced up to 15 and 35 times when CT scans were performed 
using 25% of the number of standard projections at 74 µm and 111 µm image pixel sizes. 
Although ROI imaging was the smallest contributor to decreasing radiation dose, it could 
become more effective when relatively-large objects are being imaged and/or if reducing the 
dose and scan time to a minimally reasonable level is critical or preferred, such as in human 
imaging. Depending on the features-of-interest in the samples and the technique used, another 
strategy to further reduce the radiation dose can be decreasing the projection exposure time. By 
reducing the projection exposure time to half in the CT-DEI technique, for example, the 
delivered dose can be reduced by 50%. This strategy was simulated in CT-DEI technique by 
reducing the gray value by 50% in the originally-collected images in CT-DEI-15% projections 
(as the DEI technique showed the highest performance among the others in visualizing scaffold 
at the 15% projection condition (Fig. 5.4)).  Comparison of the reconstructed slices from half-
exposure DEI to that from standard DEI at 15% of projections showed that the image correlation 
is almost in the same level as that for the case of full exposure time. This shows that in the case 
of CT-DEI technique, reduction of the projection exposure time may be feasible for further dose 
reduction. 
  The low dose imaging strategies were most compatible and effective for the CT-DEI 
technique. The strong refraction contrast signal combined with the scatter-free characteristic of 
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DEI made it the most resistant method to impaired signal contrast when low dose strategies were 
applied. This particular feature makes CT-DEI a superior technique for high quality and detailed 
assessment imaging with reasonably low and practical radiation doses. The lack of such a 
mechanism in extended-distance CT-PCI led to greater deterioration of the image quality 
because background noise increased as the number of tomographic projections and image 
resolution decreased. This might be addressed by increasing the sample-to-detector propagation 
distance to increase the intensity of the phase-contrast fringes and compensate for the increased 
background noise. However, there is a limit to this approach depending on the properties of the 
employed imaging station. In BMIT-BM beamline with the vertical and horizontal source sizes 
(σ) of 51 and 173 µm, respectively, and source to sample distance of 21 m, workable propagation 
distance in PCI at 40 keV is limited by the detector resolution and penumbral blurring effect. The 
most suitable propagation length for PCI at 40 keV and 37 µm resolution in BMIT-BM end-
station was found to be in the range of 4.6 to 6 m, based on the method descried in [49]. Beyond 
this range the penumbral blurring effect increasingly dominates the phase fringe width at the 
detector. The given suitable range is associated with the Frensel regime zone of the X-ray wave 
front that gives rise to edge contrast in the phase image and followed by the Fraunhofer regime 
zone where the phase-contrast fringes become blurred and image quality is impaired. Since the 
suitable range for PCI propagation distance is dependent on the properties of imaging end-station 
and setup, it is suggested that the workable propagation distance be calculated for different X-ray 
sources and imaging setups. Where longer propagation distance is an option for an imaging end-
station, it would be interesting to discover the influence of longer propagation distance on the 
background noise increased by applying the low dose strategies.  
5.6 Conclusions 
In this study, synchrotron phase-based X-ray imaging techniques of CT-DEI, CT-ABI, 
and extended-distance CT-PCI have been demonstrated promising for visualizing low density 
scaffolds and soft tissues in situ, thus will facilitate applications to longitudinal non-invasive 
tissue engineering assessments in in vivo animal studies. Low-dose imaging strategies of 
decreasing the number of CT projections, region of interest, and low resolution imaging were 
examined and illustrated effective for reducing the radiation dose and scan time without 
considerable loss of the image quality, owing to the strong image contrast from the synchrotron 
phase-based X-ray imaging techniques. The low-dose imaging strategies reduced the radiation 
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does and scan time to the levels comparable to clinical CT scans and practical for longitudinal 
live animal studies. Compared to other examined techniques, CT-DEI exhibited the highest 
performance and dose efficiency in low-dose imaging. The reduced number of CT projections 
and low resolution imaging were observed to be more effective than other strategy in reducing 
the imaging dose.  
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CHAPTER 6: CONCLUSIONS AND FURTHER RESEARCH 
6.1 Conclusions 
This research was aimed at addressing two key issues: hybrid-construct bioprinting and 
synchrotron-based non-invasive assessment for cartilage tissue engineering. Hybrid constructs 
with solid polymeric and hydrogels components are promising for use in cartilage repair as they 
can provide both biological and biomechanical properties as desired. Fabrication of such hybrid 
constructs is, however, still in its infancy due to the issues related to the structural integrity and 
the functions of cells incorporated in the constructs. One aim of this thesis was to address these 
issues by developing 3D printing biofabrication processes that uses cytocompatible melted-
polymer and soft, low concentration hydrogel for making hybrid cartilage tissue constructs with 
physically stable and biologically conducive properties. Development of such suitable 
fabrication processes make it possible to develop constructs with synergistic properties without 
compromising physical and structural fidelity for biological functionality.    
Synchrotron phase-based X-ray imaging techniques rely on X-ray refraction properties of 
materials, rather than their absorption, for producing image contrast. As such, these techniques 
have shown great promises in imaging soft tissues and biological microstructures in situ. With 
the high penetration depth of X-rays, these methods are promising candidates for non-invasive 
soft tissue engineering monitoring and assessments, thus enabling the longitudinal evaluation of 
animal models and even human patients throughout the repair process without the need to scarify 
the animal and interrupt the repair process. The other aim of this research was to explore various 
phase-based X-ray imaging techniques for developing non-invasive methods appropriate for in 
situ assessments of scaffold-based cartilage and soft tissue engineering strategies. 
 
Followings are the main conclusions drawn from this research:  
1. The 3D printing-based biofabrication process is able to fabricate hybrid cartilage tissue 
constructs with two complementary structural components of solid framework and 
hydrogel matrix, similar to biphasic nature of cartilage tissue, thus providing both 
mechanical and biological supports for the impregnated cells during tissue regeneration. 
2.  The materials properties of both PCL polymer and alginate hydrogel as well as the 
processing conditions (such as dispensing temperatures) were illustrated critical for 
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maintaining the structural integrity and cell functions of the hybrid constructs, and if 
properly determined they enable a cytocompatible hybrid 3D-pritning process that 
preserves cell functions and maintains the structural integrity of the constructs throughout 
the fabrications. 
3. The hybrid constructs developed in this research are able to provide the conducive 
environment for promising biological activities (viability, proliferation, and cartilage 
ECM secretion) of cells during long-term tissue regeneration process in vitro.  
4. The phased-based X-ray imaging techniques of CT-DEI, CT-ABI, and extended-distance 
CT-PCI have been shown suitable for in situ imaging and characterization of low density 
cartilage tissues constructs, moreover with better performance than clinical gold standard 
MRI technique as examined by means of a pig animal model in this research. 
5. It has been demonstrated that the CT-DEI, CT-ABI, and extended-distance CT-PCI 
techniques have the capability for distinctly visualizing tissue constructs, various soft 
tissues, and hard tissues with detailed microstructural features, favorable for non-invasive 
assessment and monitoring applications of cartilage as well as other soft and hard tissues 
engineering repair. 
6. Low dose imaging strategies including lower number of projection CT imaging, region of 
interest imaging, and low resolution imaging, have been developed and successfully 
adopted to the phase-based imaging techniques with reduced effective doses comparable 
to the dose for clinical X-ray scans, and without compromising the image quality. 
7. Among the tested phase-based imaging techniques, CT-DEI exhibited the highest 
performance by maintaining a high image contrast and information at substantially low 
dose imaging settings. In other words, CT-DEI contrast mechanism allowed making the 
best use of reduced number of photons at low dose imaging, and, as such, is the most 
efficient method for substantially low-dose imaging in live animals.   
6.2 Recommendation for future research 
This research has shown the promising biological functionality and chondrogenic matrix 
production of the 3D hybrid constructs by means of the in vitro studies. It is suggested that these 
constructs be further implanted in animal models such as immunodeficient mice, for 
investigating the integrity of the construct and continuation of the cartilage tissue regeneration 
over long term in vivo. Moving forward with in vivo studies, upon obtaining successful results 
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from subcutaneous in vivo cartilage tissue growth in immunocompetent mice the functionality of 
the hybrid constructs can then be investigated for repairing damaged cartilage of load bearing, 
articular joints in larger animal models, such as pig and goat.  Particularly, the effectiveness of 
the hybrid construct strategy over clinically-relevant long term in vivo period (such as 8-10 
month) in large animal models is interesting to be probed in the future. Furthermore, with the 
capability of making customized, defect-matching shape constructs, the 3D hybrid construct 
bioprinting can be explored for repairing complex-shape defects from osteoarthritis in 
osteoarthritic animal models. It is noteworthy to mention that identifying the optimum 
implantation time of the hybrid constructs or the required in vitro culture time before in vivo 
implantation, is important to successful integration with host tissue and the maturation of newly 
regenerated tissue, and is recommended to be searched in the future.  
The biocompatibility of the hybrid 3D bioprinting for incorporating viable cells during 
construct fabrication was demonstrated in this study, suggesting the potential for incorporating 
other biological components, such as bioactive molecules and growth factors, along with the 
cells during construct bioprinting. It would be interesting to explore the 3D hybrid bioprinting 
for localized and spatially designed deposition of bioactive molecules in the 3D construct to 
promote biomimetic, non-uniform cell differentiation (e.g. when mesenchymal stem cells are 
used), and/or ECM formation as seen in the natural cartilage or other spatially-organized tissues 
in the body. This is particularly suggested to be investigated for biomimetic cartilage tissue 
engineering where regenerating zonal structure of cartilage is important for natural-like 
functionality of the new tissue substitute. Designing and biofabricating hybrid constructs that 
have zonal cells and bioactive molecules distribution and/or zonal mechanical stimulation pattern 
(through zonal architectural designs) are suggested to be explored for biomimetic cartilage tissue 
engineering.  To facilitate such biomimetic strategy, it is needed that the mechanical properties 
of the hybrid constructs after fabrication and following abandon cartilage matrix formation be 
investigated for constructs with different architectural designs, with or without mechanical 
stimulations during the culture time. Such comprehensive study will be very beneficial to the 
field and is suggested to be considered in the future research. 
Although the developed hybrid biofabrication process used PCL, alginate and cartilage 
cells as the construct materials, the technique has the capability to use multiple dissimilar 
materials and cells for making complex, heterogeneous tissue constructs. Such potential is worth 
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examining for the regeneration of composite tissues and organs or tissue interfaces made of both 
soft and hard tissues. The developed 3D hybrid biorpinting technique used non-cross-linked, low 
concentration alginate, which is a hydrogel material commonly used in cartilage and soft tissue 
engineering applications. This fabrication method is, however, not limited to the alginate 
hydrogel and has the potential to be used with other soft, non-cross-linked hydrogel materials 
(e.g. hyalouronic acid, gelatin). Further exploration of this hybrid 3D bioprinting method with 
other hydrogel materials suitable for engineering other tissues is suggested for future research.  
In this research, the synchrotron-based X-ray imaging techniques were shown to be 
promising methods for visualization and characterization of soft tissue scaffolds in situ in a 
dissected animal model joint. With the lower dose imaging strategies adopted with these 
techniques, future studies are recommended to investigate these non-invasive methods for 
scaffold and tissue regeneration assessments in live animal models during longitudinal in vivo 
studies. To identify how far non-invasive assessment methods could replace the conventional 
methods for cartilage and soft tissue engineering applications, the level of information that can 
be obtained from non-invasive imaging is urged to be compared with the information obtained 
from the conventional assessment methods.  
This research focused mainly on the qualitative assessment aspects of scaffold imaging. 
However, the presented methods have great potential to be explored in the future for providing 
quantitative information on the scaffold material and the natural and regenerated cartilage tissue 
both in situ and in vitro (e.g. in culture plate or bioreactor). Evaluating the similarity of the 
regenerated cartilage tissue density to that of host healthy tissue in vitro and particularly in vivo, 
studying the degradation profile of tissue scaffolds, and regeneration profile of the newly formed 
tissue by time in vivo during long-term studies using the proposed non-invasive techniques will 
considerably improve cartilage tissue engineering strategies-through design of better materials 
and scaffolds- and improve the current knowledge-state of the tissue engineering repair. Future 
studies are encouraged to apply the presented imaging-based assessment methods to these 
research issues. The combination of non-invasive imaging-based assessments with other 
analyzing methods, such as finite element modeling, is interesting to be explored in order to 
generate more sophisticated evaluation methods such as tracking the change in biomechanical 
properties of scaffold in situ during the repair process.  
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By developing more accessible X-ray sources that can produce X-rays with essential 
synchrotron-X-ray properties, phase-based imaging technique could become more available to a 
wider range of researchers and clinicians in the field of tissue engineering and regenerative 
medicine to perform longitudinal non-invasive assessments. It is recommended that more 
accessible X-ray sources suitable for phase-based X-ray imaging be investigated and developed. 
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Appendix A 
Video of 3D bioprinting process: 3D bioprinting process of creating cell-impregnated 
hybrid tissue constructs by co-deposition of PCL and cell-embedded alginate hydrogel. 
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Appendix B 
Video of 3D synchrotron imaging: 3D volumetric visualization of tissue scaffold and 
soft tissues in a piglet joint in situ using computed tomography diffraction enhanced X-ray 
imaging (CT-DEI). 
